rank	score	disease_name	disease_identifier
1	0.8716	Platelet disorder, familial, with associated myeloid malignancy	OMIM:601399
2	0.8694	Hermansky-Pudlak syndrome 3	OMIM:614072
3	0.8604	Thrombocytopenia, autosomal dominant, 7	OMIM:619130
4	0.8489	Hermansky-Pudlak syndrome 11	OMIM:619172
5	0.8421	Hermansky-Pudlak syndrome 6	OMIM:614075
6	0.8343	Hermansky-Pudlak syndrome 5	OMIM:614074
7	0.788	Hermansky-Pudlak syndrome 2	OMIM:608233
8	0.7818	Hermansky-Pudlak syndrome 4	OMIM:614073
9	0.7764	Glanzmann thrombasthenia 1	OMIM:273800
10	0.7658	Monosomy 7 myelodysplasia and leukemia syndrome 1	OMIM:252270
11	0.7649	Glanzmann thrombasthenia 2	OMIM:619267
12	0.7615	SLC35A1-CDG	ORPHA:238459
13	0.7614	Familial thrombocytosis	ORPHA:71493
13	0.7614	Familial thrombocytosis	ORPHA:71493
13	0.7614	Familial thrombocytosis	ORPHA:71493
16	0.7596	?Hermansky-Pudlak syndrome 9	OMIM:614171
17	0.7556	Chediak-Higashi syndrome	OMIM:214500
18	0.7534	Fanconi anemia, complementation group D1	OMIM:605724
18	0.7534	Gray platelet syndrome	OMIM:139090
20	0.7532	Bleeding disorder, platelet-type, 17	OMIM:187900
21	0.7421	Glanzmann thrombasthenia	ORPHA:849
21	0.7421	Glanzmann thrombasthenia	ORPHA:849
23	0.7418	?Neutropenia, nonimmune chronic idiopathic, of adults	OMIM:607847
24	0.7415	Bleeding disorder, platelet-type, 15	OMIM:615193
25	0.7408	?Erythroleukemia, familial, susceptibility to	OMIM:133180
26	0.7386	Moyamoya disease with early-onset achalasia	ORPHA:401945
27	0.7383	Fanconi anemia, complementation group T	OMIM:616435
28	0.737	AMED syndrome, digenic	OMIM:619151
29	0.7308	Shwachman-Diamond syndrome 1	OMIM:260400
30	0.7293	Bleeding disorder, platelet-type, 24, autosomal dominant	OMIM:619271
31	0.7162	Autosomal dominant severe congenital neutropenia	ORPHA:486
31	0.7162	Autosomal dominant severe congenital neutropenia	ORPHA:486
31	0.7162	Autosomal dominant severe congenital neutropenia	ORPHA:486
31	0.7162	Autosomal dominant severe congenital neutropenia	ORPHA:486
31	0.7162	Autosomal dominant severe congenital neutropenia	ORPHA:486
31	0.7162	Autosomal dominant severe congenital neutropenia	ORPHA:486
37	0.7138	Emberger syndrome	OMIM:614038
38	0.7107	Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to	OMIM:616871
39	0.7104	Bernard-Soulier syndrome	ORPHA:274
39	0.7104	Bernard-Soulier syndrome	ORPHA:274
39	0.7104	Bernard-Soulier syndrome	ORPHA:274
42	0.7098	Monosomy 7 myelodysplasia and leukemia syndrome 2	OMIM:619041
43	0.7096	Bone marrow failure syndrome 3	OMIM:617052
44	0.7095	Bleeding disorder, platelet-type, 21	OMIM:617443
45	0.7066	Wiskott-Aldrich syndrome	ORPHA:906
45	0.7066	Wiskott-Aldrich syndrome	ORPHA:906
47	0.7046	Thrombocythemia 1	OMIM:187950
47	0.7046	Thrombocythemia, somatic	OMIM:187950
47	0.7046	Thrombocythemia, somatic	OMIM:187950
50	0.7019	Ataxia-pancytopenia syndrome	ORPHA:2585
51	0.7006	Thrombocytopenia with beta-thalassemia, X-linked	OMIM:314050
52	0.6987	Congenital disorder of glycosylation, type IIf	OMIM:603585
53	0.6963	Bleeding disorder, platelet-type, 11	OMIM:614201
54	0.6953	Beta-thalassemia-X-linked thrombocytopenia syndrome	ORPHA:231393
55	0.6945	Sweet syndrome	ORPHA:3243
56	0.6944	Dyskeratosis congenita, X-linked	OMIM:305000
57	0.693	LIG4 syndrome	OMIM:606593
58	0.6912	Leukemia, acute myeloid	OMIM:601626
58	0.6912	Leukemia, acute myeloid, somatic	OMIM:601626
58	0.6912	Leukemia, acute myeloid, susceptibility to	OMIM:601626
58	0.6912	Leukemia, acute myeloid, somatic	OMIM:601626
58	0.6912	?Leukemia, acute myeloid	OMIM:601626
58	0.6912	Leukemia, acute myeloid	OMIM:601626
58	0.6912	Acute myeloid leukemia, somatic	OMIM:601626
58	0.6912	Leukemia, acute myeloid, somatic	OMIM:601626
58	0.6912	Leukemia, acute myeloid, reduced survival in, somatic	OMIM:601626
58	0.6912	Leukemia, acute myeloid, somatic	OMIM:601626
58	0.6912	Leukemia, acute myeloid, somatic	OMIM:601626
58	0.6912	Leukemia, acute myeloid	OMIM:601626
58	0.6912	Leukemia, acute myeloid	OMIM:601626
58	0.6912	Leukemia, acute myeloid, somatic	OMIM:601626
58	0.6912	Leukemia, acute myeloid, somatic	OMIM:601626
58	0.6912	Leukemia, acute myeloid, somatic	OMIM:601626
58	0.6912	Leukemia, acute myeloid	OMIM:601626
58	0.6912	Leukemia, acute myeloid	OMIM:601626
76	0.6902	?Bleeding disorder, platelet-type, 22	OMIM:618462
77	0.6891	Bernard-Soulier syndrome, type A2 (dominant)	OMIM:153670
78	0.6881	Quebec platelet disorder	OMIM:601709
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
79	0.6873	Noonan syndrome	ORPHA:648
93	0.6863	Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality	ORPHA:86841
94	0.6854	Glioblastoma 3	OMIM:613029
95	0.684	Bleeding disorder, platelet-type, 16, autosomal dominant	OMIM:187800
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
95	0.684	Diamond-Blackfan anemia	ORPHA:124
123	0.6822	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	OMIM:155100
124	0.6806	Bleeding disorder, platelet-type, 13, susceptibility to	OMIM:614009
125	0.6804	?Bleeding disorder, platelet-type, 18	OMIM:615888
126	0.6797	Shwachman-Diamond syndrome	ORPHA:811
126	0.6797	Shwachman-Diamond syndrome	ORPHA:811
126	0.6797	Shwachman-Diamond syndrome	ORPHA:811
126	0.6797	Shwachman-Diamond syndrome	ORPHA:811
130	0.6796	Deafness, autosomal dominant 1, with or without thrombocytopenia	OMIM:124900
131	0.6757	Macrothrombocytopenia, isolated, 1, autosomal dominant	OMIM:613112
132	0.6723	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	OMIM:618372
132	0.6723	Ellis Van Creveld syndrome	ORPHA:289
132	0.6723	Ellis Van Creveld syndrome	ORPHA:289
132	0.6723	Ellis Van Creveld syndrome	ORPHA:289
132	0.6723	Ellis Van Creveld syndrome	ORPHA:289
132	0.6723	Ellis Van Creveld syndrome	ORPHA:289
132	0.6723	Ellis Van Creveld syndrome	ORPHA:289
139	0.6698	Alpha-thalassemia-myelodysplastic syndrome	ORPHA:231401
140	0.6679	Bloom syndrome	ORPHA:125
141	0.6677	Dubowitz syndrome	ORPHA:235
141	0.6677	Dubowitz syndrome	ORPHA:235
143	0.6659	Essential thrombocythemia	ORPHA:3318
143	0.6659	Essential thrombocythemia	ORPHA:3318
143	0.6659	Essential thrombocythemia	ORPHA:3318
143	0.6659	Essential thrombocythemia	ORPHA:3318
143	0.6659	Essential thrombocythemia	ORPHA:3318
143	0.6659	Essential thrombocythemia	ORPHA:3318
149	0.6648	Thrombocytopenia 5	OMIM:616216
150	0.6643	Neutropenia, severe congenital 3, autosomal recessive	OMIM:610738
151	0.6629	Primary erythromelalgia	ORPHA:90026
151	0.6629	Primary erythromelalgia	ORPHA:90026
151	0.6629	Primary erythromelalgia	ORPHA:90026
154	0.6607	von Willebrand disease, type 3	OMIM:277480
155	0.6586	Hermansky-Pudlak syndrome 7	OMIM:614076
155	0.6586	Hermansky-Pudlak syndrome 8	OMIM:614077
157	0.6562	Leukemia, acute promyelocytic, somatic	OMIM:612376
157	0.6562	Leukemia, acute promyelocytic	OMIM:612376
159	0.6561	Bone marrow failure and diabetes mellitus syndrome	OMIM:620044
160	0.6558	Deafness-lymphedema-leukemia syndrome	ORPHA:3226
161	0.6529	Ataxia-pancytopenia syndrome	OMIM:159550
162	0.6528	Immunodeficiency, common variable, 13	OMIM:616873
163	0.6524	Nijmegen breakage syndrome	ORPHA:647
164	0.6514	LIG4 syndrome	ORPHA:99812
164	0.6514	LIG4 syndrome	ORPHA:99812
166	0.6509	Polycythemia vera	ORPHA:729
166	0.6509	Polycythemia vera	ORPHA:729
166	0.6509	Polycythemia vera	ORPHA:729
169	0.6491	Fanconi anemia, complementation group G	OMIM:614082
170	0.6477	Bleeding disorder, platelet-type, 8	OMIM:609821
171	0.6464	MGAT2-CDG	ORPHA:79329
172	0.6451	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	OMIM:300835
173	0.6448	Leukemia, megakaryoblastic, with or without Down syndrome, somatic	OMIM:190685
174	0.6444	Neutropenia, severe congenital 1, autosomal dominant	OMIM:202700
175	0.6386	Sitosterolemia 1	OMIM:210250
176	0.6356	von Willebrand disease, type 1	OMIM:193400
177	0.6326	Bernard-Soulier syndrome, type A1 (recessive)	OMIM:231200
177	0.6326	Giant platelet disorder, isolated	OMIM:231200
177	0.6326	Bernard-Soulier syndrome, type C	OMIM:231200
180	0.6323	Wolfram syndrome 2	OMIM:604928
181	0.6316	Ch√©diak-Higashi syndrome	ORPHA:167
182	0.6308	Tumor predisposition syndrome 2	OMIM:619975
183	0.6293	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	OMIM:608232
183	0.6293	Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic	OMIM:608232
185	0.6273	Li-Fraumeni syndrome	ORPHA:524
185	0.6273	Li-Fraumeni syndrome	ORPHA:524
185	0.6273	Li-Fraumeni syndrome	ORPHA:524
185	0.6273	Li-Fraumeni syndrome	ORPHA:524
189	0.6263	Fanconi anemia, complementation group A	OMIM:227650
189	0.6263	Fanconi anemia, complementation group E	OMIM:600901
191	0.6254	CHIME syndrome	ORPHA:3474
191	0.6254	Nasu-Hakola disease	ORPHA:2770
191	0.6254	Nasu-Hakola disease	ORPHA:2770
194	0.6238	Ataxia-telangiectasia	OMIM:208900
195	0.6224	Chronic myeloid leukemia	ORPHA:521
195	0.6224	Chronic myeloid leukemia	ORPHA:521
195	0.6224	Chronic myeloid leukemia	ORPHA:521
198	0.6195	Chronic visceral acid sphingomyelinase deficiency	ORPHA:77293
199	0.6172	Fanconi anemia, complementation group C	OMIM:227645
199	0.6172	Fanconi anemia, complementation group D2	OMIM:227646
201	0.616	CHIME syndrome	OMIM:280000
202	0.6123	Myeloproliferative disorder with eosinophilia	OMIM:131440
203	0.611	?Immunodeficiency 81	OMIM:619374
204	0.6095	Leukemia, acute lymphoblastic, somatic	OMIM:613065
204	0.6095	Leukemia, T-cell acute lymphoblastic, somatic	OMIM:613065
204	0.6095	Leukemia, acute lymphoblastic	OMIM:613065
204	0.6095	Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic	OMIM:613065
204	0.6095	T-cell acute lymphoblastic leukemia, somatic	OMIM:613065
204	0.6095	Leukemia, acute lymphoblastic, somatic	OMIM:613065
204	0.6095	Leukemia, T-cell acute lymphocytic, somatic	OMIM:613065
204	0.6095	Leukemia, T-cell acute lymphocytic, somatic	OMIM:613065
212	0.6065	Aicardi-Gouti√®res syndrome	ORPHA:51
212	0.6065	Aicardi-Gouti√®res syndrome	ORPHA:51
212	0.6065	Aicardi-Gouti√®res syndrome	ORPHA:51
212	0.6065	Aicardi-Gouti√®res syndrome	ORPHA:51
212	0.6065	Aicardi-Gouti√®res syndrome	ORPHA:51
212	0.6065	Aicardi-Gouti√®res syndrome	ORPHA:51
212	0.6065	Aicardi-Gouti√®res syndrome	ORPHA:51
212	0.6065	Aicardi-Gouti√®res syndrome	ORPHA:51
220	0.6062	Porphyria due to ALA dehydratase deficiency	ORPHA:100924
221	0.6055	Bloom syndrome	OMIM:210900
222	0.6029	Congenital factor XIII deficiency	ORPHA:331
222	0.6029	Congenital factor XIII deficiency	ORPHA:331
224	0.6025	Macroglobulinemia, Waldenstrom, somatic	OMIM:153600
225	0.6005	Syndromic recessive X-linked ichthyosis	ORPHA:281090
226	0.5994	RAS-associated autoimmune leukoproliferative disorder	OMIM:614470
226	0.5994	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic	OMIM:614470
228	0.5989	Pseudohypoparathyroidism type 1A	ORPHA:79443
229	0.5987	Agammaglobulinemia 8B, autosomal recessive	OMIM:619824
230	0.5942	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 1	OMIM:614742
231	0.5916	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	OMIM:607685
232	0.5913	Myelofibrosis, somatic	OMIM:254450
232	0.5913	Myelofibrosis with myeloid metaplasia, somatic	OMIM:254450
232	0.5913	Myelofibrosis, somatic	OMIM:254450
232	0.5913	Myelofibrosis, somatic	OMIM:254450
236	0.5884	Noonan syndrome 1	OMIM:163950
237	0.5878	Noonan syndrome 2	OMIM:605275
238	0.5868	Mosaic variegated aneuploidy syndrome	ORPHA:1052
238	0.5868	Mosaic variegated aneuploidy syndrome	ORPHA:1052
238	0.5868	Mosaic variegated aneuploidy syndrome	ORPHA:1052
238	0.5868	Mosaic variegated aneuploidy syndrome	ORPHA:1052
238	0.5868	Mosaic variegated aneuploidy syndrome	ORPHA:1052
243	0.5835	Waldenstr√∂m macroglobulinemia	ORPHA:33226
244	0.5819	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 4	OMIM:619951
245	0.5814	Mismatch repair cancer syndrome 2	OMIM:619096
246	0.5792	Immunodeficiency 21	OMIM:614172
247	0.5784	Rothmund-Thomson syndrome type 2	ORPHA:221016
248	0.5778	Bartter syndrome, type 2	OMIM:241200
249	0.5747	Rothmund-Thomson syndrome type 1	ORPHA:221008
250	0.5718	Microcephaly-lymphedema-chorioretinopathy syndrome	ORPHA:2526
251	0.5697	Noonan syndrome 6	OMIM:613224
252	0.5687	Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria	ORPHA:99646
253	0.5641	Sotos syndrome	ORPHA:821
253	0.5641	Sotos syndrome	ORPHA:821
253	0.5641	Sotos syndrome	ORPHA:821
256	0.5635	Li-Fraumeni syndrome	OMIM:151623
257	0.5601	Rubinstein-Taybi syndrome 1	OMIM:180849
258	0.5589	Immunodeficiency 36	OMIM:616005
259	0.5537	Thrombocytopenia 2	OMIM:188000
260	0.5535	MYH9-related disease	ORPHA:182050
261	0.5502	Legius syndrome	ORPHA:137605
262	0.549	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	OMIM:602501
263	0.5474	Mosaic variegated aneuploidy syndrome 1	OMIM:257300
264	0.5467	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	OMIM:613563
265	0.5444	Tatton-Brown-Rahman syndrome	ORPHA:404443
266	0.543	Mismatch repair cancer syndrome 1	OMIM:276300
267	0.5428	Retinoblastoma, trilateral	OMIM:180200
268	0.542	Noonan syndrome 3	OMIM:609942
268	0.542	?Juvenile myelomonocytic leukemia	OMIM:607785
268	0.542	Leukemia, juvenile myelomonocytic, somatic	OMIM:607785
268	0.542	Leukemia, juvenile myelomonocytic	OMIM:607785
268	0.542	Leukemia, juvenile myelomonocytic, somatic	OMIM:607785
273	0.5415	Glioma susceptibility 9	OMIM:616568
274	0.54	Lathosterolosis	ORPHA:46059
275	0.5283	DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome	ORPHA:494444
276	0.5272	17q11 microdeletion syndrome	ORPHA:97685
277	0.5258	Thrombocytopenia 4	OMIM:612004
278	0.5252	Turcot syndrome with polyposis	ORPHA:99818
279	0.5243	Pelger-Huet anomaly	OMIM:169400
280	0.5233	Takenouchi-Kosaki syndrome	OMIM:616737
280	0.5233	Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome	ORPHA:487796
282	0.5198	Thrombocytopenia 3	OMIM:273900
283	0.5186	Spherocytosis, type 5	OMIM:612690
284	0.5182	Schinzel-Giedion syndrome	ORPHA:798
285	0.5144	Intestinal pseudoobstruction, neuronal	OMIM:300048
286	0.5099	Congenital disorder of glycosylation, type IIg	OMIM:611209
287	0.5042	?IVIC syndrome	OMIM:147750
287	0.5042	IVIC syndrome	ORPHA:2307
289	0.5037	Platelet glycoprotein IV deficiency	OMIM:608404
290	0.5035	Lathosterolosis	OMIM:607330
291	0.5025	Gray platelet syndrome	ORPHA:721
292	0.5019	Atelis syndrome 1	OMIM:620184
293	0.5003	Wiskott-Aldrich syndrome	OMIM:301000
293	0.5003	Systemic lupus erythematosus, susceptibility to	OMIM:152700
293	0.5003	Systemic lupus erythematosus, susceptibility to	OMIM:152700
293	0.5003	Lupus nephritis, susceptibility to	OMIM:152700
293	0.5003	Systemic lupus erythematosus susceptibility to	OMIM:152700
293	0.5003	Systemic lupus erythematosus, susceptibility to	OMIM:152700
293	0.5003	Systemic lupus erythematosus, susceptibility to	OMIM:152700
300	0.4998	Thrombocytopenia, X-linked, intermittent	OMIM:313900
301	0.4992	Systemic lupus erythematosus 17	OMIM:301080
302	0.4987	Syndromic diarrhea	ORPHA:84064
302	0.4987	Syndromic diarrhea	ORPHA:84064
304	0.4984	Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia	OMIM:617718
305	0.4963	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7	OMIM:620365
306	0.4961	?Anemia, sideroblastic, 5	OMIM:619523
307	0.496	Juvenile arthritis	OMIM:618795
308	0.4958	Gaucher disease, type I	OMIM:230800
309	0.4942	Specific granule deficiency 2	OMIM:617475
310	0.494	Autoinflammatory syndrome, familial, Behcet-like 1	OMIM:616744
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
311	0.4918	Fanconi anemia	ORPHA:84
333	0.4912	Adams-Oliver syndrome	ORPHA:974
333	0.4912	Adams-Oliver syndrome	ORPHA:974
333	0.4912	Adams-Oliver syndrome	ORPHA:974
333	0.4912	Adams-Oliver syndrome	ORPHA:974
333	0.4912	Adams-Oliver syndrome	ORPHA:974
333	0.4912	Adams-Oliver syndrome	ORPHA:974
339	0.491	Retinitis pigmentosa and erythrocytic microcytosis	OMIM:616959
340	0.4907	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
340	0.4907	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
340	0.4907	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
340	0.4907	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
340	0.4907	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
340	0.4907	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
346	0.4904	Bone marrow failure syndrome 2	OMIM:615715
347	0.489	Stevens-Johnson syndrome	ORPHA:36426
347	0.489	Stevens-Johnson syndrome	ORPHA:36426
349	0.4887	Fanconi anemia, complementation group B	OMIM:300514
350	0.4886	?Pontocerebellar hypoplasia, type 15	OMIM:619302
351	0.4882	Sea-blue histiocyte disease	OMIM:269600
351	0.4882	Pontocerebellar hypoplasia, type 14	OMIM:619301
353	0.4881	Thrombocytopenia, congenital amegakaryocytic	OMIM:604498
354	0.4879	VEXAS syndrome, somatic	OMIM:301054
355	0.4858	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	OMIM:300367
356	0.4849	Bone marrow failure syndrome 4	OMIM:618116
357	0.4848	Imerslund-Gr√§sbeck syndrome	ORPHA:35858
357	0.4848	Imerslund-Gr√§sbeck syndrome	ORPHA:35858
359	0.4847	Trichohepatoenteric syndrome 1	OMIM:222470
359	0.4847	Agammaglobulinemia 9, autosomal recessive	OMIM:619693
361	0.4845	Thiamine-responsive megaloblastic anemia syndrome	ORPHA:49827
361	0.4845	Phosphoglycerate dehydrogenase deficiency	OMIM:601815
363	0.4844	Megaloblastic anemia due to dihydrofolate reductase deficiency	OMIM:613839
364	0.4828	Dyskeratosis congenita, autosomal dominant 3	OMIM:613990
365	0.4825	Cerebroretinal microangiopathy with calcifications and cysts	OMIM:612199
366	0.4824	Diamond-Blackfan anemia 1	OMIM:105650
367	0.4815	Wiskott-Aldrich syndrome 2	OMIM:614493
367	0.4815	Schimke immuno-osseous dysplasia	ORPHA:1830
369	0.4812	Polycythemia vera, somatic	OMIM:263300
370	0.481	Ghosal hematodiaphyseal syndrome	OMIM:231095
371	0.4809	Jacobsen syndrome	ORPHA:2308
372	0.4808	Wolfram syndrome 1	OMIM:222300
373	0.4807	Cernunnos-XLF deficiency	ORPHA:169079
374	0.4806	Shwachman-Diamond syndrome 2	OMIM:617941
375	0.4804	Thiamine-responsive megaloblastic anemia syndrome	OMIM:249270
376	0.4803	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	OMIM:605432
377	0.48	Immunodeficiency 40	OMIM:616433
378	0.4791	Isovaleric acidemia	OMIM:243500
379	0.4786	Dyskeratosis congenita, autosomal dominant 2	OMIM:613989
380	0.478	Dyskeratosis congenita, autosomal recessive 2	OMIM:613987
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
381	0.4777	Acute promyelocytic leukemia	ORPHA:520
394	0.4773	Gastrointestinal defects and immunodeficiency syndrome	OMIM:243150
395	0.4771	Neutropenia, severe congenital, 5, autosomal recessive	OMIM:615285
395	0.4771	?Braddock-Carey syndrome 2	OMIM:619981
397	0.4765	Congenital disorder of glycosylation, type IIw	OMIM:619525
398	0.4759	Gaucher disease, type II	OMIM:230900
398	0.4759	Osteopetrosis, autosomal recessive 8	OMIM:615085
400	0.4757	Immunodeficiency 46	OMIM:616740
401	0.4756	Fanconi anemia, complementation group F	OMIM:603467
401	0.4756	Vitamin B12-unresponsive methylmalonic acidemia type mut0	ORPHA:289916
403	0.4755	?Thrombocytopenia, anemia, and myelofibrosis	OMIM:617441
403	0.4755	Folate malabsorption, hereditary	OMIM:229050
405	0.4754	?Bleeding disorder, platelet-type, 19	OMIM:616176
406	0.4753	?Dyskeratosis congenita, autosomal recessive 1	OMIM:224230
407	0.475	Idiopathic aplastic anemia	ORPHA:88
407	0.475	Idiopathic aplastic anemia	ORPHA:88
407	0.475	Idiopathic aplastic anemia	ORPHA:88
407	0.475	Idiopathic aplastic anemia	ORPHA:88
411	0.4747	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	OMIM:616738
411	0.4747	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	OMIM:304790
411	0.4747	Gaucher disease, type III	OMIM:231000
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
414	0.4743	Dyskeratosis congenita	ORPHA:1775
426	0.4742	Aicardi-Goutieres syndrome 6	OMIM:615010
426	0.4742	Porphyria, congenital erythropoietic	OMIM:263700
428	0.4741	Hereditary folate malabsorption	ORPHA:90045
429	0.474	Schimke immunoosseous dysplasia	OMIM:242900
430	0.4734	Osteopetrosis, autosomal recessive 2	OMIM:259710
431	0.4732	Osteopetrosis, autosomal recessive 4	OMIM:611490
432	0.4729	Diamond-Blackfan anemia 21	OMIM:620072
432	0.4729	Aicardi-Goutieres syndrome 1, dominant and recessive	OMIM:225750
432	0.4729	Pseudo-TORCH syndrome 1	OMIM:251290
435	0.4727	Thrombocythemia 3	OMIM:614521
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
436	0.4724	Systemic lupus erythematosus	ORPHA:536
466	0.4722	Alport syndrome 1, X-linked	OMIM:301050
466	0.4722	Mitochondrial complex III deficiency, nuclear type 10	OMIM:618775
468	0.4718	Roberts syndrome	ORPHA:3103
469	0.4717	Prolidase deficiency	OMIM:170100
470	0.4715	Immunodeficiency 10	OMIM:612783
471	0.4714	Sea-blue histiocytosis	ORPHA:158029
472	0.4712	Asplenia, isolated congenital	OMIM:271400
473	0.4709	Primary myelofibrosis	ORPHA:824
473	0.4709	Primary myelofibrosis	ORPHA:824
473	0.4709	Primary myelofibrosis	ORPHA:824
473	0.4709	Primary myelofibrosis	ORPHA:824
473	0.4709	?Thrombocytopenia 6	OMIM:616937
478	0.4708	MIRAGE syndrome	OMIM:617053
479	0.4706	DOORS syndrome	ORPHA:79500
479	0.4706	DOORS syndrome	ORPHA:79500
479	0.4706	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked	OMIM:301056
482	0.4705	Lymphoproliferative syndrome 1	OMIM:613011
483	0.4695	?Fanconi anemia, complementation group V	OMIM:617243
484	0.4694	Nijmegen breakage syndrome	OMIM:251260
484	0.4694	Pseudo-TORCH syndrome 3	OMIM:618886
484	0.4694	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome	OMIM:620005
484	0.4694	Immunodeficiency, common variable, 8, with autoimmunity	OMIM:614700
488	0.4693	Dehydrated hereditary stomatocytosis 2	OMIM:616689
489	0.4691	Gaucher disease type 1	ORPHA:77259
489	0.4691	Gaucher disease type 1	ORPHA:77259
491	0.4689	Thrombocythemia 2	OMIM:601977
492	0.4681	Noonan syndrome 4	OMIM:610733
493	0.468	Congenital amegakaryocytic thrombocytopenia	ORPHA:3319
493	0.468	Congenital amegakaryocytic thrombocytopenia	ORPHA:3319
495	0.4678	Celiac disease, susceptibility to	OMIM:212750
495	0.4678	Celiac disease, susceptibility to	OMIM:212750
497	0.4673	Noonan syndrome 12	OMIM:618624
498	0.467	Wilson disease	ORPHA:905
499	0.4669	?Immunodeficiency 22	OMIM:615758
500	0.4667	Osteopetrosis, autosomal recessive 1	OMIM:259700
501	0.4664	Gaucher disease, atypical	OMIM:610539
502	0.4661	Immunodeficiency 14B, autosomal recessive	OMIM:619281
502	0.4661	Gaucher disease type 3	ORPHA:77261
504	0.4658	Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders	ORPHA:505248
505	0.4657	Mucopolysaccharidosis-plus syndrome	OMIM:617303
506	0.4656	Immunodeficiency 92	OMIM:619652
506	0.4656	Hepatic veno-occlusive disease-immunodeficiency syndrome	ORPHA:79124
508	0.4654	Osteopetrosis with renal tubular acidosis	ORPHA:2785
508	0.4654	Transcobalamin deficiency	ORPHA:859
508	0.4654	Fetal Gaucher disease	ORPHA:85212
511	0.4653	Lymphoproliferative syndrome, X-linked, 1	OMIM:308240
512	0.4652	Aicardi-Goutieres syndrome 3	OMIM:610329
512	0.4652	Neurodevelopmental disorder with epilepsy and hemochromatosis	OMIM:301072
512	0.4652	Portal hypertension, noncirrhotic, 2	OMIM:619463
515	0.465	Transaldolase deficiency	OMIM:606003
515	0.465	Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome	ORPHA:2072
517	0.4648	Inflammatory bowel disease, immunodeficiency, and encephalopathy	OMIM:618213
518	0.4647	Sickle cell anemia	ORPHA:232
519	0.4639	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	OMIM:617780
520	0.4635	RECON progeroid syndrome	OMIM:620370
521	0.4632	Thrombocytopenia-absent radius syndrome	ORPHA:3320
522	0.4625	Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia	OMIM:619005
523	0.4623	Stormorken syndrome	OMIM:185070
523	0.4623	3-methylglutaconic aciduria, type VIIB, autosomal recessive	OMIM:616271
525	0.4621	Vitamin B12-unresponsive methylmalonic acidemia type mut-	ORPHA:79312
526	0.4619	Hemophagocytic lymphohistiocytosis, familial, 4	OMIM:603552
526	0.4619	Dursun syndrome	OMIM:612541
528	0.4616	Lysyl hydroxylase 3 deficiency	OMIM:612394
529	0.4614	Aicardi-Goutieres syndrome 4	OMIM:610333
530	0.4612	Tufted angioma	ORPHA:1063
531	0.4608	Albers-Sch√∂nberg osteopetrosis	ORPHA:53
532	0.4606	?Immunodeficiency 69, mycobacteriosis	OMIM:618963
533	0.4605	Autoinflammation with infantile enterocolitis	OMIM:616050
534	0.4599	22q11.2 deletion syndrome	ORPHA:567
534	0.4599	22q11.2 deletion syndrome	ORPHA:567
534	0.4599	22q11.2 deletion syndrome	ORPHA:567
534	0.4599	22q11.2 deletion syndrome	ORPHA:567
534	0.4599	22q11.2 deletion syndrome	ORPHA:567
534	0.4599	22q11.2 deletion syndrome	ORPHA:567
534	0.4599	22q11.2 deletion syndrome	ORPHA:567
534	0.4599	22q11.2 deletion syndrome	ORPHA:567
534	0.4599	22q11.2 deletion syndrome	ORPHA:567
543	0.4598	Niemann-Pick disease, type B	OMIM:607616
544	0.4596	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	OMIM:615688
544	0.4596	Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome	ORPHA:391487
544	0.4596	Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome	ORPHA:391487
547	0.4595	Periodic fever, immunodeficiency, and thrombocytopenia syndrome	OMIM:150550
547	0.4595	STING-associated vasculopathy, infantile-onset	OMIM:615934
547	0.4595	Immunodeficiency 98 with autoinflammation, X-linked	OMIM:301078
550	0.4594	Alpha-thalassemia myelodysplasia syndrome, somatic	OMIM:300448
550	0.4594	COG4-CDG	ORPHA:263501
550	0.4594	Thrombocytopenia-absent radius syndrome	OMIM:274000
553	0.4591	Aicardi-Goutieres syndrome 7	OMIM:615846
554	0.4588	Intermediate osteopetrosis	ORPHA:210110
554	0.4588	Intermediate osteopetrosis	ORPHA:210110
554	0.4588	Intermediate osteopetrosis	ORPHA:210110
557	0.4584	Paroxysmal nocturnal hemoglobinuria	ORPHA:447
558	0.4583	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	OMIM:226990
559	0.4582	Severe combined immunodeficiency due to complete RAG1/2 deficiency	ORPHA:331206
559	0.4582	Severe combined immunodeficiency due to complete RAG1/2 deficiency	ORPHA:331206
559	0.4582	Immunodeficiency 47	OMIM:300972
562	0.4581	Autoinflammatory syndrome, familial, X-linked, Behcet-like 2	OMIM:301074
562	0.4581	Hydrops, lactic acidosis, and sideroblastic anemia	OMIM:617021
562	0.4581	?Proteasome-associated autoinflammatory syndrome 3 and digenic forms	OMIM:617591
562	0.4581	?Proteasome-associated autoinflammatory syndrome 3, digenic	OMIM:617591
566	0.4579	Osteopetrosis, autosomal recessive 5	OMIM:259720
566	0.4579	Autoimmune lymphoproliferative syndrome, type II	OMIM:603909
568	0.4578	Immunodeficiency 87 and autoimmunity	OMIM:619573
569	0.4576	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
569	0.4576	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
569	0.4576	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
569	0.4576	Proteasome-associated autoinflammatory syndrome 2	OMIM:618048
569	0.4576	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
574	0.4574	Ogden syndrome	OMIM:300855
575	0.4571	Congenital disorder of glycosylation, type IIl	OMIM:614576
576	0.4569	Thrombocytopenia with congenital dyserythropoietic anemia	ORPHA:67044
576	0.4569	Sarcoidosis	ORPHA:797
576	0.4569	Sarcoidosis	ORPHA:797
579	0.4568	von Willebrand disease, types 2A, 2B, 2M, and 2N	OMIM:613554
579	0.4568	Moyamoya 6 with achalasia	OMIM:615750
579	0.4568	Bilateral striopallidodentate calcinosis	ORPHA:1980
579	0.4568	Aicardi-Goutieres syndrome 5	OMIM:612952
579	0.4568	Bleeding disorder, platelet-type, 20	OMIM:616913
579	0.4568	Bilateral striopallidodentate calcinosis	ORPHA:1980
579	0.4568	Bilateral striopallidodentate calcinosis	ORPHA:1980
579	0.4568	Stuve-Wiedemann syndrome 2	OMIM:619751
579	0.4568	Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome	ORPHA:457351
579	0.4568	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities	OMIM:616577
579	0.4568	Congenital disorder of glycosylation, type Ix	OMIM:615597
579	0.4568	STT3B-CDG	ORPHA:370924
579	0.4568	Cornelia de Lange syndrome 1	OMIM:122470
579	0.4568	Bilateral striopallidodentate calcinosis	ORPHA:1980
579	0.4568	Bilateral striopallidodentate calcinosis	ORPHA:1980
579	0.4568	Bilateral striopallidodentate calcinosis	ORPHA:1980
579	0.4568	Immune thrombocytopenia	ORPHA:3002
596	0.4564	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease	OMIM:613101
597	0.4561	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	OMIM:604416
597	0.4561	Lysinuric protein intolerance	OMIM:222700
599	0.456	Omenn syndrome	OMIM:603554
599	0.456	Omenn syndrome	OMIM:603554
599	0.456	Omenn syndrome	OMIM:603554
602	0.4556	Congenital erythropoietic porphyria	ORPHA:79277
602	0.4556	Congenital erythropoietic porphyria	ORPHA:79277
602	0.4556	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	OMIM:613845
605	0.4552	Propionicacidemia	OMIM:606054
605	0.4552	Propionicacidemia	OMIM:606054
607	0.4551	Immunodeficiency, X-linked, with hyper-IgM	OMIM:308230
608	0.4548	X-linked agammaglobulinemia	ORPHA:47
609	0.4543	Epilepsy, progressive myoclonic 4, with or without renal failure	OMIM:254900
610	0.454	Immunodeficiency, common variable, 12	OMIM:616576
611	0.4538	ALG12-CDG	ORPHA:79324
612	0.4534	Immunodeficiency 91 and hyperinflammation	OMIM:619644
613	0.4532	Tangier disease	ORPHA:31150
613	0.4532	Combined oxidative phosphorylation deficiency 14	OMIM:614946
615	0.453	ALG8-CDG	ORPHA:79325
616	0.4526	Methylmalonic aciduria, vitamin B12-responsive, cblB type	OMIM:251110
616	0.4526	Methylmalonic aciduria, vitamin B12-responsive, cblA type	OMIM:251100
618	0.4525	Farber disease	ORPHA:333
619	0.4523	Mevalonic aciduria	OMIM:610377
619	0.4523	Gaucher disease, perinatal lethal	OMIM:608013
621	0.4519	Cyclic neutropenia	ORPHA:2686
622	0.4517	Immunodeficiency 27A, mycobacteriosis, AR	OMIM:209950
623	0.4516	Nephrotic syndrome, type 7	OMIM:615008
623	0.4516	Hemolytic uremic syndrome, atypical, susceptibility to, 7	OMIM:615008
625	0.4513	Hypertension, pregnancy-induced	OMIM:189800
626	0.4509	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	OMIM:300853
627	0.4506	Methylmalonic aciduria, mut(0) type	OMIM:251000
628	0.4496	Anemia, sideroblastic, 4	OMIM:182170
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Cholesteryl ester storage disease	OMIM:278000
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
629	0.4494	Common variable immunodeficiency	ORPHA:1572
642	0.4489	Methylmalonic aciduria and homocystinuria, cblF type	OMIM:277380
643	0.4485	Hemolytic uremic syndrome, atypical, susceptibility to, 5	OMIM:612925
643	0.4485	Hemolytic uremic syndrome, atypical, susceptibility to, 6	OMIM:612926
643	0.4485	Hemolytic uremic syndrome, atypical, susceptibility to, 3	OMIM:612923
643	0.4485	Hemolytic uremic syndrome, atypical, susceptibility to, 2	OMIM:612922
643	0.4485	Hemolytic uremic syndrome, atypical, susceptibility to, 4	OMIM:612924
648	0.4484	Immunodeficiency 97 with autoinflammation	OMIM:619802
648	0.4484	3-hydroxy-3-methylglutaric aciduria	ORPHA:20
650	0.4479	von Willebrand disease, platelet-type	OMIM:177820
650	0.4479	Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome	ORPHA:71289
650	0.4479	Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome	ORPHA:71289
653	0.4473	MOGS-CDG	ORPHA:79330
654	0.4469	Hemolytic uremic syndrome, atypical, susceptibility to, 1	OMIM:235400
654	0.4469	Hemolytic uremic syndrome, atypical, susceptibility to	OMIM:235400
654	0.4469	Hemolytic uremic syndrome, atypical, susceptibility to	OMIM:235400
657	0.4467	Heme oxygenase-1 deficiency	OMIM:614034
658	0.4466	Omenn syndrome	ORPHA:39041
658	0.4466	Omenn syndrome	ORPHA:39041
658	0.4466	Omenn syndrome	ORPHA:39041
658	0.4466	Omenn syndrome	ORPHA:39041
658	0.4466	Omenn syndrome	ORPHA:39041
658	0.4466	Omenn syndrome	ORPHA:39041
658	0.4466	Omenn syndrome	ORPHA:39041
658	0.4466	Omenn syndrome	ORPHA:39041
666	0.4465	Smith-Kingsmore syndrome	OMIM:616638
667	0.4464	Thrombotic thrombocytopenic purpura, hereditary	OMIM:274150
668	0.4461	Hemophagocytic lymphohistiocytosis, familial, 2	OMIM:603553
669	0.4458	DiGeorge syndrome	OMIM:188400
669	0.4458	Sengers syndrome	OMIM:212350
671	0.4453	Overhydrated hereditary stomatocytosis	ORPHA:3203
672	0.4452	Congenital disorder of glycosylation, type Ih	OMIM:608104
673	0.4449	Atelis syndrome 2	OMIM:620185
674	0.4445	Preeclampsia	ORPHA:275555
674	0.4445	Preeclampsia	ORPHA:275555
674	0.4445	Preeclampsia	ORPHA:275555
677	0.4444	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6	OMIM:619767
678	0.4441	Interstitial lung and liver disease	OMIM:615486
678	0.4441	Holocarboxylase synthetase deficiency	OMIM:253270
678	0.4441	Holocarboxylase synthetase deficiency	ORPHA:79242
681	0.4439	Autosomal dominant hyper-IgE syndrome	ORPHA:2314
681	0.4439	Autosomal dominant hyper-IgE syndrome	ORPHA:2314
683	0.4435	Pseudo-TORCH syndrome 2	OMIM:617397
683	0.4435	Methylmalonic aciduria and homocystinuria, cblJ type	OMIM:614857
685	0.4434	Transaldolase deficiency	ORPHA:101028
685	0.4434	Congenital disorder of glycosylation, type IIk	OMIM:614727
687	0.443	Beta-ketothiolase deficiency	ORPHA:134
687	0.443	?Immunodeficiency 53	OMIM:617585
689	0.4427	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	OMIM:256040
690	0.4426	Bone marrow failure syndrome 1	OMIM:614675
691	0.4425	Hardikar syndrome	OMIM:301068
692	0.4423	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	OMIM:226300
693	0.4417	Macrocytic anemia, refractory, due to 5q deletion, somatic	OMIM:153550
694	0.4416	Congenital disorder of glycosylation, type Ia	OMIM:212065
695	0.4409	Immunodeficiency due to purine nucleoside phosphorylase deficiency	OMIM:613179
695	0.4409	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	OMIM:614868
697	0.4407	Mitochondrial complex I deficiency, nuclear type 20	OMIM:611126
698	0.4406	Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome	ORPHA:477814
699	0.4404	Arthrogryposis, renal dysfunction, and cholestasis 1	OMIM:208085
700	0.4403	Autoinflammatory syndrome, familial, with or without immunodeficiency	OMIM:619375
701	0.4397	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	OMIM:617710
702	0.4393	WARS2-related combined oxidative phosphorylation defect	ORPHA:572798
703	0.4392	Lymphoproliferative syndrome 2	OMIM:615122
704	0.4391	Wilson disease	OMIM:277900
705	0.439	Autoimmune disease, multisystem, infantile-onset, 2	OMIM:617006
706	0.4389	T-B+ severe combined immunodeficiency due to gamma chain deficiency	ORPHA:276
707	0.4388	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	OMIM:251880
708	0.4383	Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency	ORPHA:436159
709	0.4378	Methylmalonic aciduria and homocystinuria, cblC type, digenic	OMIM:277400
709	0.4378	Arthrogryposis multiplex congenita 5	OMIM:618947
709	0.4378	Methylmalonic aciduria and homocystinuria, cblC type	OMIM:277400
712	0.4374	Methylmalonic acidemia with homocystinuria, type cblC	ORPHA:79282
713	0.4373	Hereditary spherocytosis	ORPHA:822
713	0.4373	Hereditary spherocytosis	ORPHA:822
713	0.4373	Hereditary spherocytosis	ORPHA:822
713	0.4373	Hereditary spherocytosis	ORPHA:822
713	0.4373	Hereditary spherocytosis	ORPHA:822
718	0.4363	Orotic aciduria	OMIM:258900
719	0.4361	Combined immunodeficiency due to ZAP70 deficiency	ORPHA:911
719	0.4361	Autoimmune disease, multisystem, infantile-onset, 1	OMIM:615952
721	0.436	Spherocytosis, type 2	OMIM:616649
722	0.4352	SCID, autosomal recessive, T-negative/B-positive type	OMIM:600802
723	0.4351	Immunodeficiency 55	OMIM:617827
724	0.435	Classic mycosis fungoides	ORPHA:2584
724	0.435	Classic mycosis fungoides	ORPHA:2584
724	0.435	Classic mycosis fungoides	ORPHA:2584
727	0.4347	Immunodeficiency 24	OMIM:615897
728	0.4341	Immunodeficiency 23	OMIM:615816
729	0.434	Autosomal recessive polycystic kidney disease	ORPHA:731
729	0.434	Lymphoproliferative syndrome 3	OMIM:618261
729	0.434	Autosomal recessive polycystic kidney disease	ORPHA:731
732	0.4337	Overhydrated hereditary stomatocytosis	OMIM:185000
733	0.4332	Liver disease, severe congenital	OMIM:619991
734	0.4328	PGM3-CDG	ORPHA:443811
735	0.4323	Hereditary elliptocytosis	ORPHA:288
735	0.4323	Hereditary elliptocytosis	ORPHA:288
735	0.4323	Hereditary elliptocytosis	ORPHA:288
735	0.4323	Hereditary elliptocytosis	ORPHA:288
739	0.4322	Rh deficiency syndrome	ORPHA:71275
739	0.4322	Rh deficiency syndrome	ORPHA:71275
739	0.4322	Rh deficiency syndrome	ORPHA:71275
742	0.4318	Immunodeficiency 49, severe combined	OMIM:617237
743	0.4317	FINCA syndrome	OMIM:618278
744	0.4316	Spherocytosis, type 4	OMIM:612653
744	0.4316	Spherocytosis, type 1	OMIM:182900
746	0.4315	Macrothrombocytopenia, isolated, 2, autosomal dominant	OMIM:619840
747	0.4309	3-methylglutaconic aciduria, type VIIA, autosomal dominant	OMIM:619835
747	0.4309	?Neutrophilia, hereditary	OMIM:162830
749	0.43	MALT lymphoma	ORPHA:52417
749	0.43	MALT lymphoma	ORPHA:52417
749	0.43	MALT lymphoma	ORPHA:52417
749	0.43	MALT lymphoma	ORPHA:52417
753	0.4298	Lysinuric protein intolerance	ORPHA:470
754	0.4296	Immunodeficiency, common variable, 6	OMIM:613496
755	0.4294	Immunodeficiency 105, severe combined	OMIM:619924
756	0.4293	Activated PI3K-delta syndrome	ORPHA:397596
756	0.4293	Activated PI3K-delta syndrome	ORPHA:397596
756	0.4293	Activated PI3K-delta syndrome	ORPHA:397596
759	0.4291	Dyserythropoietic anemia, congenital, type Ib	OMIM:615631
760	0.4289	DEEAH syndrome	OMIM:619004
761	0.4282	Immunodeficiency 52	OMIM:617514
762	0.4281	Dehydrated hereditary stomatocytosis	ORPHA:3202
762	0.4281	Dehydrated hereditary stomatocytosis	ORPHA:3202
762	0.4281	Dehydrated hereditary stomatocytosis	ORPHA:3202
765	0.4277	Oculocerebrorenal syndrome of Lowe	ORPHA:534
766	0.4274	T-B+ severe combined immunodeficiency due to JAK3 deficiency	ORPHA:35078
767	0.427	Autoimmune lymphoproliferative syndrome, type III	OMIM:615559
768	0.4269	Severe combined immunodeficiency, X-linked	OMIM:300400
769	0.4254	Sickle cell disease	OMIM:603903
770	0.425	Combined oxidative phosphorylation deficiency 55	OMIM:619743
770	0.425	Glycogen storage disease Ic	OMIM:232240
772	0.4246	Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome	ORPHA:444463
772	0.4246	Acyl-CoA dehydrogenase 9 deficiency	ORPHA:99901
774	0.4245	Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant	OMIM:614162
775	0.4244	?Immunodeficiency 62	OMIM:618459
776	0.4243	Immunodeficiency 54	OMIM:609981
777	0.4241	Immunodeficiency 109 with lymphoproliferation	OMIM:620282
778	0.424	Purine nucleoside phosphorylase deficiency	ORPHA:760
779	0.4237	Immunodeficiency, common variable, 2	OMIM:240500
780	0.4236	Iron-refractory iron deficiency anemia	OMIM:206200
781	0.4234	?Anemia, hypochromic microcytic, with iron overload 2	OMIM:615234
782	0.4233	Hodgkin lymphoma, susceptibility to	OMIM:236000
783	0.4231	Hemolytic anemia, G6PD deficient (favism)	OMIM:300908
784	0.423	Dyserythropoietic anemia, congenital, type Ia	OMIM:224120
785	0.4222	Spondyloenchondrodysplasia with immune dysregulation	OMIM:607944
786	0.4221	Adenosine deaminase deficiency, partial	OMIM:102700
787	0.4219	Anemia, hemolytic, Rh-null, regulator type	OMIM:268150
787	0.4219	?Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias	OMIM:619846
789	0.4215	Immunodeficiency by defective expression of MHC class II	ORPHA:572
789	0.4215	Immunodeficiency by defective expression of MHC class II	ORPHA:572
789	0.4215	Immunodeficiency by defective expression of MHC class II	ORPHA:572
789	0.4215	Immunodeficiency by defective expression of MHC class II	ORPHA:572
793	0.4209	Autoimmune lymphoproliferative syndrome	ORPHA:3261
793	0.4209	Autoimmune lymphoproliferative syndrome	ORPHA:3261
793	0.4209	Autoimmune lymphoproliferative syndrome	ORPHA:3261
793	0.4209	Autoimmune lymphoproliferative syndrome	ORPHA:3261
793	0.4209	Autoimmune lymphoproliferative syndrome	ORPHA:3261
798	0.4207	Congenital dyserythropoietic anemia type III	ORPHA:98870
798	0.4207	Congenital dyserythropoietic anemia type III	ORPHA:98870
800	0.4204	Immunodeficiency 102	OMIM:301082
801	0.4202	Beta-thalassemia major	ORPHA:231214
802	0.4195	Dyserythropoietic anemia, congenital, type IV	OMIM:613673
803	0.4192	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	OMIM:616084
804	0.4189	Immunoglobulin A deficiency 2	OMIM:609529
805	0.4184	Pyropoikilocytosis	OMIM:266140
806	0.4182	Immunodeficiency 80 with or without cardiomyopathy	OMIM:619313
807	0.418	T-cell lymphoma, subcutaneous panniculitis-like	OMIM:618398
808	0.4178	Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation	OMIM:616100
809	0.4176	Autoimmune lymphoproliferative syndrome, type IB	OMIM:601859
809	0.4176	Spondyloenchondrodysplasia	ORPHA:1855
809	0.4176	Autoimmune lymphoproliferative syndrome, type IA	OMIM:601859
809	0.4176	Autoimmune lymphoproliferative syndrome	OMIM:601859
813	0.4175	Immunodeficiency 64	OMIM:618534
814	0.4174	Immunodeficiency 75	OMIM:619126
815	0.4171	Multiple myeloma, resistance to	OMIM:254500
815	0.4171	Multiple myeloma, susceptibility to	OMIM:254500
817	0.4167	Pyruvate kinase deficiency	OMIM:266200
818	0.4161	Deficiency in anterior pituitary function-variable immunodeficiency syndrome	ORPHA:293978
819	0.416	Cryohydrocytosis	OMIM:185020
820	0.4159	Elliptocytosis-1	OMIM:611804
821	0.4154	T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency	ORPHA:169154
822	0.4153	ICF syndrome	ORPHA:2268
822	0.4153	Hemolytic anemia due to red cell pyruvate kinase deficiency	ORPHA:766
822	0.4153	ICF syndrome	ORPHA:2268
822	0.4153	ICF syndrome	ORPHA:2268
822	0.4153	ICF syndrome	ORPHA:2268
827	0.4152	Stormorken-Sjaastad-Langslet syndrome	ORPHA:3204
827	0.4152	Stormorken-Sjaastad-Langslet syndrome	ORPHA:3204
827	0.4152	Anemia, neonatal hemolytic, fatal or near-fatal	OMIM:617948
830	0.415	?Epidermodysplasia verruciformis, susceptibility to, 4	OMIM:618307
831	0.4148	?Fanconi anemia, complementation group W	OMIM:617784
832	0.4147	Greenberg dysplasia	ORPHA:1426
832	0.4147	?Joint contracture, osteochondromas, and B-cell lymphoma	OMIM:620232
834	0.4143	?Megaloblastic anemia, folate-responsive	OMIM:601775
835	0.4129	Recurrent infections associated with rare immunoglobulin isotypes deficiency	ORPHA:183675
835	0.4129	Recurrent infections associated with rare immunoglobulin isotypes deficiency	ORPHA:183675
837	0.4122	Developmental and epileptic encephalopathy 50	OMIM:616457
838	0.4121	Immunodeficiency 76	OMIM:619164
839	0.411	CINCA syndrome	ORPHA:1451
840	0.4103	Follicular lymphoma	ORPHA:545
840	0.4103	Follicular lymphoma	ORPHA:545
840	0.4103	Follicular lymphoma	ORPHA:545
843	0.4088	Leukocyte adhesion deficiency, type III	OMIM:612840
844	0.4081	?Infantile liver failure syndrome 1	OMIM:615438
844	0.4081	Immunodeficiency 78 with autoimmunity and developmental delay	OMIM:619220
844	0.4081	Severe congenital hypochromic anemia with ringed sideroblasts	ORPHA:300298
847	0.4072	Short stature, microcephaly, and endocrine dysfunction	OMIM:616541
848	0.407	Immunodeficiency 82 with systemic inflammation	OMIM:619381
849	0.4069	Kabuki syndrome 1	OMIM:147920
850	0.4068	Giant cell arteritis	ORPHA:397
850	0.4068	Giant cell arteritis	ORPHA:397
850	0.4068	Giant cell arteritis	ORPHA:397
850	0.4068	Giant cell arteritis	ORPHA:397
854	0.4067	Pseudoxanthoma elasticum	ORPHA:758
854	0.4067	Pseudoxanthoma elasticum	ORPHA:758
856	0.4064	Reticular dysgenesis	ORPHA:33355
856	0.4064	Reticular dysgenesis	ORPHA:33355
858	0.4052	Choreoacanthocytosis	ORPHA:2388
859	0.4045	Delta-beta-thalassemia	ORPHA:231237
859	0.4045	Delta-beta-thalassemia	ORPHA:231237
859	0.4045	Delta-beta-thalassemia	ORPHA:231237
862	0.4043	Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome	ORPHA:37042
863	0.404	Khan-Khan-Katsanis syndrome	OMIM:618460
864	0.4036	Hemophagocytic lymphohistiocytosis, familial, 3	OMIM:608898
864	0.4036	?Immunodeficiency 84	OMIM:619437
866	0.4032	Diamond-Blackfan anemia 10	OMIM:613309
867	0.403	Camurati-Engelmann disease	ORPHA:1328
868	0.4028	Thalassemia-beta, dominant inclusion-body	OMIM:603902
868	0.4028	?Inflammatory bowel disease (infantile ulcerative colitis) 31	OMIM:619398
870	0.4021	EEC syndrome	ORPHA:1896
871	0.4016	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	OMIM:300990
871	0.4016	Short stature with microcephaly and distinctive facies	OMIM:615789
873	0.4015	Immunodeficiency 18	OMIM:615615
874	0.4014	Leukocyte adhesion deficiency type II	ORPHA:99843
875	0.4013	Familial pseudohyperkalemia	ORPHA:90044
876	0.4008	Dominant beta-thalassemia	ORPHA:231226
877	0.4005	Hemolytic anemia due to elevated adenosine deaminase	OMIM:301083
878	0.4003	Telangiectasia, hereditary hemorrhagic, type 1	OMIM:187300
878	0.4003	Telangiectasia, hereditary hemorrhagic, type 2	OMIM:600376
880	0.3999	Beta-thalassemia intermedia	ORPHA:231222
880	0.3999	Hatipoglu immunodeficiency syndrome	OMIM:620331
882	0.3997	Hereditary cryohydrocytosis with reduced stomatin	ORPHA:168577
883	0.3996	Trichothiodystrophy	ORPHA:33364
883	0.3996	Trichothiodystrophy	ORPHA:33364
883	0.3996	Trichothiodystrophy	ORPHA:33364
883	0.3996	Trichothiodystrophy	ORPHA:33364
883	0.3996	Trichothiodystrophy	ORPHA:33364
883	0.3996	Trichothiodystrophy	ORPHA:33364
883	0.3996	Trichothiodystrophy	ORPHA:33364
883	0.3996	Stomatin-deficient cryohydrocytosis with neurologic defects	OMIM:608885
883	0.3996	Trichothiodystrophy	ORPHA:33364
883	0.3996	Trichothiodystrophy	ORPHA:33364
893	0.3995	Spherocytosis, type 3	OMIM:270970
893	0.3995	Ovalocytosis, SA type	OMIM:166900
895	0.3994	Developmental and epileptic encephalopathy 66	OMIM:618067
896	0.399	Anemia, sideroblastic, 2, pyridoxine-refractory	OMIM:205950
897	0.3988	Aspartylglucosaminuria	OMIM:208400
898	0.3985	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	OMIM:300946
899	0.3981	Diamond-blackfan anemia 3	OMIM:610629
900	0.398	?Bone marrow failure syndrome 6	OMIM:618849
901	0.3974	Krabbe disease	OMIM:245200
902	0.3972	Immunodeficiency 96	OMIM:619774
903	0.3971	Diamond-Blackfan anemia 6	OMIM:612561
903	0.3971	IMAGE-I syndrome	OMIM:618336
905	0.3964	Myopathy with lactic acidosis, hereditary	OMIM:255125
906	0.396	Diamond-Blackfan anemia 7	OMIM:612562
906	0.396	Diamond-Blackfan anemia 8	OMIM:612563
908	0.3959	Hereditary orotic aciduria	ORPHA:30
909	0.3957	Neutrophil immunodeficiency syndrome	ORPHA:183707
910	0.3952	McLeod syndrome with or without chronic granulomatous disease	OMIM:300842
911	0.3944	Elliptocytosis-2	OMIM:130600
912	0.3943	Alpha-thalassemia/impaired intellectual development syndrome	OMIM:301040
913	0.3942	Specific granule deficiency	OMIM:245480
913	0.3942	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	OMIM:616910
913	0.3942	Subcutaneous panniculitis-like T-cell lymphoma	ORPHA:86884
913	0.3942	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	OMIM:616911
917	0.3939	Renal tubular acidosis, proximal, with ocular abnormalities	OMIM:604278
918	0.3937	Agammaglobulinemia, X-linked 1	OMIM:300755
919	0.3936	Immunodeficiency 19, severe combined	OMIM:615617
920	0.3933	Congenital disorder of glycosylation, type Ii	OMIM:607906
921	0.3925	?Agammaglobulinemia 7, autosomal recessive	OMIM:615214
921	0.3925	Intrinsic factor deficiency	OMIM:261000
923	0.3923	Hereditary sensory and autonomic neuropathy type 4	ORPHA:642
924	0.3921	Focal facial dermal dysplasia type IV	ORPHA:398189
925	0.3919	Fanconi anemia, complementation group P	OMIM:613951
925	0.3919	Barth syndrome	ORPHA:111
927	0.3918	Immunodeficiency 17, CD3 gamma deficient	OMIM:615607
928	0.3916	Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16	ORPHA:98791
928	0.3916	Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16	ORPHA:98791
930	0.3915	Griscelli syndrome, type 2	OMIM:607624
931	0.3914	Camurati-Engelmann disease	OMIM:131300
931	0.3914	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	OMIM:259730
931	0.3914	Fanconi anemia, complementation group R	OMIM:617244
931	0.3914	Fanconi anemia, complementation group L	OMIM:614083
935	0.3912	Wolman disease	ORPHA:75233
936	0.391	Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome	ORPHA:46532
936	0.391	Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome	ORPHA:46532
936	0.391	Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome	ORPHA:46532
936	0.391	Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome	ORPHA:46532
940	0.3908	Diamond-Blackfan anemia 5	OMIM:612528
940	0.3908	Reticular dysgenesis	OMIM:267500
940	0.3908	Reticular dysgenesis	OMIM:267500
943	0.3907	Agammaglobulinemia 2	OMIM:613500
944	0.3906	Agammaglobulinemia 3	OMIM:613501
944	0.3906	?Immunodeficiency 108 with autoinflammation	OMIM:260570
946	0.3904	Trimethylaminuria	OMIM:602079
947	0.3897	Agammaglobulinemia 6	OMIM:612692
948	0.3895	Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis	OMIM:608203
949	0.3893	Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome	ORPHA:86818
949	0.3893	Neurodegeneration with brain iron accumulation 1	OMIM:234200
949	0.3893	Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome	ORPHA:86818
949	0.3893	Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome	ORPHA:86818
949	0.3893	Ichthyosis, congenital, autosomal recessive 5	OMIM:604777
954	0.3892	?Agammaglobulinemia 4	OMIM:613502
955	0.389	Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib	ORPHA:79259
956	0.3889	Coenzyme Q10 deficiency, primary, 1	OMIM:607426
957	0.3886	Severe hemophilia A	ORPHA:169802
958	0.3885	Hemoglobin H disease, nondeletional	OMIM:613978
958	0.3885	Hemoglobin H disease, deletional and nondeletional	OMIM:613978
958	0.3885	Isolated sedoheptulokinase deficiency	ORPHA:440713
958	0.3885	Immunodeficiency 26, with or without neurologic abnormalities	OMIM:615966
962	0.388	OKT4 epitope deficiency	OMIM:613949
962	0.388	Salla disease	OMIM:604369
962	0.388	Ceroid lipofuscinosis, neuronal, 1	OMIM:256730
962	0.388	Ceroid lipofuscinosis, neuronal, 5	OMIM:256731
962	0.388	Ceroid lipofuscinosis, neuronal, 3	OMIM:204200
967	0.3877	Congenital factor II deficiency	ORPHA:325
968	0.3876	Hemochromatosis, type 3	OMIM:604250
969	0.3875	Congenital disorder of glycosylation, type Iq	OMIM:612379
970	0.3869	Mannosidosis, alpha-, types I and II	OMIM:248500
971	0.3866	DEGCAGS syndrome	OMIM:619488
972	0.3865	Lymphoproliferative syndrome, X-linked, 2	OMIM:300635
972	0.3865	Lymphoproliferative syndrome, X-linked, 2	OMIM:300635
974	0.3864	Mismatch repair cancer syndrome 3	OMIM:619097
974	0.3864	Hb Bart's hydrops fetalis	ORPHA:163596
974	0.3864	Hb Bart's hydrops fetalis	ORPHA:163596
977	0.3863	Epidermolysis bullosa dystrophica, autosomal recessive, modifier of	OMIM:226600
977	0.3863	Epidermolysis bullosa dystrophica inversa	OMIM:226600
979	0.3862	Bannayan-Riley-Ruvalcaba syndrome	ORPHA:109
979	0.3862	Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome	ORPHA:251380
979	0.3862	Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome	ORPHA:251380
979	0.3862	Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome	ORPHA:251380
979	0.3862	Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome	ORPHA:251380
979	0.3862	Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome	ORPHA:251380
979	0.3862	Erythrocytosis, familial, 8	OMIM:222800
986	0.3861	Leukocyte adhesion deficiency	OMIM:116920
987	0.3852	Thrombophilia 5 due to protein S deficiency, autosomal recessive	OMIM:614514
987	0.3852	Glutathione synthetase deficiency	OMIM:266130
987	0.3852	Dyskeratosis congenita, autosomal dominant 4	OMIM:615190
990	0.3851	Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5	ORPHA:353
991	0.3849	?Diamond-Blackfan anemia 18	OMIM:618310
991	0.3849	Autoinflammatory-pancytopenia syndrome	OMIM:619858
993	0.3847	DPAGT1-CDG	ORPHA:86309
993	0.3847	Hemolytic anemia due to triosephosphate isomerase deficiency	OMIM:615512
993	0.3847	Autosomal dominant generalized epidermolysis bullosa simplex, severe form	ORPHA:79396
993	0.3847	Autosomal dominant generalized epidermolysis bullosa simplex, severe form	ORPHA:79396
997	0.3846	Severe generalized junctional epidermolysis bullosa	ORPHA:79404
997	0.3846	Severe generalized junctional epidermolysis bullosa	ORPHA:79404
997	0.3846	Severe generalized junctional epidermolysis bullosa	ORPHA:79404
1000	0.3844	Fabry disease, cardiac variant	OMIM:301500
1001	0.3842	Abetalipoproteinemia	ORPHA:14
1002	0.3839	CINCA syndrome	OMIM:607115
1003	0.3835	Hyperammonemia due to N-acetylglutamate synthase deficiency	ORPHA:927
1004	0.3834	Erythrocytosis, somatic	OMIM:133100
1004	0.3834	Erythrocytosis, somatic	OMIM:133100
1004	0.3834	Ghosal hematodiaphyseal dysplasia	ORPHA:1802
1004	0.3834	X-linked sideroblastic anemia	ORPHA:75563
1004	0.3834	Autoinflammation with pulmonary and cutaneous vasculitis	OMIM:620296
1004	0.3834	Osteopetrosis, autosomal dominant 3	OMIM:618107
1004	0.3834	Muckle-Wells syndrome	ORPHA:575
1011	0.3832	Tubulointerstitial kidney disease, autosomal dominant, 5	OMIM:617056
1012	0.383	Erythrocytosis, familial, 2	OMIM:263400
1013	0.3828	Thalassemia, beta	OMIM:613985
1013	0.3828	Thalassemias, alpha-	OMIM:604131
1013	0.3828	Thalassemia, alpha-	OMIM:604131
1016	0.3826	Vici syndrome	OMIM:242840
1017	0.3825	Niemann-Pick disease, type A	OMIM:257200
1018	0.3823	Anemia, sideroblastic, 3, pyridoxine-refractory	OMIM:616860
1018	0.3823	HARP syndrome	OMIM:607236
1020	0.3821	Abetalipoproteinemia	OMIM:200100
1021	0.3819	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	OMIM:194380
1021	0.3819	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia	OMIM:618042
1023	0.3817	Potocki-Shaffer syndrome	ORPHA:52022
1023	0.3817	Potocki-Shaffer syndrome	ORPHA:52022
1023	0.3817	Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia	OMIM:620210
1023	0.3817	Potocki-Shaffer syndrome	ORPHA:52022
1027	0.3816	?Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies	OMIM:619321
1027	0.3816	Osteopetrosis, autosomal recessive 7	OMIM:612301
1029	0.3815	Muir-Torre syndrome	ORPHA:587
1029	0.3815	Muir-Torre syndrome	ORPHA:587
1029	0.3815	Muir-Torre syndrome	ORPHA:587
1032	0.3813	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	OMIM:613470
1033	0.3811	Myopathy, lactic acidosis, and sideroblastic anemia 1	OMIM:600462
1033	0.3811	GM1-gangliosidosis, type II	OMIM:230600
1035	0.3809	Chylomicron retention disease	ORPHA:71
1036	0.3808	Polyglucosan body myopathy 1 with or without immunodeficiency	OMIM:615895
1037	0.3806	Combined oxidative phosphorylation deficiency 18	OMIM:615578
1038	0.3798	CLN3 disease	ORPHA:228346
1039	0.3797	Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia	OMIM:618986
1039	0.3797	Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome	ORPHA:309854
1041	0.3796	Majeed syndrome	ORPHA:77297
1041	0.3796	Niemann-Pick disease, type C1	OMIM:257220
1041	0.3796	Niemann-pick disease, type C2	OMIM:607625
1044	0.3794	Glycogen storage disease XII	OMIM:611881
1044	0.3794	Leukoencephalopathy, progressive, infantile-onset, with or without deafness	OMIM:619147
1046	0.3793	Immunodeficiency 9	OMIM:612782
1046	0.3793	Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly	OMIM:618019
1046	0.3793	Majeed syndrome	OMIM:609628
1046	0.3793	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	OMIM:614800
1046	0.3793	Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly	OMIM:620075
1051	0.3792	Immunodeficiency 12	OMIM:615468
1052	0.3791	Dyskeratosis congenita, digenic	OMIM:620040
1053	0.379	Incontinentia pigmenti	OMIM:308300
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1054	0.3789	Familial isolated dilated cardiomyopathy	ORPHA:154
1105	0.3788	Immunodeficiency 41 with lymphoproliferation and autoimmunity	OMIM:606367
1105	0.3788	Fabry disease	ORPHA:324
1107	0.3786	Bone marrow failure syndrome 5	OMIM:618165
1107	0.3786	Formiminoglutamic aciduria	ORPHA:51208
1109	0.3785	Psoriasis 14, pustular	OMIM:614204
1110	0.3782	Griscelli syndrome type 2	ORPHA:79477
1110	0.3782	SRD5A3-CDG	ORPHA:324737
1112	0.378	Neutral lipid storage disease with ichthyosis	ORPHA:98907
1112	0.378	Fucosidosis	OMIM:230000
1114	0.3778	Glutamate formiminotransferase deficiency	OMIM:229100
1115	0.3777	Autoinflammation, panniculitis, and dermatosis syndrome	OMIM:617099
1116	0.3776	Cyanosis, transient neonatal	OMIM:613977
1116	0.3776	Methylcobalamin deficiency type cblE	ORPHA:2169
1116	0.3776	Short-rib thoracic dysplasia 9 with or without polydactyly	OMIM:266920
1119	0.377	Primary sclerosing cholangitis	ORPHA:171
1119	0.377	Primary sclerosing cholangitis	ORPHA:171
1119	0.377	Primary sclerosing cholangitis	ORPHA:171
1119	0.377	Primary sclerosing cholangitis	ORPHA:171
1123	0.3769	Ollier disease	ORPHA:296
1123	0.3769	Ollier disease	ORPHA:296
1123	0.3769	Ollier disease	ORPHA:296
1123	0.3769	?Immunodeficiency, common variable, 5	OMIM:613495
1127	0.3763	Anemia, hypochromic microcytic, with iron overload 1	OMIM:206100
1128	0.3761	Immunodeficiency 51	OMIM:613953
1129	0.3758	Choreoacanthocytosis	OMIM:200150
1130	0.3757	Recessive dystrophic epidermolysis bullosa inversa	ORPHA:79409
1130	0.3757	Localized dystrophic epidermolysis bullosa, pretibial form	ORPHA:79410
1130	0.3757	Self-improving dystrophic epidermolysis bullosa	ORPHA:79411
1133	0.3756	Combined immunodeficiency, X-linked, moderate	OMIM:312863
1134	0.3752	Primary familial polycythemia	ORPHA:90042
1135	0.3751	Juvenile polyposis of infancy	ORPHA:79076
1135	0.3751	Juvenile polyposis of infancy	ORPHA:79076
1137	0.3748	Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form	ORPHA:79408
1137	0.3748	Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form	ORPHA:79408
1139	0.3747	GM1-gangliosidosis, type I	OMIM:230500
1140	0.3746	Gastrointestinal stromal tumor	ORPHA:44890
1140	0.3746	Gastrointestinal stromal tumor	ORPHA:44890
1140	0.3746	Hypobetalipoproteinemia	OMIM:615558
1140	0.3746	Immunodeficiency 67	OMIM:607676
1140	0.3746	Gastrointestinal stromal tumor	ORPHA:44890
1140	0.3746	Gastrointestinal stromal tumor	ORPHA:44890
1140	0.3746	Gastrointestinal stromal tumor	ORPHA:44890
1147	0.3745	?Immunodeficiency, common variable, 11	OMIM:615767
1148	0.3743	?Diamond-Blackfan anemia 19	OMIM:618312
1149	0.3742	Baller-Gerold syndrome	ORPHA:1225
1149	0.3742	Rajab interstitial lung disease with brain calcifications 1	OMIM:613658
1149	0.3742	Multiple myeloma	ORPHA:29073
1152	0.3741	Anemia, sideroblastic, 1	OMIM:300751
1153	0.374	Alpha-thalassemia-X-linked intellectual disability syndrome	ORPHA:847
1154	0.3739	Afibrinogenemia, congenital	OMIM:202400
1154	0.3739	Hypofibrinogenemia, congenital	OMIM:202400
1154	0.3739	Hypofibrinogenemia, congenital	OMIM:202400
1154	0.3739	Distal renal tubular acidosis 4 with hemolytic anemia	OMIM:611590
1158	0.3738	Immunodeficiency, common variable, 3	OMIM:613493
1158	0.3738	Blue rubber bleb nevus	ORPHA:1059
1160	0.3736	Granulomatosis with polyangiitis	ORPHA:900
1160	0.3736	Granulomatosis with polyangiitis	ORPHA:900
1160	0.3736	Granulomatosis with polyangiitis	ORPHA:900
1160	0.3736	Granulomatosis with polyangiitis	ORPHA:900
1160	0.3736	Granulomatosis with polyangiitis	ORPHA:900
1165	0.3731	Chronic granulomatous disease 4, autosomal recessive	OMIM:233690
1165	0.3731	Chronic granulomatous disease 2, autosomal recessive	OMIM:233710
1165	0.3731	Chronic granulomatous disease 1, autosomal recessive	OMIM:233700
1168	0.3729	Autosomal recessive malignant osteopetrosis	ORPHA:667
1168	0.3729	Autosomal recessive malignant osteopetrosis	ORPHA:667
1168	0.3729	Autosomal recessive malignant osteopetrosis	ORPHA:667
1168	0.3729	Autosomal recessive malignant osteopetrosis	ORPHA:667
1172	0.3726	Hereditary chronic pancreatitis	ORPHA:676
1172	0.3726	Hereditary chronic pancreatitis	ORPHA:676
1172	0.3726	Muckle-Wells syndrome	OMIM:191900
1172	0.3726	Familial cold inflammatory syndrome 1	OMIM:120100
1172	0.3726	Hereditary chronic pancreatitis	ORPHA:676
1172	0.3726	Hereditary chronic pancreatitis	ORPHA:676
1172	0.3726	Hereditary chronic pancreatitis	ORPHA:676
1172	0.3726	Sialidosis, type II	OMIM:256550
1172	0.3726	Hereditary chronic pancreatitis	ORPHA:676
1181	0.3725	Generalized juvenile polyposis/juvenile polyposis coli	ORPHA:329971
1181	0.3725	Generalized juvenile polyposis/juvenile polyposis coli	ORPHA:329971
1181	0.3725	Generalized juvenile polyposis/juvenile polyposis coli	ORPHA:329971
1184	0.3724	Fumarase deficiency	OMIM:606812
1185	0.3723	Heinz body anemia	OMIM:140700
1185	0.3723	Heinz body anemias, alpha-	OMIM:140700
1185	0.3723	Heinz body anemia	OMIM:140700
1188	0.372	Diamond-Blackfan anemia 12	OMIM:615550
1189	0.3719	Neuroblastoma, susceptibility to, 1	OMIM:256700
1190	0.3716	Chronic granulomatous disease, X-linked	OMIM:306400
1191	0.3715	Immunodeficiency, common variable, 4	OMIM:613494
1192	0.3714	Pachydermoperiostosis	ORPHA:2796
1192	0.3714	Pachydermoperiostosis	ORPHA:2796
1194	0.3713	Chronic granulomatous disease	ORPHA:379
1194	0.3713	Chronic granulomatous disease	ORPHA:379
1194	0.3713	Tyrosinemia, type I	OMIM:276700
1194	0.3713	Chronic granulomatous disease	ORPHA:379
1194	0.3713	Chronic granulomatous disease	ORPHA:379
1194	0.3713	Chronic granulomatous disease	ORPHA:379
1194	0.3713	Chronic granulomatous disease	ORPHA:379
1201	0.3712	Myelodysplastic syndrome, susceptibility to	OMIM:614286
1201	0.3712	Myelodysplastic syndrome, somatic	OMIM:614286
1201	0.3712	Myelodysplastic syndrome, somatic	OMIM:614286
1201	0.3712	Myelodysplastic syndrome, somatic	OMIM:614286
1201	0.3712	Lymphoma, non-Hodgkin, somatic	OMIM:605027
1201	0.3712	Lymphoma, non-Hodgkin, somatic	OMIM:605027
1201	0.3712	Lymphoma, follicular, somatic	OMIM:605027
1201	0.3712	Lymphoma, non-Hodgkin, somatic	OMIM:605027
1201	0.3712	Myelodysplastic syndrome, somatic	OMIM:614286
1201	0.3712	Lymphoma, non-Hodgkin	OMIM:605027
1211	0.3711	NTHL1-related attenuated familial adenomatous polyposis	ORPHA:454840
1212	0.371	Erythrocytosis, familial, 6	OMIM:617980
1212	0.371	Erythrocytosis, familial, 7	OMIM:617981
1212	0.371	Erythrocytosis, familial, 7	OMIM:617981
1212	0.371	Punctate palmoplantar keratoderma type 1	ORPHA:79501
1212	0.371	Punctate palmoplantar keratoderma type 1	ORPHA:79501
1217	0.3706	Hemochromatosis, type 2B	OMIM:613313
1218	0.3705	H syndrome	ORPHA:168569
1218	0.3705	Blau syndrome	ORPHA:90340
1218	0.3705	Poikiloderma with neutropenia	OMIM:604173
1221	0.3704	TARP syndrome	ORPHA:2886
1222	0.3702	Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin	OMIM:619769
1223	0.3701	Norum disease	OMIM:245900
1223	0.3701	Cohen syndrome	OMIM:216550
1225	0.37	Senior-Boichis syndrome	ORPHA:84081
1225	0.37	Senior-Boichis syndrome	ORPHA:84081
1227	0.3698	Immunodeficiency 20	OMIM:615707
1228	0.3697	Immunodeficiency, common variable, 1	OMIM:607594
1228	0.3697	Glycogen storage disease due to liver phosphorylase kinase deficiency	ORPHA:264580
1228	0.3697	Glycogen storage disease due to liver phosphorylase kinase deficiency	ORPHA:264580
1231	0.3695	Immunodeficiency 103, susceptibility to fungal infection	OMIM:212050
1232	0.3694	Chronic granulomatous disease 5, autosomal recessive	OMIM:618935
1233	0.3693	Fanconi anemia, complementation group S	OMIM:617883
1233	0.3693	Cerebroretinal microangiopathy with calcifications and cysts 2	OMIM:617341
1233	0.3693	Hemolytic anemia due to hexokinase deficiency	OMIM:235700
1236	0.3692	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	OMIM:175050
1236	0.3692	Adenosine triphosphate, elevated, of erythrocytes	OMIM:102900
1236	0.3692	Methemoglobinemia, type I	OMIM:250800
1239	0.3691	Vertebral anomalies and variable endocrine and T-cell dysfunction	OMIM:618223
1240	0.3688	Severe combined immunodeficiency due to adenosine deaminase deficiency	ORPHA:277
1240	0.3688	Sialic acid storage disorder, infantile	OMIM:269920
1242	0.3687	Immunodeficiency 48	OMIM:269840
1243	0.3685	Werner syndrome	OMIM:277700
1243	0.3685	Alacrimia-choreoathetosis-liver dysfunction syndrome	ORPHA:404454
1245	0.3684	Noonan syndrome with multiple lentigines	ORPHA:500
1245	0.3684	Noonan syndrome with multiple lentigines	ORPHA:500
1245	0.3684	Lymphatic malformation 7	OMIM:617300
1245	0.3684	Noonan syndrome with multiple lentigines	ORPHA:500
1249	0.3682	Diamond-Blackfan anemia 13	OMIM:615909
1250	0.3681	Respiratory infections, recurrent, and failure to thrive with or without diarrhea	OMIM:620233
1251	0.368	PMM2-CDG	ORPHA:79318
1252	0.3679	Hepatoerythropoietic porphyria	ORPHA:95159
1253	0.3678	Herpes simplex virus encephalitis	ORPHA:1930
1253	0.3678	Herpes simplex virus encephalitis	ORPHA:1930
1253	0.3678	Herpes simplex virus encephalitis	ORPHA:1930
1253	0.3678	Herpes simplex virus encephalitis	ORPHA:1930
1253	0.3678	Herpes simplex virus encephalitis	ORPHA:1930
1253	0.3678	Erythrocytosis, familial, 3	OMIM:609820
1259	0.3676	GLUT1 deficiency syndrome 2, childhood onset	OMIM:612126
1260	0.3675	Erythrocytosis, familial, 5	OMIM:617907
1260	0.3675	Erythrocytosis, familial, 4	OMIM:611783
1260	0.3675	Tn polyagglutination syndrome, somatic	OMIM:300622
1260	0.3675	Classic glucose transporter type 1 deficiency syndrome	ORPHA:71277
1264	0.3674	Congenital disorder of glycosylation, type Ie	OMIM:608799
1264	0.3674	Serrated polyposis syndrome	ORPHA:157798
1266	0.3673	Congenital disorder of glycosylation, type IIa	OMIM:212066
1267	0.3671	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2	OMIM:619418
1267	0.3671	?Immunodeficiency 16	OMIM:615593
1269	0.3669	?Caspase 8 lymphadenopathy syndrome	OMIM:607271
1270	0.3668	Mismatch repair cancer syndrome 4	OMIM:619101
1271	0.3667	Noonan syndrome-like with loose anagen hair 1	OMIM:607721
1272	0.3666	Hyper-IgD syndrome	OMIM:260920
1272	0.3666	Immunodeficiency 50	OMIM:300988
1274	0.3665	WHIM syndrome	ORPHA:51636
1275	0.3664	Heterotopia, periventricular, 1	OMIM:300049
1275	0.3664	Glutamate-cysteine ligase deficiency	ORPHA:33574
1275	0.3664	Aceruloplasminemia	ORPHA:48818
1278	0.3662	?Immunodeficiency 73C with defective neutrophil chemotaxis and hypogammaglobulinemia	OMIM:618987
1278	0.3662	B4GALT1-CDG	ORPHA:79332
1280	0.3661	Diamond Blackfan anemia 15 with mandibulofacial dysostosis	OMIM:606164
1280	0.3661	Bare lymphocyte syndrome, type II, complementation group A	OMIM:209920
1280	0.3661	Bare lymphocyte syndrome, type II, complementation group C	OMIM:209920
1280	0.3661	Bare lymphocyte syndrome, type II, complementation group B	OMIM:209920
1280	0.3661	Bare lymphocyte syndrome, type II, complementation group D	OMIM:209920
1285	0.3657	Hyperparathyroidism, neonatal	OMIM:239200
1286	0.3655	Klippel-Tr√©naunay syndrome	ORPHA:90308
1287	0.3653	Vitamin K-dependent clotting factors, combined deficiency of, 1	OMIM:277450
1288	0.3649	HMG-CoA lyase deficiency	OMIM:246450
1289	0.3648	Familial Mediterranean fever, AR	OMIM:249100
1290	0.3647	Immunodeficiency 68	OMIM:612260
1291	0.3644	Familial cold autoinflammatory syndrome 2	OMIM:611762
1292	0.3643	Isolated growth hormone deficiency, type III, with agammaglobulinemia	OMIM:307200
1292	0.3643	Congenital bile acid synthesis defect type 2	ORPHA:79303
1294	0.3642	Combined immunodeficiency with facio-oculo-skeletal anomalies	ORPHA:221139
1294	0.3642	Combined immunodeficiency with facio-oculo-skeletal anomalies	ORPHA:221139
1296	0.3637	?Immunodeficiency 85 and autoimmunity	OMIM:619510
1297	0.3636	Glycogen storage disease due to phosphoglycerate kinase 1 deficiency	ORPHA:713
1298	0.3635	Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency	ORPHA:79240
1298	0.3635	Immunoskeletal dysplasia with neurodevelopmental abnormalities	OMIM:617425
1300	0.3634	Immunodeficiency 11A	OMIM:615206
1301	0.3633	?Diamond-Blackfan anemia 20	OMIM:618313
1302	0.3631	Immunodeficiency with hyper-IgM, type 3	OMIM:606843
1302	0.3631	Dyskeratosis congenita, autosomal recessive 8	OMIM:620133
1304	0.3629	Diamond-Blackfan anemia 4	OMIM:612527
1304	0.3629	Diamond-Blackfan anemia 4	OMIM:612527
1306	0.3628	Transcobalamin II deficiency	OMIM:275350
1307	0.3623	Pitt-Hopkins syndrome	ORPHA:2896
1308	0.3622	Immunodeficiency 60 and autoimmunity	OMIM:618394
1309	0.3621	Sneddon syndrome	OMIM:182410
1309	0.3621	?Diamond-Blackfan anemia-like	OMIM:617911
1311	0.362	T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant	OMIM:618806
1312	0.3615	Johanson-Blizzard syndrome	ORPHA:2315
1313	0.3612	Harderoporphyria	OMIM:618892
1314	0.3611	Generalized pustular psoriasis	ORPHA:247353
1314	0.3611	Immunodeficiency 15B	OMIM:615592
1314	0.3611	Generalized pustular psoriasis	ORPHA:247353
1317	0.3609	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities	OMIM:618092
1318	0.3606	Congenital disorder of glycosylation, type IIc	OMIM:266265
1318	0.3606	Caroli disease	ORPHA:53035
1320	0.3605	Histiocytosis-lymphadenopathy plus syndrome	OMIM:602782
1320	0.3605	Hyper-IgE recurrent infection syndrome 4A, autosomal dominant	OMIM:619752
1320	0.3605	Lipodystrophy, congenital generalized, type 2	OMIM:269700
1323	0.3604	Tumor necrosis factor receptor 1 associated periodic syndrome	ORPHA:32960
1324	0.3602	T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta	ORPHA:169160
1324	0.3602	T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta	ORPHA:169160
1324	0.3602	T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta	ORPHA:169160
1327	0.3601	Peripheral primitive neuroectodermal tumor	ORPHA:370348
1327	0.3601	Glomerulosclerosis, focal segmental, 1	OMIM:603278
1327	0.3601	Congenital disorder of glycosylation, type IIr	OMIM:301045
1330	0.36	Peutz-Jeghers syndrome	ORPHA:2869
1330	0.36	Trichothiodystrophy 3, photosensitive	OMIM:616395
1332	0.3598	Immunodeficiency 95	OMIM:619773
1332	0.3598	Severe combined immunodeficiency, Athabascan type	OMIM:602450
1332	0.3598	Congenital plasminogen activator inhibitor type 1 deficiency	ORPHA:465
1335	0.3597	Methylmalonic aciduria, cblD type, variant 2	OMIM:277410
1336	0.3595	Severe combined immunodeficiency due to DCLRE1C deficiency	ORPHA:275
1337	0.3591	Sarcoidosis, susceptibility to, 1	OMIM:181000
1337	0.3591	Anemia, congenital dyserythropoietic, type IIIA	OMIM:105600
1337	0.3591	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	OMIM:242860
1340	0.359	Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	OMIM:618451
1340	0.359	Immunodeficiency 93 and hypertrophic cardiomyopathy	OMIM:619705
1340	0.359	Hamamy syndrome	OMIM:611174
1343	0.3589	?Diamond-Blackfan anemia 16	OMIM:617408
1343	0.3589	Diamond-Blackfan anemia 9	OMIM:613308
1343	0.3589	?Diamond-Blackfan anemia 17	OMIM:617409
1343	0.3589	Wolfram syndrome	ORPHA:3463
1343	0.3589	Wolfram syndrome	ORPHA:3463
1343	0.3589	Mitochondrial myopathy and sideroblastic anemia	ORPHA:2598
1343	0.3589	Congenital atransferrinemia	ORPHA:1195
1343	0.3589	Fibrodysplasia ossificans progressiva	ORPHA:337
1343	0.3589	Takayasu arteritis	ORPHA:3287
1343	0.3589	Intermediate generalized junctional epidermolysis bullosa	ORPHA:79402
1343	0.3589	Intermediate generalized junctional epidermolysis bullosa	ORPHA:79402
1343	0.3589	Microcephalic osteodysplastic primordial dwarfism type II	ORPHA:2637
1343	0.3589	Takayasu arteritis	ORPHA:3287
1343	0.3589	Spondyloepimetaphyseal dysplasia, Isidor-Toutain type	OMIM:618728
1343	0.3589	Intermediate generalized junctional epidermolysis bullosa	ORPHA:79402
1343	0.3589	Intermediate generalized junctional epidermolysis bullosa	ORPHA:79402
1343	0.3589	Intermediate generalized junctional epidermolysis bullosa	ORPHA:79402
1343	0.3589	X-linked sideroblastic anemia and spinocerebellar ataxia	ORPHA:2802
1343	0.3589	?Mitochondrial complex I deficiency, nuclear type 39	OMIM:620135
1343	0.3589	Mitochondrial myopathy and sideroblastic anemia	ORPHA:2598
1343	0.3589	Nephronophthisis 11	OMIM:613550
1343	0.3589	Nephronophthisis 1, juvenile	OMIM:256100
1343	0.3589	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	ORPHA:3042
1343	0.3589	Senior-Loken syndrome 4	OMIM:606996
1343	0.3589	Nephronophthisis 4	OMIM:606966
1343	0.3589	Isobutyryl-CoA dehydrogenase deficiency	OMIM:611283
1343	0.3589	?COACH syndrome 3	OMIM:619113
1343	0.3589	Ehlers-Danlos syndrome, vascular type	OMIM:130050
1343	0.3589	Takayasu arteritis	ORPHA:3287
1343	0.3589	Epidermolysis bullosa simplex 5B, with muscular dystrophy	OMIM:226670
1373	0.3586	?Diamond-Blackfan anemia 11	OMIM:614900
1373	0.3586	?Immunodeficiency 13	OMIM:615518
1375	0.3585	Anemia, congenital dyserythropoietic, type IIIb, autosomal recessive	OMIM:619789
1376	0.358	Anemia, sideroblastic, with ataxia	OMIM:301310
1377	0.3578	Lung disease, immunodeficiency, and chromosome breakage syndrome	OMIM:617241
1378	0.3577	Orthostatic hypotension 2	OMIM:618182
1379	0.3576	Immunodeficiency 8	OMIM:615401
1379	0.3576	Barth syndrome	OMIM:302060
1381	0.3573	Hemolytic anemia due to glutathione peroxidase deficiency	OMIM:614164
1382	0.3572	Immunodeficiency 44	OMIM:616636
1382	0.3572	Immunodeficiency 63 with lymphoproliferation and autoimmunity	OMIM:618495
1382	0.3572	FGFR2-related bent bone dysplasia	ORPHA:313855
1382	0.3572	Glycogen storage disease VII	OMIM:232800
1386	0.3569	Pancreatic and cerebellar agenesis	OMIM:609069
1387	0.3567	Primary hyperoxaluria type 1	ORPHA:93598
1388	0.3565	Neutropenia, severe congenital, X-linked	OMIM:300299
1388	0.3565	Cushing disease	ORPHA:96253
1388	0.3565	Cushing disease	ORPHA:96253
1388	0.3565	Cushing disease	ORPHA:96253
1388	0.3565	?Dyskeratosis congenita, autosomal recessive 7	OMIM:616553
1388	0.3565	Cushing disease	ORPHA:96253
1388	0.3565	Cushing disease	ORPHA:96253
1388	0.3565	Cushing disease	ORPHA:96253
1388	0.3565	Cushing disease	ORPHA:96253
1397	0.3564	Tubulointerstitial kidney disease, autosomal dominant, 4	OMIM:613092
1397	0.3564	Lesch-Nyhan syndrome	ORPHA:510
1397	0.3564	Glycogen storage disease due to muscle phosphofructokinase deficiency	ORPHA:371
1400	0.3562	DEND syndrome	ORPHA:79134
1400	0.3562	Seckel syndrome 1	OMIM:210600
1400	0.3562	ATTRV122I amyloidosis	ORPHA:85451
1400	0.3562	MELAS	ORPHA:550
1400	0.3562	MELAS	ORPHA:550
1400	0.3562	MELAS	ORPHA:550
1400	0.3562	MELAS	ORPHA:550
1400	0.3562	DEND syndrome	ORPHA:79134
1400	0.3562	Mitochondrial complex IV deficiency, nuclear type 1	OMIM:220110
1400	0.3562	MELAS	ORPHA:550
1400	0.3562	MELAS	ORPHA:550
1400	0.3562	DEND syndrome	ORPHA:79134
1400	0.3562	MELAS	ORPHA:550
1400	0.3562	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	OMIM:604273
1414	0.3561	DPM1-CDG	ORPHA:79322
1414	0.3561	Phosphoglycerate kinase 1 deficiency	OMIM:300653
1416	0.356	Osteootohepatoenteric syndrome	OMIM:619377
1417	0.3559	Macrocephaly/autism syndrome	OMIM:605309
1418	0.3558	Immunodeficiency 14A, autosomal dominant	OMIM:615513
1418	0.3558	Neutrophilic dermatosis, acute febrile	OMIM:608068
1418	0.3558	Cockayne syndrome type 1	ORPHA:90321
1418	0.3558	Cockayne syndrome type 1	ORPHA:90321
1418	0.3558	C1q deficiency 2	OMIM:620321
1418	0.3558	Cockayne syndrome type 1	ORPHA:90321
1418	0.3558	Cockayne syndrome type 1	ORPHA:90321
1425	0.3557	Pyridoxamine 5'-phosphate oxidase deficiency	OMIM:610090
1426	0.3556	Autoimmune disease, multisystem, with facial dysmorphism	OMIM:613385
1427	0.3554	Dyserythropoietic anemia, congenital, type II	OMIM:224100
1427	0.3554	Hemochromatosis, type 4	OMIM:606069
1429	0.3552	?ABCD syndrome	OMIM:600501
1430	0.3549	Hereditary coproporphyria	ORPHA:79273
1430	0.3549	Porphyria variegata	ORPHA:79473
1430	0.3549	Congenital bile acid synthesis defect type 1	ORPHA:79301
1430	0.3549	Senior-Loken syndrome-1	OMIM:266900
1430	0.3549	Hypophosphatasia, infantile	OMIM:241500
1435	0.3547	Dopamine beta-hydroxylase deficiency	ORPHA:230
1436	0.3546	Hypothyroidism, congenital, nongoitrous, 6	OMIM:614450
1437	0.3545	Autosomal dominant optic atrophy, classic form	ORPHA:98673
1437	0.3545	Autosomal dominant optic atrophy, classic form	ORPHA:98673
1437	0.3545	?Birk-Aharoni syndrome	OMIM:620071
1437	0.3545	Vascular malformation, primary intraosseous	OMIM:606893
1437	0.3545	?Mitochondrial DNA depletion syndrome 18	OMIM:618811
1442	0.3544	Familial renal glucosuria	ORPHA:69076
1443	0.3543	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	OMIM:614878
1443	0.3543	Hyper-IgE recurrent infection syndrome, autosomal recessive	OMIM:243700
1445	0.354	?Bile acid synthesis defect, congenital, 5	OMIM:616278
1446	0.3539	Burkitt lymphoma, somatic	OMIM:113970
1447	0.3537	Classic galactosemia	ORPHA:79239
1448	0.3536	Immunodeficiency 57 with autoinflammation	OMIM:618108
1449	0.3535	Tubulointerstitial kidney disease, autosomal dominant, 2	OMIM:174000
1450	0.3534	Hereditary mixed polyposis syndrome	ORPHA:157794
1450	0.3534	Hereditary mixed polyposis syndrome	ORPHA:157794
1450	0.3534	Immunodeficiency with hyper IgM, type 5	OMIM:608106
1453	0.3533	Polyposis, juvenile intestinal	OMIM:174900
1453	0.3533	Polyposis, juvenile intestinal	OMIM:174900
1453	0.3533	Immunodeficiency with hyper-IgM, type 2	OMIM:605258
1456	0.3532	Severe combined immunodeficiency, B cell-negative	OMIM:601457
1456	0.3532	Severe combined immunodeficiency, B cell-negative	OMIM:601457
1458	0.3531	?Immunodeficiency 25	OMIM:610163
1458	0.3531	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
1458	0.3531	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
1458	0.3531	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
1458	0.3531	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
1463	0.3529	Autosomal erythropoietic protoporphyria	ORPHA:79278
1463	0.3529	Agammaglobulinemia 1	OMIM:601495
1465	0.3526	Combined cellular and humoral immune defects with granulomas	OMIM:233650
1465	0.3526	Combined cellular and humoral immune defects with granulomas	OMIM:233650
1467	0.3525	Neutropenia, severe congenital, 8, autosomal dominant	OMIM:618752
1467	0.3525	Immunodeficiency 72 with autoinflammation	OMIM:618982
1469	0.3524	?Immunodeficiency, common variable, 14	OMIM:617765
1470	0.3522	Kenny-Caffey syndrome, type 1	OMIM:244460
1470	0.3522	?Osteopetrosis, autosomal recessive 9	OMIM:620366
1472	0.352	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	OMIM:614069
1473	0.3517	von Hippel-Lindau syndrome	OMIM:193300
1473	0.3517	von Hippel-Lindau syndrome, modifier of	OMIM:193300
1475	0.3516	Agammaglobulinemia 10, autosomal dominant	OMIM:619707
1475	0.3516	MPI-CDG	ORPHA:79319
1475	0.3516	Hyperlysinemia	OMIM:238700
1475	0.3516	Kenny-Caffey syndrome, type 2	OMIM:127000
1479	0.3515	Agammaglobulinemia 8A, autosomal dominant	OMIM:616941
1479	0.3515	Cerebellar ataxia	OMIM:604290
1481	0.3514	Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	OMIM:612714
1482	0.351	Vitamin K-dependent clotting factors, combined deficiency of, 2	OMIM:607473
1483	0.3509	Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction	OMIM:613759
1483	0.3509	Methemoglobinemia, beta type	OMIM:617971
1483	0.3509	Delta-beta thalassemia	OMIM:141749
1483	0.3509	Fetal hemoglobin quantitative trait locus 1	OMIM:141749
1483	0.3509	Dias-Logan syndrome	OMIM:617101
1483	0.3509	Methemoglobinemia, alpha type	OMIM:617973
1483	0.3509	Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	OMIM:616192
1483	0.3509	Fetal hemoglobin quantitative trait locus 1	OMIM:141749
1483	0.3509	Hereditary methemoglobinemia	ORPHA:621
1483	0.3509	Microcephaly, epilepsy, and diabetes syndrome 2	OMIM:619278
1483	0.3509	Maturity-onset diabetes of the young, type 14	OMIM:616511
1483	0.3509	Hereditary methemoglobinemia	ORPHA:621
1495	0.3506	Neonatal intrahepatic cholestasis due to citrin deficiency	ORPHA:247598
1496	0.3505	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	OMIM:610842
1496	0.3505	?Hemochromatosis, type 5	OMIM:615517
1498	0.3503	Maturity-onset diabetes of the young, type VIII	OMIM:609812
1498	0.3503	Corticosteroid-binding globulin deficiency	OMIM:611489
1500	0.3502	Acatalasemia	ORPHA:926
1500	0.3502	ALG6-CDG	ORPHA:79320
1502	0.3501	Neutropenia, severe congenital 2, autosomal dominant	OMIM:613107
1502	0.3501	Ataxia-telangiectasia	ORPHA:100
1502	0.3501	?Combined oxidative phosphorylation deficiency 41	OMIM:618838
1502	0.3501	Combined oxidative phosphorylation deficiency 40	OMIM:618835
1502	0.3501	Combined oxidative phosphorylation deficiency 42	OMIM:618839
1507	0.35	Protoporphyria, erythropoietic, X-linked	OMIM:300752
1507	0.35	?Protoporphyria, erythropoietic, 2	OMIM:618015
1507	0.35	Imerslund-Grasbeck syndrome 1	OMIM:261100
1507	0.35	Jervell and Lange-Nielsen syndrome	ORPHA:90647
1507	0.35	Jervell and Lange-Nielsen syndrome	ORPHA:90647
1507	0.35	Jervell and Lange-Nielsen syndrome	ORPHA:90647
1507	0.35	3-methylglutaconic aciduria, type V	OMIM:610198
1507	0.35	Imerslund-Grasbeck syndrome 2	OMIM:618882
1515	0.3499	?Polyendocrine-polyneuropathy syndrome	OMIM:616113
1516	0.3498	Mitochondrial complex III deficiency, nuclear type 8	OMIM:615838
1517	0.3496	Hypohidrotic ectodermal dysplasia with immunodeficiency	ORPHA:98813
1517	0.3496	Hypohidrotic ectodermal dysplasia with immunodeficiency	ORPHA:98813
1517	0.3496	?Immunodeficiency 89 and autoimmunity	OMIM:619632
1520	0.3495	Aplastic anemia, susceptibility to	OMIM:609135
1520	0.3495	Aplastic anemia	OMIM:609135
1520	0.3495	Revesz syndrome	OMIM:268130
1520	0.3495	Aplastic anemia	OMIM:609135
1520	0.3495	Aplastic anemia	OMIM:609135
1525	0.3494	?Immunodeficiency 59 and hypoglycemia	OMIM:233600
1526	0.3493	Anemia, hemolytic, due to UMPH1 deficiency	OMIM:266120
1527	0.3492	Congenital disorder of glycosylation, type Ib	OMIM:602579
1528	0.3491	Noonan syndrome 14	OMIM:619745
1528	0.3491	Aicardi-Goutieres syndrome 2	OMIM:610181
1528	0.3491	Gastrointestinal defects and immunodeficiency syndrome 2	OMIM:619708
1528	0.3491	Acquired partial lipodystrophy	ORPHA:79087
1528	0.3491	Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome	ORPHA:391307
1533	0.3489	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay	OMIM:616539
1534	0.3488	Autosomal dominant Kenny-Caffey syndrome	ORPHA:93325
1535	0.3487	Maturity-onset diabetes of the young, type 13	OMIM:616329
1535	0.3487	Diabetes mellitus, transient neonatal 3	OMIM:610582
1535	0.3487	Diabetes mellitus, permanent neonatal 1	OMIM:606176
1535	0.3487	Diabetes mellitus, permanent neonatal 4	OMIM:618858
1539	0.3486	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	OMIM:612300
1539	0.3486	Hereditary hemorrhagic telangiectasia	ORPHA:774
1539	0.3486	Hereditary hemorrhagic telangiectasia	ORPHA:774
1539	0.3486	Hereditary hemorrhagic telangiectasia	ORPHA:774
1539	0.3486	?Paroxysmal nocturnal hemoglobinuria 2	OMIM:615399
1539	0.3486	Hereditary hemorrhagic telangiectasia	ORPHA:774
1545	0.3485	Immunodeficiency 15A	OMIM:618204
1545	0.3485	Gaucher disease, type IIIC	OMIM:231005
1545	0.3485	ROSAH syndrome	OMIM:614979
1548	0.3483	Protoporphyria, erythropoietic, 1	OMIM:177000
1548	0.3483	Mandibuloacral dysplasia progeroid syndrome	OMIM:619127
1550	0.3482	Autoinflammation with episodic fever and lymphadenopathy	OMIM:618852
1551	0.3481	Hypermanganesemia with dystonia 1	OMIM:613280
1552	0.348	Autoinflammatory disease, systemic, X-linked	OMIM:301081
1553	0.3478	Immunodeficiency 70	OMIM:618969
1553	0.3478	Myopathy with extrapyramidal signs	OMIM:615673
1555	0.3476	Immunodeficiency 43	OMIM:241600
1555	0.3476	S-adenosylhomocysteine hydrolase deficiency	ORPHA:88618
1557	0.3474	Neurodevelopmental disorder with hypotonia and dysmorphic facies	OMIM:619503
1558	0.3472	Mastocytosis, cutaneous	OMIM:154800
1558	0.3472	Triokinase and FMN cyclase deficiency syndrome	OMIM:618805
1558	0.3472	Myopathy, lactic acidosis, and sideroblastic anemia 2	OMIM:613561
1558	0.3472	?Mitochondrial DNA depletion syndrome 19	OMIM:618972
1562	0.3471	SPONASTRIME dysplasia	ORPHA:93357
1563	0.3468	Congenital factor XI deficiency	ORPHA:329
1564	0.3464	Atransferrinemia	OMIM:209300
1565	0.3463	Syndromic multisystem autoimmune disease due to Itch deficiency	ORPHA:228426
1566	0.3461	Von Hippel-Lindau disease	ORPHA:892
1566	0.3461	Von Hippel-Lindau disease	ORPHA:892
1568	0.3459	Sialuria	ORPHA:3166
1569	0.3457	Hyper-IgE recurrent infection syndrome 5, autosomal recessive	OMIM:618944
1570	0.3456	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	OMIM:618282
1571	0.3454	?Immunodeficiency 37	OMIM:616098
1572	0.3451	Combined immunodeficiency due to partial RAG1 deficiency	ORPHA:231154
1573	0.345	X-linked severe congenital neutropenia	ORPHA:86788
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1573	0.345	MODY	ORPHA:552
1587	0.3448	Wolcott-Rallison syndrome	ORPHA:1667
1588	0.3447	Dyskeratosis congenita, autosomal recessive 3	OMIM:613988
1588	0.3447	Alpha-mannosidosis, infantile form	ORPHA:309282
1588	0.3447	Alpha-mannosidosis, adult form	ORPHA:309288
1591	0.3445	Spondylometaphyseal dysplasia, 'corner fracture' type	ORPHA:93315
1591	0.3445	Spondylometaphyseal dysplasia, 'corner fracture' type	ORPHA:93315
1593	0.3444	Abdominal obesity-metabolic syndrome 4	OMIM:618620
1594	0.344	Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations	ORPHA:247691
1594	0.344	B-cell expansion with NFKB and T-cell anergy	OMIM:616452
1594	0.344	?Epidermodysplasia verruciformis, susceptibility to, 5	OMIM:618309
1597	0.3437	Spondyloepimetaphyseal dysplasia, sponastrime type	OMIM:271510
1597	0.3437	Immunodeficiency due to defect in MAPBP-interacting protein	OMIM:610798
1599	0.3436	Farber lipogranulomatosis	OMIM:228000
1600	0.3435	Hemophilia B	OMIM:306900
1600	0.3435	Factor V deficiency	OMIM:227400
1602	0.3434	Lead poisoning, susceptibility to	OMIM:612740
1602	0.3434	Porphyria, acute hepatic	OMIM:612740
1602	0.3434	Hemolytic anemia due to glutathione synthetase deficiency	OMIM:231900
1602	0.3434	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	OMIM:230450
1602	0.3434	Hemolytic anemia due to adenylate kinase deficiency	OMIM:612631
1602	0.3434	Galactosemia	OMIM:230400
1602	0.3434	?Hemolytic anemia, congenital, X-linked	OMIM:301015
1609	0.3433	Lesch-Nyhan syndrome	OMIM:300322
1610	0.3431	Bile acid synthesis defect, congenital, 2	OMIM:235555
1611	0.343	Immunodeficiency 79	OMIM:619238
1612	0.3428	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	OMIM:251900
1613	0.3427	RENI syndrome	OMIM:617575
1613	0.3427	Combined deficiency of factor V and factor VIII	ORPHA:35909
1613	0.3427	Combined deficiency of factor V and factor VIII	ORPHA:35909
1616	0.3423	Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis	OMIM:612852
1617	0.3421	Congenital disorder of glycosylation, type Ig	OMIM:607143
1618	0.3419	Immunodeficiency 86, mycobacteriosis	OMIM:619549
1619	0.3418	Obesity due to leptin receptor gene deficiency	ORPHA:179494
1619	0.3418	Obesity due to congenital leptin deficiency	ORPHA:66628
1619	0.3418	Methemoglobinemia and ambiguous genitalia	OMIM:250790
1622	0.3417	Bile acid synthesis defect, congenital, 1	OMIM:607765
1623	0.3407	Pseudohyperkalemia, familial, 2, due to red cell leak	OMIM:609153
1623	0.3407	Combined immunodeficiency due to DOCK8 deficiency	ORPHA:217390
1625	0.3405	Methylmalonic acidemia with homocystinuria type cblF	ORPHA:79284
1626	0.3402	Factor XII deficiency	OMIM:234000
1627	0.3397	Brain small vessel disease with or without ocular anomalies	OMIM:175780
1628	0.3395	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	OMIM:601705
1629	0.339	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A	OMIM:620358
1630	0.3389	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	OMIM:618321
1631	0.3387	Combined oxidative phosphorylation deficiency 53	OMIM:619423
1632	0.3383	Factor X deficiency	OMIM:227600
1633	0.338	Dilated cardiomyopathy with ataxia	ORPHA:66634
1633	0.338	Hennekam syndrome	ORPHA:2136
1633	0.338	Hennekam syndrome	ORPHA:2136
1633	0.338	Hennekam syndrome	ORPHA:2136
1637	0.3377	Glycogen storage disease due to aldolase A deficiency	ORPHA:57
1638	0.3374	Immunodeficiency 11B with atopic dermatitis	OMIM:617638
1639	0.3373	Fanconi anemia, complementation group N	OMIM:610832
1640	0.3372	?Immunodeficiency 94 with autoinflammation and dysmorphic facies	OMIM:619750
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1641	0.3371	Autosomal agammaglobulinemia	ORPHA:33110
1651	0.3369	Ectodermal dysplasia and immunodeficiency 1	OMIM:300291
1652	0.3368	Immunodeficiency 7, TCR-alpha/beta deficient	OMIM:615387
1653	0.3367	Autoinflammation with arthritis and dyskeratosis	OMIM:617388
1653	0.3367	WHIM syndrome 1	OMIM:193670
1653	0.3367	Acrodermatitis enteropathica	OMIM:201100
1653	0.3367	Seckel syndrome 10	OMIM:617253
1657	0.3365	Hyper-IgE recurrent infection syndrome 4B, autosomal recessive	OMIM:618523
1657	0.3365	Peeling skin syndrome 1	OMIM:270300
1659	0.3362	?Reynolds syndrome	OMIM:613471
1660	0.3357	?Combined oxidative phosphorylation deficiency 34	OMIM:617872
1660	0.3357	?Proteasome-associated autoinflammatory syndrome 4	OMIM:619183
1662	0.3356	Severe combined immunodeficiency due to FOXN1 deficiency	ORPHA:169095
1662	0.3356	?Rajab interstitial lung disease with brain calcifications 2	OMIM:619013
1662	0.3356	?Leukodystrophy, hypomyelinating, 24	OMIM:619851
1665	0.3351	Cholestasis, progressive familial intrahepatic, 12	OMIM:620010
1666	0.3342	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	OMIM:612073
1667	0.334	Congenital disorder of glycosylation, type IIt	OMIM:618885
1668	0.3337	Congenital disorder of glycosylation, type It	OMIM:614921
1669	0.3336	CHARGE syndrome	OMIM:214800
1670	0.3332	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	ORPHA:70592
1670	0.3332	Intellectual developmental disorder, autosomal dominant 54	OMIM:617799
1670	0.3332	Developmental delay, hypotonia, and impaired language	OMIM:620012
1670	0.3332	Saul-Wilson syndrome	OMIM:618150
1670	0.3332	Primary immunodeficiency syndrome due to LAMTOR2 deficiency	ORPHA:90023
1670	0.3332	Cohen syndrome	ORPHA:193
1676	0.3329	Essential fructosuria	ORPHA:2056
1677	0.3327	Immunodeficiency 58	OMIM:618131
1678	0.3326	Hemolytic anemia due to glutathione reductase deficiency	OMIM:618660
1679	0.332	Noonan syndrome 10	OMIM:616564
1680	0.3319	Homocystinuria-megaloblastic anemia, cbl E type	OMIM:236270
1680	0.3319	3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form	ORPHA:79351
1682	0.3316	Combined immunodeficiency-enteropathy spectrum	ORPHA:436252
1682	0.3316	Autosomal dominant hypophosphatemic rickets	ORPHA:89937
1682	0.3316	Lethal ataxia with deafness and optic atrophy	ORPHA:1187
1682	0.3316	Combined immunodeficiency-enteropathy spectrum	ORPHA:436252
1686	0.3315	Neutropenia, severe congenital, 7, autosomal recessive	OMIM:617014
1686	0.3315	Hyper-IgE recurrent infection syndrome	OMIM:147060
1686	0.3315	Neutropenia, severe congenital, 6, autosomal recessive	OMIM:616022
1689	0.3313	Netherton syndrome	OMIM:256500
1690	0.3309	VISS syndrome	OMIM:619472
1691	0.3304	Mitochondrial complex IV deficiency, nuclear type 3	OMIM:619046
1691	0.3304	Immunodeficiency 104, severe combined	OMIM:608971
1693	0.3303	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	OMIM:614893
1693	0.3303	Congenital disorder of glycosylation with defective fucosylation 1	OMIM:618005
1695	0.3299	Infantile liver failure syndrome 3	OMIM:618641
1696	0.3296	Neutropenia, cyclic	OMIM:162800
1697	0.3295	Cowden syndrome 1	OMIM:158350
1698	0.3289	Bile acid synthesis defect, congenital, 3	OMIM:613812
1699	0.3287	Factor XIIIA deficiency	OMIM:613225
1699	0.3287	Factor XIIIB deficiency	OMIM:613235
1699	0.3287	PAPA syndrome	ORPHA:69126
1699	0.3287	Thrombophilia 7 due to antithrombin III deficiency	OMIM:613118
1699	0.3287	Hereditary thrombophilia due to congenital antithrombin deficiency	ORPHA:82
1699	0.3287	Congenital disorder of glycosylation, type Ic	OMIM:603147
1705	0.3278	?WHIM syndrome 2	OMIM:619407
1706	0.3273	Factor XI deficiency, autosomal dominant	OMIM:612416
1706	0.3273	Thrombophilia 11 due to HRG deficiency	OMIM:613116
1706	0.3273	Congenital factor XII deficiency	ORPHA:330
1709	0.3271	?Hermansky-Pudlak syndrome 10	OMIM:617050
1710	0.3268	3-methylglutaconic aciduria type 7	ORPHA:445038
1711	0.3266	Tall stature-intellectual disability-renal anomalies syndrome	ORPHA:500095
1712	0.3263	Moderate hemophilia A	ORPHA:169805
1713	0.3259	Spinocerebellar ataxia, autosomal recessive 23	OMIM:616949
1714	0.3253	Thrombophilia, susceptibility to, due to factor V Leiden	OMIM:188055
1714	0.3253	Thrombophilia 2 due to activated protein C resistance	OMIM:188055
1716	0.325	Congenital factor X deficiency	ORPHA:328
1716	0.325	3-methylglutaconic aciduria, type VIII	OMIM:617248
1718	0.3248	?Immunodeficiency, common variable, 7	OMIM:614699
1719	0.3246	Mowat-Wilson syndrome due to a ZEB2 point mutation	ORPHA:261552
1719	0.3246	Mowat-Wilson syndrome due to monosomy 2q22	ORPHA:261537
1721	0.3244	Gitelman syndrome	ORPHA:358
1721	0.3244	Gitelman syndrome	ORPHA:358
1723	0.3243	McCune-Albright syndrome	ORPHA:562
1723	0.3243	RIDDLE syndrome	ORPHA:420741
1723	0.3243	Thauvin-Robinet-Faivre syndrome	OMIM:617107
1726	0.324	Peutz-Jeghers syndrome	OMIM:175200
1727	0.3239	Factor V and factor VIII, combined deficiency of	OMIM:613625
1727	0.3239	Combined factor V and VIII deficiency	OMIM:227300
1729	0.3237	Hyperimmunoglobulinemia D with periodic fever	ORPHA:343
1730	0.3231	Homocystinuria-megaloblastic anemia, cblG complementation type	OMIM:250940
1731	0.3227	Pyridoxal phosphate-responsive seizures	ORPHA:79096
1732	0.3224	Hemophilia A	OMIM:306700
1732	0.3224	Bleeding disorder in hemophilia A carriers	ORPHA:177926
1732	0.3224	Thrombophilia 8, X-linked, due to factor IX defect	OMIM:300807
1732	0.3224	Deep venous thrombosis, protection against	OMIM:300807
1736	0.3222	Hepatic venoocclusive disease with immunodeficiency	OMIM:235550
1737	0.3214	Fanconi anemia, complementation group I	OMIM:609053
1738	0.3213	Mitochondrial complex I deficiency, nuclear type 33	OMIM:618253
1739	0.3207	Glycogen storage disease Ib	OMIM:232220
1740	0.3193	Burkitt lymphoma	ORPHA:543
1741	0.3191	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
1741	0.3191	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
1741	0.3191	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
1744	0.3185	SSR4-CDG	ORPHA:370927
1745	0.3182	X-linked intellectual disability, Nascimento type	ORPHA:163956
1746	0.3169	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	OMIM:615471
1747	0.3162	Mucoepithelial dysplasia, hereditary	OMIM:158310
1747	0.3162	?Immunodeficiency 88	OMIM:619630
1747	0.3162	Ichthyosis-prematurity syndrome	ORPHA:88621
1750	0.3133	Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian)	OMIM:220111
1751	0.3132	Wrinkly skin syndrome	ORPHA:2834
1752	0.3125	Incontinentia pigmenti	ORPHA:464
1753	0.3113	Thrombophilia 5 due to protein S deficiency, autosomal dominant	OMIM:612336
1753	0.3113	Thrombophilia 3 due to protein C deficiency, autosomal recessive	OMIM:612304
1753	0.3113	Thrombophilia 3 due to protein C deficiency, autosomal dominant	OMIM:176860
1756	0.3107	Bile acid synthesis defect, congenital, 4	OMIM:214950
1757	0.3106	Hypoprothrombinemia	OMIM:613679
1758	0.3097	Hypoplasminogenemia	ORPHA:722
1758	0.3097	Dysplasminogenemia	OMIM:217090
1760	0.3095	Muscular dystrophy, limb-girdle, autosomal recessive 1	OMIM:253600
1761	0.3093	Hereditary fructose intolerance	ORPHA:469
1762	0.3088	Congenital disorder of glycosylation, type Ij	OMIM:608093
1763	0.3078	Proteus syndrome	ORPHA:744
1763	0.3078	Autoinflammation, immune dysregulation, and eosinophilia	OMIM:618999
1763	0.3078	Factor VII deficiency	OMIM:227500
1763	0.3078	Proteus syndrome	ORPHA:744
1767	0.3074	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	OMIM:614739
1768	0.3073	Combined low LDL and fibrinogen	OMIM:620364
1769	0.3072	Pyruvate dehydrogenase E3 deficiency	ORPHA:2394
1770	0.3069	Mitochondrial complex IV deficiency, nuclear type 22	OMIM:619355
1771	0.3065	Simpson-Golabi-Behmel syndrome	ORPHA:373
1771	0.3065	Simpson-Golabi-Behmel syndrome	ORPHA:373
1773	0.3064	Congenital muscular dystrophy with intellectual disability and severe epilepsy	ORPHA:329178
1774	0.3054	Warburg-Cinotti syndrome	OMIM:618175
1775	0.3053	Lipodystrophy, congenital generalized, type 4	OMIM:613327
1776	0.3043	Malignant hyperthermia susceptibility 1	OMIM:145600
1777	0.3041	Malignant hyperthermia of anesthesia	ORPHA:423
1777	0.3041	Malignant hyperthermia of anesthesia	ORPHA:423
1779	0.3033	Cholestasis, progressive familial intrahepatic, 5	OMIM:617049
1780	0.3026	Thrombophilia 13, X-linked, due to factor VIII defect	OMIM:301071
1780	0.3026	Scott syndrome	OMIM:262890
1782	0.3017	Dubin-Johnson syndrome	ORPHA:234
1783	0.3015	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	ORPHA:415
1784	0.2997	Fletcher factor (prekallikrein) deficiency	OMIM:612423
1785	0.2996	Liver failure, transient infantile	OMIM:613070
1786	0.2994	Familial papillary or follicular thyroid carcinoma	ORPHA:319487
1786	0.2994	Familial papillary or follicular thyroid carcinoma	ORPHA:319487
1786	0.2994	Familial papillary or follicular thyroid carcinoma	ORPHA:319487
1789	0.2993	Glycosylphosphatidylinositol deficiency	OMIM:610293
1790	0.2992	Familial Mediterranean fever	ORPHA:342
1790	0.2992	Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency	ORPHA:71212
1790	0.2992	COG2-CDG	ORPHA:435934
1793	0.2986	Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome	ORPHA:457485
1793	0.2986	Mitochondrial complex IV deficiency, nuclear type 12	OMIM:619055
1795	0.2984	ALG2-CDG	ORPHA:79326
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency	ORPHA:91135
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	RFT1-CDG	ORPHA:244310
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Zellweger syndrome	ORPHA:912
1795	0.2984	Congenital disorder of glycosylation, type Iy	OMIM:300934
1795	0.2984	Zellweger syndrome	ORPHA:912
1812	0.2969	Congenital disorder of glycosylation, type IId	OMIM:607091
1813	0.2967	Lymphatic malformation 6	OMIM:616843
1814	0.2966	Hypoparathyroidism-sensorineural deafness-renal disease syndrome	ORPHA:2237
1815	0.2956	Pulmonary fibrosis, idiopathic, susceptibility to	OMIM:178500
1815	0.2956	Interstitial lung disease 2	OMIM:178500
1817	0.2955	AGel amyloidosis	ORPHA:85448
1818	0.2954	Trichothiodystrophy 1, photosensitive	OMIM:601675
1819	0.2952	Combined oxidative phosphorylation deficiency 37	OMIM:618329
1820	0.2951	Amyloidosis, familial visceral	OMIM:105200
1820	0.2951	?Amyloidosis, familial visceral	OMIM:105200
1820	0.2951	Amyloidosis, 3 or more types	OMIM:105200
1820	0.2951	Amyloidosis, renal	OMIM:105200
1820	0.2951	Polycystic kidney disease 4, with or without hepatic disease	OMIM:263200
1825	0.295	Meige disease	ORPHA:90186
1825	0.295	Cutis laxa, autosomal recessive, type IC	OMIM:613177
1827	0.2945	Multiple endocrine neoplasia type 1	ORPHA:652
1827	0.2945	Multiple endocrine neoplasia type 1	ORPHA:652
1827	0.2945	Multiple endocrine neoplasia type 1	ORPHA:652
1827	0.2945	Multiple endocrine neoplasia type 1	ORPHA:652
1827	0.2945	Multiple endocrine neoplasia type 1	ORPHA:652
1832	0.2944	Gracile bone dysplasia	OMIM:602361
1833	0.2938	Congenital analbuminemia	ORPHA:86816
1834	0.2936	Fanconi anemia, complementation group Q	OMIM:615272
1834	0.2936	Osteopetrosis, autosomal dominant 2	OMIM:166600
1834	0.2936	Fanconi anemia, complementation group J	OMIM:609054
1834	0.2936	Dyskeratosis congenita, autosomal recessive 6	OMIM:616353
1834	0.2936	Methylmalonic acidemia with homocystinuria, type cblD	ORPHA:79283
1834	0.2936	Cranioectodermal dysplasia 4	OMIM:614378
1834	0.2936	?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 5	OMIM:618674
1841	0.2935	Lymphoma, MALT, somatic	OMIM:137245
1842	0.2933	Diarrhea 10, protein-losing enteropathy type	OMIM:618183
1843	0.2927	Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion	ORPHA:363700
1844	0.2926	?Immunodeficiency 61	OMIM:300310
1844	0.2926	Hypermethioninemia due to adenosine kinase deficiency	OMIM:614300
1846	0.2923	Pancreatic hypoplasia-diabetes-congenital heart disease syndrome	ORPHA:2255
1846	0.2923	DDOST-CDG	ORPHA:300536
1846	0.2923	Thrombophilia 12 due to thrombomodulin defect	OMIM:614486
1846	0.2923	Congenital disorder of glycosylation, type If	OMIM:609180
1846	0.2923	Congenital disorder of glycosylation, type In	OMIM:612015
1846	0.2923	HSD10 disease, neonatal type	ORPHA:391457
1846	0.2923	Developmental and epileptic encephalopathy 36	OMIM:300884
1846	0.2923	Biliary, renal, neurologic, and skeletal syndrome	OMIM:619534
1854	0.2922	Mucopolysaccharidosis type 7	ORPHA:584
1855	0.2917	Multiple endocrine neoplasia type 4	ORPHA:276152
1856	0.2914	CD8 deficiency, familial	OMIM:608957
1857	0.2913	Budd-Chiari syndrome	ORPHA:131
1857	0.2913	Budd-Chiari syndrome	ORPHA:131
1857	0.2913	Budd-Chiari syndrome	ORPHA:131
1857	0.2913	Sclerosing cholangitis, neonatal	OMIM:617394
1861	0.2912	Lymphangioleiomyomatosis	ORPHA:538
1861	0.2912	Lymphangioleiomyomatosis	ORPHA:538
1863	0.291	Neutropenia, severe congenital, 9, autosomal dominant	OMIM:619813
1864	0.2909	Ornithine transcarbamylase deficiency	OMIM:311250
1865	0.2907	Velocardiofacial syndrome	OMIM:192430
1866	0.2906	Johanson-Blizzard syndrome	OMIM:243800
1867	0.2894	Greenberg skeletal dysplasia	OMIM:215140
1867	0.2894	Infantile liver failure syndrome 2	OMIM:616483
1869	0.2891	Pleural mesothelioma	ORPHA:50251
1870	0.289	Glycogen storage disease IV	OMIM:232500
1870	0.289	Congenital disorder of glycosylation, type Il	OMIM:608776
1872	0.2889	Pulmonary capillary hemangiomatosis	ORPHA:199241
1873	0.2884	HFE hemochromatosis, modifier of	OMIM:235200
1873	0.2884	Hemochromatosis, type 1	OMIM:235200
1875	0.2879	Systemic-onset juvenile idiopathic arthritis	ORPHA:85414
1875	0.2879	Systemic-onset juvenile idiopathic arthritis	ORPHA:85414
1875	0.2879	Systemic-onset juvenile idiopathic arthritis	ORPHA:85414
1875	0.2879	Cystinosis, nephropathic	OMIM:219800
1875	0.2879	Systemic-onset juvenile idiopathic arthritis	ORPHA:85414
1880	0.2878	Cholestasis, progressive familial intrahepatic 3	OMIM:602347
1881	0.2877	Okur-Chung neurodevelopmental syndrome	OMIM:617062
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1882	0.2876	Beh√ßet disease	ORPHA:117
1895	0.2872	Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome	ORPHA:500150
1896	0.2867	Congenital alpha2-antiplasmin deficiency	ORPHA:79
1897	0.2857	COG8-CDG	ORPHA:95428
1898	0.2854	Netherton syndrome	ORPHA:634
1899	0.2849	Familial pancreatic carcinoma	ORPHA:1333
1899	0.2849	Familial pancreatic carcinoma	ORPHA:1333
1899	0.2849	Familial pancreatic carcinoma	ORPHA:1333
1899	0.2849	Familial pancreatic carcinoma	ORPHA:1333
1899	0.2849	Congenital disorder of glycosylation, type IIb	OMIM:606056
1899	0.2849	Familial pancreatic carcinoma	ORPHA:1333
1899	0.2849	Familial pancreatic carcinoma	ORPHA:1333
1899	0.2849	Familial pancreatic carcinoma	ORPHA:1333
1899	0.2849	Familial pancreatic carcinoma	ORPHA:1333
1899	0.2849	Familial pancreatic carcinoma	ORPHA:1333
1909	0.2847	Immunodeficiency, common variable, 10	OMIM:615577
1910	0.2841	Cystic fibrosis lung disease, modifier of	OMIM:219700
1910	0.2841	Cystic fibrosis	OMIM:219700
1910	0.2841	Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis	OMIM:219700
1913	0.284	Fish-eye disease	ORPHA:79292
1914	0.2836	Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency	ORPHA:319600
1914	0.2836	Immunodeficiency 38	OMIM:616126
1914	0.2836	Deafness, autosomal dominant 34, with or without inflammation	OMIM:617772
1917	0.2835	Primary biliary cholangitis	ORPHA:186
1917	0.2835	Primary biliary cholangitis	ORPHA:186
1917	0.2835	Primary biliary cholangitis	ORPHA:186
1917	0.2835	Primary biliary cholangitis	ORPHA:186
1917	0.2835	Primary biliary cholangitis	ORPHA:186
1917	0.2835	Primary biliary cholangitis	ORPHA:186
1917	0.2835	Primary biliary cholangitis	ORPHA:186
1917	0.2835	Primary biliary cholangitis	ORPHA:186
1925	0.2832	Immunodeficiency, developmental delay, and hypohomocysteinemia	OMIM:617744
1925	0.2832	Squamous cell carcinoma of the esophagus	ORPHA:99977
1925	0.2832	Squamous cell carcinoma of the esophagus	ORPHA:99977
1925	0.2832	Perlman syndrome	OMIM:267000
1925	0.2832	Squamous cell carcinoma of the esophagus	ORPHA:99977
1925	0.2832	Squamous cell carcinoma of the esophagus	ORPHA:99977
1931	0.283	Lymphatic malformation 13	OMIM:620244
1932	0.2825	Infantile systemic hyalinosis	ORPHA:2176
1933	0.2818	Periodic fever, familial	OMIM:142680
1934	0.2811	Hyperlipoproteinemia, type 1D	OMIM:615947
1935	0.2809	Nephroblastoma	ORPHA:654
1935	0.2809	Nephroblastoma	ORPHA:654
1935	0.2809	Nephroblastoma	ORPHA:654
1935	0.2809	Nephroblastoma	ORPHA:654
1935	0.2809	Nephroblastoma	ORPHA:654
1935	0.2809	Nephroblastoma	ORPHA:654
1935	0.2809	Nephroblastoma	ORPHA:654
1935	0.2809	Nephroblastoma	ORPHA:654
1943	0.2802	Proteus-like syndrome	ORPHA:2969
1944	0.2797	Proteus syndrome, somatic	OMIM:176920
1945	0.2791	Cherubism	OMIM:118400
1945	0.2791	Matthew-Wood syndrome	ORPHA:2470
1945	0.2791	Matthew-Wood syndrome	ORPHA:2470
1945	0.2791	Immunodeficiency 27B, mycobacteriosis, AD	OMIM:615978
1945	0.2791	Matthew-Wood syndrome	ORPHA:2470
1945	0.2791	Fraser syndrome 1	OMIM:219000
1951	0.2783	Familial atrial myxoma	ORPHA:615
1951	0.2783	Paroxysmal nocturnal hemoglobinuria, somatic	OMIM:300818
1951	0.2783	Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome	ORPHA:369837
1954	0.2782	Diabetes mellitus, neonatal, with congenital hypothyroidism	OMIM:610199
1955	0.2775	Smith-Lemli-Opitz syndrome	OMIM:270400
1955	0.2775	Sarcoidosis, susceptibility to, 2	OMIM:612387
1957	0.2772	Galactosialidosis	OMIM:256540
1958	0.2763	Hemolytic disease of fetus and newborn, RH-induced	OMIM:619462
1959	0.2762	Noonan syndrome 9	OMIM:616559
1959	0.2762	Congenital factor VII deficiency	ORPHA:327
1961	0.2761	Solitary fibrous tumor	ORPHA:2126
1961	0.2761	Microphthalmia, syndromic 9	OMIM:601186
1961	0.2761	Solitary fibrous tumor	ORPHA:2126
1964	0.276	Alveolar capillary dysplasia with misalignment of pulmonary veins	OMIM:265380
1965	0.2758	Lymphatic malformation 1	OMIM:153100
1966	0.2757	Meckel syndrome 1	OMIM:249000
1967	0.2756	Feingold syndrome 1	OMIM:164280
1968	0.2755	Cranioectodermal dysplasia 2	OMIM:613610
1969	0.2754	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	ORPHA:69735
1970	0.2753	Truncus arteriosus	ORPHA:3384
1970	0.2753	Truncus arteriosus	ORPHA:3384
1972	0.275	Cockayne syndrome, type A	OMIM:216400
1972	0.275	D-bifunctional protein deficiency	OMIM:261515
1974	0.2748	22q11.2 duplication syndrome	ORPHA:1727
1974	0.2748	Hyperparathyroidism, transient neonatal	OMIM:618188
1976	0.2747	Hyperlipoproteinemia, type Ib	OMIM:207750
1977	0.2746	Kaposi sarcoma, susceptibility to	OMIM:148000
1977	0.2746	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	OMIM:615508
1979	0.2743	Mucolipidosis II alpha/beta	OMIM:252500
1980	0.2742	Cutis marmorata telangiectatica congenita	ORPHA:1556
1980	0.2742	Cutis marmorata telangiectatica congenita	ORPHA:1556
1982	0.2741	Branchiooculofacial syndrome	OMIM:113620
1983	0.2739	Symptomatic form of HFE-related hemochromatosis	ORPHA:465508
1983	0.2739	Symptomatic form of HFE-related hemochromatosis	ORPHA:465508
1985	0.2738	Myotonic dystrophy 2	OMIM:602668
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Heterotaxy, visceral, 4, autosomal	OMIM:613751
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Heterotaxy, visceral, 2, autosomal	OMIM:605376
1986	0.2736	Right atrial isomerism (Ivemark)	OMIM:208530
1986	0.2736	Congenital heart defects, nonsyndromic, 1, X-linked	OMIM:306955
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Renal-hepatic-pancreatic dysplasia 1	OMIM:208540
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Primary ciliary dyskinesia	ORPHA:244
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Meckel syndrome	ORPHA:564
1986	0.2736	Meckel syndrome	ORPHA:564
2056	0.273	Lipoprotein lipase deficiency	OMIM:238600
2056	0.273	Roberts-SC phocomelia syndrome	OMIM:268300
2058	0.2725	Lethal congenital contracture syndrome 10	OMIM:617022
2059	0.2724	Mulibrey nanism	OMIM:253250
2060	0.2719	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	OMIM:240300
2061	0.2717	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	OMIM:606002
2062	0.2713	Adams-Oliver syndrome 5	OMIM:616028
2062	0.2713	Cardiofaciocutaneous syndrome	OMIM:115150
2064	0.2712	Myopathy, epilepsy, and progressive cerebral atrophy	OMIM:619036
2065	0.271	Immunodeficiency 33	OMIM:300636
2066	0.2707	Carpenter syndrome	OMIM:201000
2066	0.2707	Carpenter syndrome	ORPHA:65759
2066	0.2707	Carpenter syndrome	ORPHA:65759
2066	0.2707	Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia	OMIM:619306
2066	0.2707	Meacham syndrome	OMIM:608978
2066	0.2707	Holoprosencephaly 11	OMIM:614226
2066	0.2707	Sweeney-Cox syndrome	OMIM:617746
2066	0.2707	?Tetra-amelia syndrome 1	OMIM:273395
2066	0.2707	Congenital heart defects, multiple types, 8, with or without heterotaxy	OMIM:619657
2066	0.2707	Stromme syndrome	OMIM:243605
2066	0.2707	Heterotaxy, visceral, 5	OMIM:270100
2066	0.2707	Renal-hepatic-pancreatic dysplasia 2	OMIM:615415
2066	0.2707	Cardiac-urogenital syndrome	OMIM:618280
2066	0.2707	Heterotaxy, visceral, 9, autosomal, with male infertility	OMIM:618948
2066	0.2707	Congenital alveolar capillary dysplasia	ORPHA:210122
2066	0.2707	Ciliary dyskinesia, primary, 1, with or without situs inversus	OMIM:244400
2066	0.2707	Ciliary dyskinesia, primary, 25	OMIM:615482
2066	0.2707	Hydrolethalus syndrome	OMIM:236680
2066	0.2707	Ciliary dyskinesia, primary, 14	OMIM:613807
2066	0.2707	Heterotaxy, visceral, 7, autosomal	OMIM:616749
2066	0.2707	Cardiofacioneurodevelopmental syndrome	OMIM:619123
2066	0.2707	Heterotaxy, visceral, 11, autosomal, with male infertility	OMIM:619608
2088	0.2706	Glycogen storage disease, type IXa2	OMIM:306000
2089	0.2703	Vici syndrome	ORPHA:1493
2090	0.2699	Palmoplantar keratoderma-esophageal carcinoma syndrome	ORPHA:2198
2090	0.2699	Pulmonary venoocclusive disease 2	OMIM:234810
2092	0.2696	Glycogen storage disease IXc	OMIM:613027
2092	0.2696	Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome	OMIM:620186
2094	0.2695	Capillary malformation-arteriovenous malformation	ORPHA:137667
2094	0.2695	Capillary malformation-arteriovenous malformation	ORPHA:137667
2096	0.2694	Mucopolysaccharidosis VII	OMIM:253220
2097	0.2691	Cholesteryl ester storage disease	ORPHA:75234
2097	0.2691	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	OMIM:261750
2099	0.2688	Glycogen storage disease of heart, lethal congenital	OMIM:261740
2100	0.2687	Multiple benign circumferential skin creases on limbs	ORPHA:2505
2100	0.2687	Multiple benign circumferential skin creases on limbs	ORPHA:2505
2102	0.2683	?Inflammatory skin and bowel disease, neonatal, 2	OMIM:616069
2103	0.2682	CLOVE syndrome, somatic	OMIM:612918
2104	0.268	Pituitary adenoma 4, ACTH-secreting, somatic	OMIM:219090
2105	0.2677	Mitochondrial complex I deficiency, nuclear type 1	OMIM:252010
2106	0.2675	Ornithine transcarbamylase deficiency	ORPHA:664
2107	0.2673	Simpson-Golabi-Behmel syndrome, type 1	OMIM:312870
2108	0.267	Congenital disorder of glycosylation, type IIe	OMIM:608779
2109	0.2668	Congenital disorder of glycosylation, type Ik	OMIM:608540
2110	0.2667	Hypoinsulinemic hypoglycemia and body hemihypertrophy	ORPHA:293964
2111	0.2665	Treacher-Collins syndrome	ORPHA:861
2111	0.2665	Treacher-Collins syndrome	ORPHA:861
2111	0.2665	Treacher-Collins syndrome	ORPHA:861
2111	0.2665	Treacher-Collins syndrome	ORPHA:861
2115	0.2663	?Immunodeficiency 66	OMIM:618847
2116	0.2662	Lipodystrophy, congenital generalized, type 3	OMIM:612526
2116	0.2662	Hereditary angioedema type 1	ORPHA:100050
2118	0.2658	Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency	ORPHA:90791
2119	0.2657	Congenital disorder of glycosylation, type IIo	OMIM:616828
2120	0.2654	Juvenile nephropathic cystinosis	ORPHA:411634
2121	0.2653	Ovarian hyperstimulation syndrome	ORPHA:64739
2122	0.265	Glycogen storage disease II	OMIM:232300
2123	0.2648	Cholestasis, progressive familial intrahepatic, 10	OMIM:619868
2124	0.2644	Kappa light chain deficiency	OMIM:614102
2125	0.2637	Growth hormone insensitivity with immune dysregulation 2, autosomal dominant	OMIM:618985
2125	0.2637	?Spondyloepimetaphyseal dysplasia, Krakow type	OMIM:618162
2127	0.2635	Primary Fanconi renotubular syndrome	ORPHA:3337
2127	0.2635	Primary Fanconi renotubular syndrome	ORPHA:3337
2127	0.2635	Primary Fanconi renotubular syndrome	ORPHA:3337
2127	0.2635	Primary Fanconi renotubular syndrome	ORPHA:3337
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2131	0.2631	Lynch syndrome	ORPHA:144
2142	0.2628	Carney complex	ORPHA:1359
2142	0.2628	Carney complex	ORPHA:1359
2144	0.2626	46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency	ORPHA:168558
2145	0.2623	Mitochondrial complex III deficiency, nuclear type 6	OMIM:615453
2146	0.2621	Wiedemann-Rautenstrauch syndrome	OMIM:264090
2147	0.2618	Hemorrhagic diathesis due to antithrombin Pittsburgh	OMIM:613490
2147	0.2618	Neonatal severe primary hyperparathyroidism	ORPHA:417
2147	0.2618	Neonatal severe primary hyperparathyroidism	ORPHA:417
2150	0.2617	Alstr√∂m syndrome	ORPHA:64
2151	0.2615	Milroy disease	ORPHA:79452
2151	0.2615	Milroy disease	ORPHA:79452
2151	0.2615	Milroy disease	ORPHA:79452
2151	0.2615	Milroy disease	ORPHA:79452
2155	0.2614	Galactokinase deficiency	ORPHA:79237
2156	0.2611	Immunodeficiency 42	OMIM:616622
2157	0.261	Gardner syndrome	ORPHA:79665
2157	0.261	Analbuminemia	OMIM:616000
2159	0.2608	Carney complex, type 1	OMIM:160980
2159	0.2608	Myoectodermal gonadal dysgenesis syndrome	OMIM:618419
2159	0.2608	Basilicata-Akhtar syndrome	OMIM:301032
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2162	0.2605	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
2178	0.2604	Pheochromocytoma, susceptibility to	OMIM:171300
2178	0.2604	Pheochromocytoma	OMIM:171300
2178	0.2604	Pheochromocytoma	OMIM:171300
2178	0.2604	Pheochromocytoma	OMIM:171300
2178	0.2604	Pheochromocytoma	OMIM:171300
2178	0.2604	Pheochromocytoma, susceptibility to	OMIM:171300
2184	0.2602	PPARG-related familial partial lipodystrophy	ORPHA:79083
2184	0.2602	Parkes Weber syndrome	ORPHA:90307
2186	0.2601	Combined oxidative phosphorylation deficiency 10	OMIM:614702
2187	0.2599	Combined oxidative phosphorylation deficiency 5	OMIM:611719
2188	0.2598	Cowden syndrome	ORPHA:201
2188	0.2598	Cowden syndrome	ORPHA:201
2188	0.2598	Cowden syndrome	ORPHA:201
2188	0.2598	Cowden syndrome	ORPHA:201
2188	0.2598	Cowden syndrome	ORPHA:201
2188	0.2598	Cowden syndrome	ORPHA:201
2188	0.2598	Cowden syndrome	ORPHA:201
2188	0.2598	Cowden syndrome	ORPHA:201
2188	0.2598	Cowden syndrome	ORPHA:201
2197	0.2597	Occipital horn syndrome	OMIM:304150
2198	0.2594	Generalized arterial calcification of infancy	ORPHA:51608
2198	0.2594	Lissencephaly syndrome, Norman-Roberts type	ORPHA:89844
2198	0.2594	Generalized arterial calcification of infancy	ORPHA:51608
2198	0.2594	Lissencephaly syndrome, Norman-Roberts type	ORPHA:89844
2198	0.2594	Lissencephaly syndrome, Norman-Roberts type	ORPHA:89844
2198	0.2594	Fraser syndrome 2	OMIM:617666
2204	0.2593	Maffucci syndrome	ORPHA:163634
2204	0.2593	APC-related attenuated familial adenomatous polyposis	ORPHA:247806
2204	0.2593	Maffucci syndrome	ORPHA:163634
2204	0.2593	Hyperparathyroidism-jaw tumor syndrome	ORPHA:99880
2204	0.2593	Parathyroid carcinoma	ORPHA:143
2209	0.2591	Hypothyroidism due to TSH receptor mutations	ORPHA:90673
2210	0.2589	Hypoaldosteronism, congenital, due to CMO II deficiency	OMIM:610600
2211	0.2588	Smith-Lemli-Opitz syndrome	ORPHA:818
2212	0.2586	Nijmegen breakage syndrome-like disorder	OMIM:613078
2212	0.2586	Neuronal intestinal pseudoobstruction	ORPHA:99811
2212	0.2586	Caffey disease	ORPHA:1310
2215	0.2585	GM1 gangliosidosis type 1	ORPHA:79255
2215	0.2585	Peroxisome biogenesis disorder 2A (Zellweger)	OMIM:214110
2217	0.2583	Tangier disease	OMIM:205400
2217	0.2583	Nephrotic syndrome, type 1	OMIM:256300
2219	0.2582	Bartter syndrome, type 1	OMIM:601678
2220	0.2581	PEHO syndrome	OMIM:260565
2221	0.2579	Schinzel-Giedion midface retraction syndrome	OMIM:269150
2222	0.2578	Cardiofaciocutaneous syndrome	ORPHA:1340
2222	0.2578	Cardiofaciocutaneous syndrome	ORPHA:1340
2222	0.2578	Cardiofaciocutaneous syndrome	ORPHA:1340
2222	0.2578	Parathyroid adenoma with cystic changes	OMIM:145001
2222	0.2578	Cardiofaciocutaneous syndrome	ORPHA:1340
2227	0.2577	Lymphatic malformation 12	OMIM:620014
2227	0.2577	Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies	OMIM:301066
2227	0.2577	Hennekam lymphangiectasia-lymphedema syndrome 1	OMIM:235510
2230	0.2575	Menkes disease	ORPHA:565
2231	0.2574	?Optic atrophy 11	OMIM:617302
2232	0.2572	Bartter syndrome type 4	ORPHA:89938
2232	0.2572	Bartter syndrome type 4	ORPHA:89938
2232	0.2572	Bartter syndrome type 4	ORPHA:89938
2235	0.2571	Generalized pseudohypoaldosteronism type 1	ORPHA:171876
2235	0.2571	Generalized pseudohypoaldosteronism type 1	ORPHA:171876
2235	0.2571	Generalized pseudohypoaldosteronism type 1	ORPHA:171876
2235	0.2571	Sensorineural deafness with mild renal dysfunction	OMIM:602522
2235	0.2571	Multiple sulfatase deficiency	OMIM:272200
2240	0.257	Hypertriglyceridemia, transient infantile	OMIM:614480
2240	0.257	Proteasome-associated autoinflammatory syndrome 5	OMIM:619175
2240	0.257	Familial partial lipodystrophy, Dunnigan type	ORPHA:2348
2243	0.2569	TSC2 angiomyolipomas, renal, modifier of	OMIM:613254
2243	0.2569	Tuberous sclerosis-2	OMIM:613254
2243	0.2569	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	OMIM:617156
2246	0.2568	Tuberous sclerosis-1	OMIM:191100
2247	0.2567	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	OMIM:163200
2247	0.2567	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	OMIM:163200
2247	0.2567	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	OMIM:163200
2250	0.2566	Infantile myofibromatosis	ORPHA:2591
2250	0.2566	Infantile myofibromatosis	ORPHA:2591
2252	0.2565	Lipodystrophy, congenital generalized, type 1	OMIM:608594
2253	0.2564	Nephrotic syndrome, type 8	OMIM:615244
2253	0.2564	?Angioedema, hereditary, 8	OMIM:619367
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2255	0.2562	Meningioma	ORPHA:2495
2266	0.256	Hemochromatosis, type 2A	OMIM:602390
2267	0.2559	Immunodeficiency 56	OMIM:615207
2267	0.2559	Mohr-Tranebjaerg syndrome	ORPHA:52368
2267	0.2559	?Agammaglobulinemia 5	OMIM:613506
2270	0.2558	Scalp-ear-nipple syndrome	OMIM:181270
2270	0.2558	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	OMIM:617913
2272	0.2557	Oculoskeletodental syndrome	OMIM:618440
2273	0.2554	Tuberous sclerosis complex	ORPHA:805
2273	0.2554	Lymphedema-distichiasis syndrome	OMIM:153400
2273	0.2554	Tuberous sclerosis complex	ORPHA:805
2273	0.2554	Tuberous sclerosis complex	ORPHA:805
2273	0.2554	Carnitine deficiency, systemic primary	OMIM:212140
2278	0.2551	Hypocalciuric hypercalcemia, type III	OMIM:600740
2279	0.255	Hypoaldosteronism, congenital, due to CMO I deficiency	OMIM:203400
2280	0.2549	Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency	ORPHA:319552
2280	0.2549	Biotinidase deficiency	OMIM:253260
2282	0.2547	Combined malonic and methylmalonic acidemia	ORPHA:289504
2283	0.2546	Full NF2-related schwannomatosis	ORPHA:637
2284	0.2544	Brain tumor-polyposis syndrome 2	OMIM:175100
2285	0.2542	Full schwannomatosis	ORPHA:93921
2285	0.2542	Full schwannomatosis	ORPHA:93921
2285	0.2542	Perlman syndrome	ORPHA:2849
2285	0.2542	Full schwannomatosis	ORPHA:93921
2285	0.2542	Full schwannomatosis	ORPHA:93921
2290	0.2541	Pseudohypoaldosteronism, type IB3, autosomal recessive	OMIM:620126
2290	0.2541	Pseudohypoaldosteronism, type IB2, autosomal recessive	OMIM:620125
2290	0.2541	Partial androgen insensitivity syndrome	ORPHA:90797
2290	0.2541	Diarrhea 1, secretory chloride, congenital	OMIM:214700
2290	0.2541	Pseudohypoaldosteronism type I, autosomal dominant	OMIM:177735
2295	0.2537	Transient neonatal diabetes mellitus	ORPHA:99886
2295	0.2537	Transient neonatal diabetes mellitus	ORPHA:99886
2295	0.2537	Transient neonatal diabetes mellitus	ORPHA:99886
2295	0.2537	Transient neonatal diabetes mellitus	ORPHA:99886
2299	0.2536	Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss	OMIM:619658
2299	0.2536	GAPO syndrome	ORPHA:2067
2299	0.2536	?Combined oxidative phosphorylation deficiency 47	OMIM:618958
2302	0.2533	?Cowden syndrome 7	OMIM:616858
2303	0.2532	?Inflammatory skin and bowel disease, neonatal, 1	OMIM:614328
2303	0.2532	RIDDLE syndrome	OMIM:611943
2303	0.2532	Immunodeficiency 35	OMIM:611521
2303	0.2532	FILS syndrome	OMIM:615139
2303	0.2532	Atopy, susceptibility to	OMIM:147050
2303	0.2532	Atopy, susceptibility to	OMIM:147050
2303	0.2532	Atopy, susceptibility to	OMIM:147050
2303	0.2532	Multiple endocrine neoplasia 1	OMIM:131100
2303	0.2532	Dystrophic epidermolysis bullosa pruriginosa	ORPHA:89843
2303	0.2532	Nephrotic syndrome, type 2	OMIM:600995
2303	0.2532	Hypotrichosis simplex of the scalp	ORPHA:90368
2303	0.2532	Sodium-dependent multivitamin transporter deficiency	OMIM:618973
2303	0.2532	Palmoplantar keratoderma, epidermolytic, 1	OMIM:144200
2303	0.2532	Hypotrichosis simplex of the scalp	ORPHA:90368
2317	0.2531	Lymphatic malformation 4	OMIM:615907
2317	0.2531	Lymphatic malformation 11	OMIM:619401
2317	0.2531	Radio-Tartaglia syndrome	OMIM:619312
2317	0.2531	Developmental and epileptic encephalopathy 100	OMIM:619777
2321	0.253	Congenital myopathy with excess of muscle spindles	OMIM:218040
2322	0.2527	Mucopolysaccharidosis type IIID	OMIM:252940
2323	0.2524	Mitochondrial DNA depletion syndrome 4A (Alpers type)	OMIM:203700
2324	0.2523	Coenzyme Q10 deficiency, primary, 3	OMIM:614652
2325	0.2521	Complete androgen insensitivity syndrome	ORPHA:99429
2326	0.2519	Cushing syndrome due to bilateral macronodular adrenocortical disease	ORPHA:189427
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Cholestasis, progressive familial intrahepatic 2	OMIM:601847
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Cholestasis, progressive familial intrahepatic 1	OMIM:211600
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Trichohepatoneurodevelopmental syndrome	OMIM:618268
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Cushing syndrome due to bilateral macronodular adrenocortical disease	ORPHA:189427
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2326	0.2519	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
2362	0.2516	Birt-Hogg-Dube syndrome	OMIM:135150
2363	0.2514	Pseudohypoaldosteronism, type IB1, autosomal recessive	OMIM:264350
2363	0.2514	Pycnodysostosis	ORPHA:763
2363	0.2514	Bartter syndrome, type 4b, digenic	OMIM:613090
2363	0.2514	Bartter syndrome, type 4b, digenic	OMIM:613090
2367	0.2513	Werner syndrome	ORPHA:902
2367	0.2513	Hypocalciuric hypercalcemia, type II	OMIM:145981
2369	0.2512	Short-rib thoracic dysplasia 15 with polydactyly	OMIM:617088
2369	0.2512	Hypercalcemia, infantile, 1	OMIM:143880
2369	0.2512	Palmoplantar hyperkeratosis and true hermaphroditism	OMIM:610644
2372	0.2511	Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type	OMIM:616897
2372	0.2511	Infantile nephropathic cystinosis	ORPHA:411629
2374	0.251	Cholesterol-ester transfer protein deficiency	ORPHA:79506
2375	0.2508	Congenital myopathy 22B, severe fetal	OMIM:620369
2375	0.2508	Adrenal hypoplasia, congenital	OMIM:300200
2375	0.2508	?Lymphatic malformation 8	OMIM:618773
2375	0.2508	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	OMIM:256810
2379	0.2506	Isobutyryl-CoA dehydrogenase deficiency	ORPHA:79159
2380	0.2505	Alagille syndrome 1	OMIM:118450
2381	0.2504	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
2381	0.2504	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
2381	0.2504	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
2381	0.2504	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
2381	0.2504	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
2386	0.2503	Beckwith-Wiedemann syndrome	OMIM:130650
2387	0.2502	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	OMIM:137940
2388	0.2501	Encephalocraniocutaneous lipomatosis	ORPHA:2396
2388	0.2501	?Angioedema, hereditary, 5	OMIM:619361
2388	0.2501	Glucose-galactose malabsorption	ORPHA:35710
2388	0.2501	Angioedema, hereditary, 6	OMIM:619363
2388	0.2501	Encephalocraniocutaneous lipomatosis	ORPHA:2396
2393	0.25	Mucopolysaccharidosis Ih	OMIM:607014
2393	0.25	Bartter syndrome, type 3	OMIM:607364
2395	0.2497	Muir-Torre syndrome	OMIM:158320
2395	0.2497	Muir-Torre syndrome	OMIM:158320
2397	0.2496	Pituitary hormone deficiency, combined, 6	OMIM:613986
2397	0.2496	Mucopolysaccharidosis type 2, severe form	ORPHA:217085
2397	0.2496	Mucopolysaccharidosis type 2, attenuated form	ORPHA:217093
2400	0.2495	Spinocerebellar ataxia, autosomal recessive 20	OMIM:616354
2400	0.2495	Coproporphyria	OMIM:121300
2400	0.2495	Tyrosinemia type 1	ORPHA:882
2400	0.2495	Mevalonic aciduria	ORPHA:29
2400	0.2495	Desmosterolosis	ORPHA:35107
2400	0.2495	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	OMIM:607626
2400	0.2495	Neonatal ichthyosis-sclerosing cholangitis syndrome	ORPHA:59303
2400	0.2495	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	OMIM:253200
2400	0.2495	Joubert syndrome with hepatic defect	ORPHA:1454
2400	0.2495	Opsismodysplasia	ORPHA:2746
2400	0.2495	Cockayne syndrome type 3	ORPHA:90324
2400	0.2495	Hypopigmentation, organomegaly, and delayed myelination and development	OMIM:618541
2400	0.2495	Ectodermal dysplasia and immunodeficiency 2	OMIM:612132
2400	0.2495	Pallister-Hall syndrome	ORPHA:672
2400	0.2495	Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease	ORPHA:163746
2400	0.2495	Aspartylglucosaminuria	ORPHA:93
2400	0.2495	Spondylometaphyseal dysplasia, axial	OMIM:602271
2400	0.2495	Sialuria	OMIM:269921
2400	0.2495	Refsum disease	ORPHA:773
2400	0.2495	CHOPS syndrome	OMIM:616368
2400	0.2495	GM1-gangliosidosis, type III	OMIM:230650
2400	0.2495	Congenital disorder of glycosylation, type IIj	OMIM:613489
2400	0.2495	Adams-Oliver syndrome 6	OMIM:616589
2400	0.2495	Joubert syndrome with hepatic defect	ORPHA:1454
2400	0.2495	COACH syndrome 1	OMIM:216360
2400	0.2495	Refsum disease	ORPHA:773
2400	0.2495	Spinocerebellar ataxia, autosomal recessive 21	OMIM:616719
2400	0.2495	Galactose epimerase deficiency	OMIM:230350
2400	0.2495	Cockayne syndrome, type B	OMIM:133540
2400	0.2495	Cockayne syndrome type 3	ORPHA:90324
2400	0.2495	Cockayne syndrome, type B	OMIM:133540
2400	0.2495	Cockayne syndrome type 3	ORPHA:90324
2400	0.2495	Scheie syndrome	ORPHA:93474
2400	0.2495	Hurler syndrome	ORPHA:93473
2400	0.2495	Hurler-Scheie syndrome	ORPHA:93476
2400	0.2495	Mucopolysaccharidosis Ih/s	OMIM:607015
2400	0.2495	Cholestasis, progressive familial intrahepatic, 9	OMIM:619849
2400	0.2495	Short-rib thoracic dysplasia 10 with or without polydactyly	OMIM:615630
2400	0.2495	Portal hypertension, noncirrhotic, 1	OMIM:617068
2400	0.2495	Spondyloepimetaphyseal dysplasia, Shohat type	OMIM:602557
2400	0.2495	Mucopolysaccharidosis type IIIB (Sanfilippo B)	OMIM:252920
2400	0.2495	Gaucher disease type 2	ORPHA:77260
2400	0.2495	Mucopolysaccharidosis type IIIA (Sanfilippo A)	OMIM:252900
2400	0.2495	Nephronophthisis 19	OMIM:616217
2400	0.2495	Joubert syndrome 33	OMIM:617767
2400	0.2495	Joubert syndrome with hepatic defect	ORPHA:1454
2400	0.2495	Mucopolysaccharidosis type IIIC (Sanfilippo C)	OMIM:252930
2400	0.2495	Joubert syndrome with hepatic defect	ORPHA:1454
2400	0.2495	Joubert syndrome 21	OMIM:615636
2400	0.2495	Prolidase deficiency	ORPHA:742
2400	0.2495	Encephalopathy due to prosaposin deficiency	ORPHA:139406
2400	0.2495	Combined SAP deficiency	OMIM:611721
2400	0.2495	Sialidosis type 1	ORPHA:812
2400	0.2495	Multiple sulfatase deficiency	ORPHA:585
2400	0.2495	Hajdu-Cheney syndrome	ORPHA:955
2400	0.2495	Intellectual developmental disorder, autosomal recessive 41	OMIM:615637
2456	0.2493	Autosomal dominant centronuclear myopathy	ORPHA:169189
2456	0.2493	Autosomal dominant centronuclear myopathy	ORPHA:169189
2456	0.2493	Autosomal dominant centronuclear myopathy	ORPHA:169189
2456	0.2493	Autosomal dominant centronuclear myopathy	ORPHA:169189
2456	0.2493	Autosomal dominant centronuclear myopathy	ORPHA:169189
2461	0.2491	Adrenocortical carcinoma	ORPHA:1501
2461	0.2491	Adrenocortical carcinoma	ORPHA:1501
2461	0.2491	Adrenocortical carcinoma	ORPHA:1501
2461	0.2491	Adrenocortical carcinoma	ORPHA:1501
2461	0.2491	Adrenocortical carcinoma	ORPHA:1501
2461	0.2491	Adrenocortical carcinoma	ORPHA:1501
2467	0.2489	Peroxisome biogenesis disorder 5A (Zellweger)	OMIM:614866
2468	0.2488	Low phospholipid-associated cholelithiasis	ORPHA:69663
2468	0.2488	Hennekam lymphangiectasia-lymphedema syndrome 2	OMIM:616006
2470	0.2487	PEHO syndrome	ORPHA:2836
2470	0.2487	PEHO syndrome	ORPHA:2836
2472	0.2486	Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency	ORPHA:95699
2473	0.2482	Pituitary hormone deficiency, combined, 2	OMIM:262600
2473	0.2482	Mucolipidosis type II	ORPHA:576
2473	0.2482	Mucopolysaccharidosis II	OMIM:309900
2476	0.2481	Acromegaly	ORPHA:963
2476	0.2481	Acromegaly	ORPHA:963
2478	0.2476	Mitchell-Riley syndrome	OMIM:615710
2479	0.2475	McKusick-Kaufman syndrome	OMIM:236700
2480	0.2472	17q21.31 microdeletion syndrome	ORPHA:363958
2481	0.247	Citrullinemia type II	ORPHA:247585
2482	0.2469	Cardiofaciocutaneous syndrome 4	OMIM:615280
2483	0.2467	Hypokalemic periodic paralysis	ORPHA:681
2483	0.2467	Hypokalemic periodic paralysis	ORPHA:681
2483	0.2467	Hypokalemic periodic paralysis	ORPHA:681
2486	0.2466	Cardiac valvular dysplasia 1	OMIM:212093
2486	0.2466	Galloway-Mowat syndrome 7	OMIM:618348
2486	0.2466	Achondrogenesis Ib	OMIM:600972
2486	0.2466	Achondrogenesis, type II or hypochondrogenesis	OMIM:200610
2490	0.2465	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
2490	0.2465	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
2490	0.2465	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
2490	0.2465	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
2490	0.2465	HNF1B-related autosomal dominant tubulointerstitial kidney disease	ORPHA:93111
2490	0.2465	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
2490	0.2465	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
2490	0.2465	Diabetes mellitus, transient neonatal 1	OMIM:601410
2498	0.2462	Hypotrichosis-lymphedema-telangiectasia syndrome	OMIM:607823
2498	0.2462	Diaphanospondylodysostosis	OMIM:608022
2498	0.2462	Pontocerebellar hypoplasia, type 13	OMIM:618606
2498	0.2462	Alkuraya-Kucinskas syndrome	OMIM:617822
2502	0.2461	Lymphatic malformation 9	OMIM:619319
2502	0.2461	Myopathy, mitochondrial, and ataxia	OMIM:617675
2504	0.2459	?Lissencephaly 7 with cerebellar hypoplasia	OMIM:616342
2504	0.2459	Multiple endocrine neoplasia IIB	OMIM:162300
2506	0.2456	Zimmermann-Laband syndrome	ORPHA:3473
2506	0.2456	Zimmermann-Laband syndrome	ORPHA:3473
2506	0.2456	Zimmermann-Laband syndrome 1	OMIM:135500
2506	0.2456	Zimmermann-Laband syndrome	ORPHA:3473
2506	0.2456	Trichothiodystrophy 5, nonphotosensitive	OMIM:300953
2506	0.2456	Zimmermann-Laband syndrome	ORPHA:3473
2512	0.2455	GCGR-related hyperglucagonemia	ORPHA:438274
2512	0.2455	Basal cell nevus syndrome 1	OMIM:109400
2514	0.2454	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures	OMIM:620224
2514	0.2454	Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome	ORPHA:502423
2516	0.2453	SADDAN	OMIM:616482
2517	0.245	Glomerulosclerosis, focal segmental, 6	OMIM:614131
2517	0.245	Nephrotic syndrome, type 6	OMIM:614196
2517	0.245	Combined oxidative phosphorylation deficiency 2	OMIM:610498
2517	0.245	Pierson syndrome	OMIM:609049
2517	0.245	Galloway-Mowat syndrome 3	OMIM:617729
2517	0.245	Nephrotic syndrome, type 9	OMIM:615573
2517	0.245	Nephrotic syndrome, type 3	OMIM:610725
2524	0.2448	Familial multinodular goiter	ORPHA:276399
2524	0.2448	Opsismodysplasia	OMIM:258480
2524	0.2448	Familial multinodular goiter	ORPHA:276399
2527	0.2447	Pituitary hormone deficiency, combined or isolated, 8	OMIM:620303
2528	0.2442	Xeroderma pigmentosum, type F/Cockayne syndrome	OMIM:278760
2528	0.2442	Paragangliomas 1, with or without deafness	OMIM:168000
2530	0.2441	Isolated thyroid-stimulating hormone deficiency	ORPHA:90674
2531	0.244	Paragangliomas 3	OMIM:605373
2532	0.2439	Familial glucocorticoid deficiency	ORPHA:361
2532	0.2439	X-linked Alport syndrome-diffuse leiomyomatosis	ORPHA:1018
2532	0.2439	X-linked Alport syndrome-diffuse leiomyomatosis	ORPHA:1018
2532	0.2439	Familial glucocorticoid deficiency	ORPHA:361
2532	0.2439	Familial glucocorticoid deficiency	ORPHA:361
2532	0.2439	Familial glucocorticoid deficiency	ORPHA:361
2532	0.2439	Familial glucocorticoid deficiency	ORPHA:361
2539	0.2438	Hyperinsulinemic hypoglycemia, familial, 8	OMIM:620211
2540	0.2437	Intrahepatic cholestasis of pregnancy	ORPHA:69665
2540	0.2437	Intrahepatic cholestasis of pregnancy	ORPHA:69665
2540	0.2437	Distal renal tubular acidosis 3, with or without sensorineural hearing loss	OMIM:602722
2540	0.2437	Papillorenal syndrome	OMIM:120330
2540	0.2437	Hereditary leiomyomatosis and renal cell cancer	ORPHA:523
2540	0.2437	Intrahepatic cholestasis of pregnancy	ORPHA:69665
2540	0.2437	Intrahepatic cholestasis of pregnancy	ORPHA:69665
2547	0.2436	Neurofibromatosis, type 1	OMIM:162200
2547	0.2436	Familial isolated hyperparathyroidism	ORPHA:99879
2547	0.2436	Multiple endocrine neoplasia, type IV	OMIM:610755
2547	0.2436	Familial isolated hyperparathyroidism	ORPHA:99879
2547	0.2436	Familial isolated hyperparathyroidism	ORPHA:99879
2552	0.2434	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	OMIM:201750
2552	0.2434	Phelan-McDermid syndrome	OMIM:606232
2552	0.2434	Monosomy 22q13.3	ORPHA:48652
2555	0.2433	Familial isolated restrictive cardiomyopathy	ORPHA:75249
2555	0.2433	Cardiomyopathy, hypertrophic, 4	OMIM:115197
2555	0.2433	PLAA-associated neurodevelopmental disorder	ORPHA:521426
2555	0.2433	Familial isolated restrictive cardiomyopathy	ORPHA:75249
2555	0.2433	RNF13-related severe early-onset epileptic encephalopathy	ORPHA:544503
2555	0.2433	Familial isolated restrictive cardiomyopathy	ORPHA:75249
2555	0.2433	Familial isolated restrictive cardiomyopathy	ORPHA:75249
2555	0.2433	Familial isolated restrictive cardiomyopathy	ORPHA:75249
2563	0.2431	Hyperchlorhidrosis, isolated	OMIM:143860
2564	0.2429	MSH3-related attenuated familial adenomatous polyposis	ORPHA:480536
2565	0.2428	Germ cell tumors, somatic	OMIM:273300
2565	0.2428	Angioedema, hereditary, 1 and 2	OMIM:106100
2565	0.2428	Testicular tumor, somatic	OMIM:273300
2565	0.2428	Male germ cell tumor, somatic	OMIM:273300
2565	0.2428	Spermatocytic seminoma, somatic	OMIM:273300
2565	0.2428	Short-rib thoracic dysplasia 7 with or without polydactyly	OMIM:614091
2565	0.2428	?Cardiomyopathy, familial restrictive, 6	OMIM:619433
2572	0.2426	Familial exudative vitreoretinopathy	ORPHA:891
2572	0.2426	Familial exudative vitreoretinopathy	ORPHA:891
2572	0.2426	Familial exudative vitreoretinopathy	ORPHA:891
2572	0.2426	Familial exudative vitreoretinopathy	ORPHA:891
2572	0.2426	Familial exudative vitreoretinopathy	ORPHA:891
2572	0.2426	Familial exudative vitreoretinopathy	ORPHA:891
2578	0.2425	Multiple endocrine neoplasia IIA	OMIM:171400
2579	0.2424	Fraser syndrome 3	OMIM:617667
2579	0.2424	Familial adenomatous polyposis 3	OMIM:616415
2581	0.2422	Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition	OMIM:620189
2582	0.2421	Familial cerebral cavernous malformation	ORPHA:221061
2582	0.2421	Familial cerebral cavernous malformation	ORPHA:221061
2582	0.2421	Familial cerebral cavernous malformation	ORPHA:221061
2582	0.2421	Familial cerebral cavernous malformation	ORPHA:221061
2586	0.2419	Paragangliomas 4	OMIM:115310
2587	0.2417	Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations	OMIM:192315
2587	0.2417	Pulmonary alveolar microlithiasis	ORPHA:60025
2589	0.2414	Hypocalciuric hypercalcemia, type I	OMIM:145980
2589	0.2414	Cirrhosis, noncryptogenic, susceptibility to	OMIM:215600
2589	0.2414	Cirrhosis, cryptogenic	OMIM:215600
2592	0.2413	Autosomal recessive hyperinsulinism due to Kir6.2 deficiency	ORPHA:79644
2593	0.2412	Nephrotic syndrome, type 22	OMIM:619155
2593	0.2412	XFE progeroid syndrome	OMIM:610965
2593	0.2412	Enterokinase deficiency	OMIM:226200
2596	0.241	Fanconi renotubular syndrome 5	OMIM:618913
2597	0.2409	Citrullinemia, type II, neonatal-onset	OMIM:605814
2597	0.2409	CPT II deficiency, lethal neonatal	OMIM:608836
2597	0.2409	Renin-angiotensin-aldosterone system-blocker-induced angioedema	ORPHA:100057
2600	0.2408	Combined hyperlipidemia, familial	OMIM:144250
2600	0.2408	Methylmalonyl-CoA epimerase deficiency	OMIM:251120
2602	0.2407	Glutaryl-CoA dehydrogenase deficiency	ORPHA:25
2603	0.2403	Pendred syndrome	OMIM:274600
2603	0.2403	Short-rib thoracic dysplasia 6 with or without polydactyly	OMIM:263520
2603	0.2403	Escobar syndrome	OMIM:265000
2603	0.2403	Hyperammonemia due to carbonic anhydrase VA deficiency	OMIM:615751
2603	0.2403	Short-rib thoracic dysplasia 14 with polydactyly	OMIM:616546
2608	0.2399	Diabetes insipidus, nephrogenic, 2	OMIM:125800
2608	0.2399	Diabetes insipidus, nephrogenic, 1	OMIM:304800
2608	0.2399	Glycogen storage disease VI	OMIM:232700
2608	0.2399	Structural heart defects and renal anomalies syndrome	OMIM:617478
2612	0.2398	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
2612	0.2398	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
2612	0.2398	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
2612	0.2398	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
2616	0.2397	Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency	ORPHA:90795
2617	0.2396	Oculoectodermal syndrome, somatic	OMIM:600268
2617	0.2396	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development	OMIM:152950
2617	0.2396	CLAPO syndrome, somatic	OMIM:613089
2617	0.2396	Noonan syndrome 13	OMIM:619087
2617	0.2396	Lymphatic malformation 10	OMIM:619369
2617	0.2396	Schneckenbecken dysplasia	ORPHA:3144
2617	0.2396	Congenital central hypoventilation syndrome	ORPHA:661
2617	0.2396	Lissencephaly 2 (Norman-Roberts type)	OMIM:257320
2617	0.2396	Congenital central hypoventilation syndrome	ORPHA:661
2617	0.2396	Spondyloocular syndrome	OMIM:605822
2617	0.2396	Hypertrichotic osteochondrodysplasia (Cantu syndrome)	OMIM:239850
2617	0.2396	Hennekam lymphangiectasia-lymphedema syndrome 3	OMIM:618154
2617	0.2396	Schneckenbecken dysplasia	ORPHA:3144
2617	0.2396	Kanzaki disease	OMIM:609242
2617	0.2396	Alpha-N-acetylgalactosaminidase deficiency type 1	ORPHA:79279
2617	0.2396	Alpha-N-acetylgalactosaminidase deficiency type 2	ORPHA:79280
2617	0.2396	Congenital central hypoventilation syndrome	ORPHA:661
2617	0.2396	Cerebrofacioarticular syndrome	ORPHA:314679
2617	0.2396	Congenital central hypoventilation syndrome	ORPHA:661
2617	0.2396	Lymphatic malformation 3	OMIM:613480
2617	0.2396	Choanal atresia and lymphedema	OMIM:613611
2617	0.2396	Cerebrofacioarticular syndrome	ORPHA:314679
2617	0.2396	?Al-Gazali-Bakalinova syndrome	OMIM:607131
2617	0.2396	Autosomal recessive spastic paraplegia type 11	ORPHA:2822
2617	0.2396	Congenital central hypoventilation syndrome	ORPHA:661
2617	0.2396	Congenital central hypoventilation syndrome	ORPHA:661
2643	0.2395	Schwannomatosis, vestibular	OMIM:101000
2644	0.2393	KID syndrome	ORPHA:477
2644	0.2393	Fructose-1,6-bisphosphatase deficiency	ORPHA:348
2644	0.2393	KID syndrome	ORPHA:477
2647	0.2392	Tumor predisposition syndrome 1	OMIM:614327
2648	0.2391	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	OMIM:610978
2648	0.2391	Birt-Hogg-Dub√© syndrome	ORPHA:122
2650	0.2388	Rabson-Mendenhall syndrome	OMIM:262190
2651	0.2387	Fanconi-Bickel syndrome	OMIM:227810
2652	0.2386	Pituitary adenoma 1, multiple types	OMIM:102200
2653	0.2385	Rabson-Mendenhall syndrome	ORPHA:769
2654	0.2384	Leiomyomatosis and renal cell cancer	OMIM:150800
2655	0.2382	Multiple osteochondromas	ORPHA:321
2655	0.2382	Exostoses, multiple, type 2	OMIM:133701
2655	0.2382	Multiple osteochondromas	ORPHA:321
2655	0.2382	Exostoses, multiple, type 1	OMIM:133700
2659	0.2381	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	OMIM:614736
2659	0.2381	Angioedema, hereditary, 3	OMIM:610618
2659	0.2381	Polycystic liver disease 1	OMIM:174050
2662	0.2378	Papillon-Lef√®vre syndrome	ORPHA:678
2663	0.2377	Reynolds syndrome	ORPHA:779
2663	0.2377	Parathyroid carcinoma	OMIM:608266
2663	0.2377	Hyperparathyroidism 4	OMIM:617343
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	Schopf-Schulz-Passarge syndrome	OMIM:224750
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2666	0.2374	46,XY partial gonadal dysgenesis	ORPHA:251510
2679	0.2373	Lymphedema-distichiasis syndrome	ORPHA:33001
2680	0.2372	Lipodystrophy, familial partial, type 2	OMIM:151660
2681	0.2371	Low density lipoprotein cholesterol level QTL 1	OMIM:603776
2681	0.2371	Hypercholesterolemia, familial, 3	OMIM:603776
2681	0.2371	Thyroid dyshormonogenesis 3	OMIM:274700
2684	0.237	Pituitary gigantism	ORPHA:99725
2684	0.237	Pituitary gigantism	ORPHA:99725
2686	0.2369	Melanoma-pancreatic cancer syndrome	OMIM:606719
2686	0.2369	Mitochondrial complex III deficiency, nuclear type 1	OMIM:124000
2688	0.2367	Frasier syndrome	ORPHA:347
2689	0.2363	Leprechaunism	ORPHA:508
2689	0.2363	Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome	ORPHA:314404
2689	0.2363	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	OMIM:604121
2689	0.2363	Nephrogenic diabetes insipidus	ORPHA:223
2689	0.2363	Nephrogenic diabetes insipidus	ORPHA:223
2689	0.2363	Cowden syndrome 6	OMIM:615109
2695	0.2362	Encephalocraniocutaneous lipomatosis, somatic mosaic	OMIM:613001
2696	0.236	Hyperchylomicronemia, late-onset	OMIM:144650
2697	0.2358	Large congenital melanocytic nevus	ORPHA:626
2697	0.2358	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	ORPHA:276580
2697	0.2358	Autosomal dominant hyperinsulinism due to SUR1 deficiency	ORPHA:276575
2697	0.2358	Large congenital melanocytic nevus	ORPHA:626
2701	0.2357	Insulin resistance, severe, digenic	OMIM:604367
2701	0.2357	46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome	ORPHA:168563
2703	0.2355	Mitochondrial trifunctional protein deficiency 2	OMIM:620300
2704	0.2353	Growth hormone deficiency, isolated, type IA	OMIM:262400
2705	0.2351	Hyperinsulinism due to INSR deficiency	ORPHA:263458
2706	0.235	Basal cell nevus syndrome 2	OMIM:620343
2706	0.235	Pituitary hormone deficiency, combined or isolated, 1	OMIM:613038
2708	0.2349	Hypoinsulinemic hypoglycemia with hemihypertrophy	OMIM:240900
2708	0.2349	Glycogen storage disease Ia	OMIM:232200
2708	0.2349	Combined oxidative phosphorylation deficiency 52	OMIM:619386
2708	0.2349	Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome	ORPHA:480864
2712	0.2348	Thyrotoxic periodic paralysis	ORPHA:79102
2712	0.2348	Thyrotoxic periodic paralysis	ORPHA:79102
2714	0.2345	Norrie disease	ORPHA:649
2715	0.2344	Cowden syndrome 5	OMIM:615108
2716	0.2343	Polyendocrine-polyneuropathy syndrome	ORPHA:453533
2717	0.2342	Mandibuloacral dysplasia	OMIM:248370
2718	0.2341	?Lethal congenital contractural syndrome 2	OMIM:607598
2718	0.2341	Familial multiple nevi flammei	ORPHA:624
2718	0.2341	Fuchs endothelial corneal dystrophy	ORPHA:98974
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	Microvillus inclusion disease	ORPHA:2290
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	Alpha-methylacetoacetic aciduria	OMIM:203750
2718	0.2341	Alternating hemiplegia of childhood	ORPHA:2131
2718	0.2341	Charcot-Marie-Tooth disease, axonal, type 2HH	OMIM:619574
2718	0.2341	Cerebrooculofacioskeletal syndrome 3	OMIM:616570
2718	0.2341	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	OMIM:617527
2718	0.2341	Microvillus inclusion disease	ORPHA:2290
2718	0.2341	Diarrhea 2, with microvillus atrophy, with or without cholestasis	OMIM:251850
2718	0.2341	Multiple pterygium syndrome, lethal type	OMIM:253290
2718	0.2341	Alternating hemiplegia of childhood	ORPHA:2131
2718	0.2341	Alternating hemiplegia of childhood	ORPHA:2131
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	Congenital multicore myopathy with external ophthalmoplegia	ORPHA:98905
2718	0.2341	Hyperoxaluria, primary, type 1	OMIM:259900
2718	0.2341	Familial cold urticaria	ORPHA:47045
2718	0.2341	Alternating hemiplegia of childhood	ORPHA:2131
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	Harlequin ichthyosis	ORPHA:457
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	Multiple pterygium syndrome, lethal type	OMIM:253290
2718	0.2341	Fuchs endothelial corneal dystrophy	ORPHA:98974
2718	0.2341	Lactase deficiency, congenital	OMIM:223000
2718	0.2341	Lethal congenital contracture syndrome 1	OMIM:253310
2718	0.2341	Diarrhea 4, malabsorptive, congenital	OMIM:610370
2718	0.2341	Enteric anendocrinosis	ORPHA:83620
2718	0.2341	Cerebrooculofacioskeletal syndrome 1	OMIM:214150
2718	0.2341	Cerebrooculofacioskeletal syndrome 1	OMIM:214150
2718	0.2341	Fuchs endothelial corneal dystrophy	ORPHA:98974
2718	0.2341	Cardiomyopathy, dilated, with woolly hair and keratoderma	OMIM:605676
2718	0.2341	Congenital short bowel syndrome	OMIM:615237
2718	0.2341	Superficial epidermolytic ichthyosis	ORPHA:455
2718	0.2341	?PEHO syndrome-like	OMIM:617507
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	Neu-Laxova syndrome 2	OMIM:616038
2718	0.2341	Multiple pterygium syndrome, lethal type	OMIM:253290
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	Congenital tufting enteropathy	ORPHA:92050
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	Galloway-Mowat syndrome 5	OMIM:617731
2718	0.2341	Fuchs endothelial corneal dystrophy	ORPHA:98974
2718	0.2341	Chondrodysplasia punctata, X-linked dominant	OMIM:302960
2718	0.2341	Achondrogenesis type 2	ORPHA:93296
2718	0.2341	Combined malonic and methylmalonic aciduria	OMIM:614265
2718	0.2341	Fuchs endothelial corneal dystrophy	ORPHA:98974
2718	0.2341	Lamellar ichthyosis	ORPHA:313
2718	0.2341	White sponge nevus 2	OMIM:615785
2770	0.234	Xeroderma pigmentosum, group C	OMIM:278720
2771	0.2339	Cowden syndrome 4	OMIM:615107
2772	0.2338	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	OMIM:616878
2773	0.2337	Carnitine palmitoyl transferase II deficiency, neonatal form	ORPHA:228308
2774	0.2336	Rubinstein-Taybi syndrome due to 16p13.3 microdeletion	ORPHA:353281
2774	0.2336	Hereditary hypophosphatemic rickets with hypercalciuria	ORPHA:157215
2774	0.2336	Abdominal obesity-metabolic syndrome 3	OMIM:615812
2774	0.2336	Hereditary hypophosphatemic rickets with hypercalciuria	ORPHA:157215
2778	0.2332	Donohue syndrome	OMIM:246200
2779	0.2326	Generalized glucocorticoid resistance syndrome	ORPHA:786
2780	0.2325	Paragangliomas 6	OMIM:618464
2780	0.2325	Congenital glucokinase-related hyperinsulinism	ORPHA:79299
2780	0.2325	Chylomicron retention disease	OMIM:246700
2780	0.2325	COG7-CDG	ORPHA:79333
2784	0.2324	Familial hyperaldosteronism type I	ORPHA:403
2784	0.2324	Familial hyperaldosteronism type I	ORPHA:403
2786	0.2323	Macrocephaly-intellectual disability-autism syndrome	ORPHA:210548
2786	0.2323	Familial thyroid dyshormonogenesis	ORPHA:95716
2786	0.2323	Familial thyroid dyshormonogenesis	ORPHA:95716
2786	0.2323	Macrocephaly-intellectual disability-autism syndrome	ORPHA:210548
2786	0.2323	Familial thyroid dyshormonogenesis	ORPHA:95716
2786	0.2323	Familial thyroid dyshormonogenesis	ORPHA:95716
2786	0.2323	Familial thyroid dyshormonogenesis	ORPHA:95716
2786	0.2323	Familial thyroid dyshormonogenesis	ORPHA:95716
2794	0.2321	Glycogen storage disease 0, liver	OMIM:240600
2795	0.232	Spinocerebellar ataxia with axonal neuropathy type 2	ORPHA:64753
2795	0.232	Mitochondrial trifunctional protein deficiency 1	OMIM:609015
2795	0.232	Very long chain acyl-CoA dehydrogenase deficiency	ORPHA:26793
2795	0.232	Familial hyperaldosteronism type II	ORPHA:404
2795	0.232	Spinocerebellar ataxia with axonal neuropathy type 2	ORPHA:64753
2800	0.2319	Dysbetalipoproteinemia	ORPHA:412
2800	0.2319	Congenital generalized lipodystrophy	ORPHA:528
2800	0.2319	Congenital generalized lipodystrophy	ORPHA:528
2800	0.2319	Congenital generalized lipodystrophy	ORPHA:528
2800	0.2319	Caudal regression syndrome	OMIM:600145
2800	0.2319	Congenital generalized lipodystrophy	ORPHA:528
2800	0.2319	Short stature-delayed bone age due to thyroid hormone metabolism deficiency	ORPHA:171706
2800	0.2319	Congenital generalized lipodystrophy	ORPHA:528
2800	0.2319	Congenital generalized lipodystrophy	ORPHA:528
2800	0.2319	Morbid obesity and spermatogenic failure	OMIM:615703
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2810	0.2317	Autosomal recessive hypophosphatemic rickets	ORPHA:289176
2810	0.2317	Autosomal recessive hypophosphatemic rickets	ORPHA:289176
2810	0.2317	Hereditary breast and/or ovarian cancer syndrome	ORPHA:145
2826	0.2314	Maple syrup urine disease, type Ia	OMIM:248600
2826	0.2314	Carnitine-acylcarnitine translocase deficiency	ORPHA:159
2826	0.2314	Maple syrup urine disease, type Ib	OMIM:248600
2826	0.2314	Maple syrup urine disease, type II	OMIM:248600
2830	0.2313	Fructose intolerance, hereditary	OMIM:229600
2831	0.2312	Carnitine-acylcarnitine translocase deficiency	OMIM:212138
2832	0.2311	Schwannomatosis-1, susceptibility to	OMIM:162091
2832	0.2311	Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14	ORPHA:96334
2832	0.2311	Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14	ORPHA:96334
2832	0.2311	Lowe syndrome	OMIM:309000
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2832	0.2311	Williams syndrome	ORPHA:904
2856	0.231	Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome	ORPHA:397709
2856	0.231	Macrocephaly-developmental delay syndrome	ORPHA:397612
2858	0.2308	Fanconi-Bickel syndrome	ORPHA:2088
2858	0.2308	Congenital isolated ACTH deficiency	ORPHA:199296
2860	0.2307	Sturge-Weber syndrome, somatic, mosaic	OMIM:185300
2860	0.2307	Xeroderma pigmentosum, group B	OMIM:610651
2862	0.2306	BDV syndrome	OMIM:619326
2863	0.2304	Rothmund-Thomson syndrome, type 2	OMIM:268400
2864	0.2303	Woodhouse-Sakati syndrome	OMIM:241080
2865	0.2301	Thyroid cancer, nonmedullary, 4	OMIM:616534
2866	0.23	Pseudoxanthoma elasticum, forme fruste	OMIM:177850
2866	0.23	Severe congenital nemaline myopathy	ORPHA:171430
2866	0.23	Ovarian hyperstimulation syndrome	OMIM:608115
2866	0.23	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1	OMIM:249210
2866	0.23	Severe congenital nemaline myopathy	ORPHA:171430
2866	0.23	Severe congenital nemaline myopathy	ORPHA:171430
2866	0.23	Fetal akinesia deformation sequence 3	OMIM:618389
2866	0.23	Neu-Laxova syndrome 1	OMIM:256520
2866	0.23	Glucose/galactose malabsorption	OMIM:606824
2866	0.23	Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome	ORPHA:2848
2866	0.23	Severe congenital nemaline myopathy	ORPHA:171430
2866	0.23	Severe congenital nemaline myopathy	ORPHA:171430
2878	0.2299	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	OMIM:617093
2878	0.2299	Mitochondrial complex III deficiency, nuclear type 5	OMIM:615160
2880	0.2298	Estrogen resistance syndrome	ORPHA:785
2881	0.2297	Li-Fraumeni syndrome 2	OMIM:609265
2882	0.2296	Pseudohypoparathyroidism Ic	OMIM:612462
2883	0.2294	Sturge-Weber syndrome	ORPHA:3205
2884	0.2293	Angioedema, hereditary, 4	OMIM:619360
2884	0.2293	Citrullinemia, adult-onset type II	OMIM:603471
2886	0.2292	Glucocorticoid resistance	OMIM:615962
2886	0.2292	Cholestasis, progressive familial intrahepatic, 8	OMIM:619662
2888	0.2291	Lhermitte-Duclos disease	ORPHA:65285
2889	0.229	Glucocorticoid deficiency, due to ACTH unresponsiveness	OMIM:202200
2889	0.229	Glucocorticoid deficiency 2	OMIM:607398
2889	0.229	Hypocalcemia, autosomal dominant, with Bartter syndrome	OMIM:601198
2892	0.2288	Metachondromatosis	ORPHA:2499
2892	0.2288	Congenital bile acid synthesis defect type 3	ORPHA:79302
2892	0.2288	Trichorhinophalangeal syndrome type 2	ORPHA:502
2892	0.2288	Trichorhinophalangeal syndrome type 2	ORPHA:502
2892	0.2288	Trichorhinophalangeal syndrome type 2	ORPHA:502
2897	0.2287	Diarrhea 7, protein-losing enteropathy type	OMIM:615863
2897	0.2287	Mitochondrial complex IV deficiency, nuclear type 4	OMIM:619048
2899	0.2286	Hyperinsulinemic hypoglycemia, familial, 7	OMIM:610021
2900	0.2285	Focal dermal hypoplasia	ORPHA:2092
2901	0.2284	Neurofibromatosis-Noonan syndrome	OMIM:601321
2901	0.2284	Lipodystrophy, familial partial, type 7	OMIM:606721
2903	0.2282	CPT deficiency, hepatic, type IA	OMIM:255120
2904	0.2281	Medium chain acyl-CoA dehydrogenase deficiency	ORPHA:42
2905	0.228	Pallister-Hall syndrome	OMIM:146510
2906	0.2279	Epidermodysplasia verruciformis 3	OMIM:618267
2906	0.2279	Mutilating palmoplantar keratoderma with periorificial keratotic plaques	ORPHA:659
2906	0.2279	Mutilating palmoplantar keratoderma with periorificial keratotic plaques	ORPHA:659
2906	0.2279	Mutilating palmoplantar keratoderma with periorificial keratotic plaques	ORPHA:659
2910	0.2278	Tolchin-Le Caignec syndrome	OMIM:618971
2910	0.2278	PLIN1-related familial partial lipodystrophy	ORPHA:280356
2912	0.2277	X-linked hypophosphatemia	ORPHA:89936
2912	0.2277	Glycogen storage disease due to liver glycogen phosphorylase deficiency	ORPHA:369
2914	0.2275	Homozygous familial hypercholesterolemia	ORPHA:391665
2914	0.2275	Homozygous familial hypercholesterolemia	ORPHA:391665
2914	0.2275	Homozygous familial hypercholesterolemia	ORPHA:391665
2914	0.2275	Ataxia-oculomotor apraxia 4	OMIM:616267
2914	0.2275	Homozygous familial hypercholesterolemia	ORPHA:391665
2914	0.2275	Xeroderma pigmentosum, variant type	OMIM:278750
2914	0.2275	Homozygous familial hypercholesterolemia	ORPHA:391665
2914	0.2275	Homozygous familial hypercholesterolemia	ORPHA:391665
2922	0.2274	3-Methylcrotonyl-CoA carboxylase 2 deficiency	OMIM:210210
2923	0.2273	Hypothyroidism, congenital, nongoitrous, 8	OMIM:301033
2923	0.2273	Pleuropulmonary blastoma	OMIM:601200
2925	0.2272	Citrullinemia	OMIM:215700
2926	0.2271	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	OMIM:616026
2927	0.227	Woodhouse-Sakati syndrome	ORPHA:3464
2928	0.2269	Oculocutaneous albinism type 2	ORPHA:79432
2928	0.2269	Oculocutaneous albinism type 2	ORPHA:79432
2930	0.2268	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	OMIM:201810
2930	0.2268	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	OMIM:218700
2932	0.2266	Hepatic lipase deficiency	OMIM:614025
2932	0.2266	Hypertriglyceridemia 2	OMIM:619324
2932	0.2266	?[Dysalbuminemic hypertriiodothyroninemia]	OMIM:615999
2932	0.2266	Congenital disorder of glycosylation, type IIp	OMIM:616829
2936	0.2265	Chondrodysplasia, Blomstrand type	OMIM:215045
2937	0.2264	Obesity, susceptibility to, BMIQ19	OMIM:617885
2938	0.2262	?Cutaneous telangiectasia and cancer syndrome, familial	OMIM:614564
2939	0.2261	Sch√∂pf-Schulz-Passarge syndrome	ORPHA:50944
2939	0.2261	Mandibuloacral dysplasia with type B lipodystrophy	OMIM:608612
2939	0.2261	Hypercholesterolemia, familial, 4	OMIM:603813
2939	0.2261	Ataxia with isolated vitamin E deficiency	OMIM:277460
2939	0.2261	Glycogen storage disease IIIa	OMIM:232400
2944	0.226	Acrodysostosis 1, with or without hormone resistance	OMIM:101800
2944	0.226	Xeroderma pigmentosum	ORPHA:910
2944	0.226	Xeroderma pigmentosum	ORPHA:910
2944	0.226	Xeroderma pigmentosum	ORPHA:910
2944	0.226	Xeroderma pigmentosum	ORPHA:910
2944	0.226	Xeroderma pigmentosum	ORPHA:910
2944	0.226	Xeroderma pigmentosum	ORPHA:910
2944	0.226	Xeroderma pigmentosum	ORPHA:910
2944	0.226	Glycogen storage disease due to hepatic glycogen synthase deficiency	ORPHA:2089
2953	0.2259	Glycerol kinase deficiency	OMIM:307030
2953	0.2259	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	OMIM:208920
2955	0.2258	Microcephaly, congenital cataract, and psoriasiform dermatitis	OMIM:616834
2955	0.2258	Hereditary motor and sensory neuropathy, Okinawa type	OMIM:604484
2955	0.2258	?Mitochondrial complex III deficiency, nuclear type 11	OMIM:620137
2955	0.2258	HSD10 disease, infantile type	ORPHA:391428
2955	0.2258	Thyroid hormone metabolism, abnormal, 2	OMIM:619855
2960	0.2257	46XY sex reversal 1	OMIM:400044
2961	0.2256	Lung cancer, somatic	OMIM:211980
2961	0.2256	Nonsmall cell lung cancer, somatic	OMIM:211980
2961	0.2256	Nonsmall cell lung cancer, somatic	OMIM:211980
2961	0.2256	Adenocarcinoma of lung, somatic	OMIM:211980
2961	0.2256	Adenocarcinoma of lung, somatic	OMIM:211980
2961	0.2256	Lung cancer, susceptibility to	OMIM:211980
2961	0.2256	Lung cancer, somatic	OMIM:211980
2961	0.2256	Lung cancer, somatic	OMIM:211980
2961	0.2256	Lung cancer, susceptibility to	OMIM:211980
2961	0.2256	Lung cancer, susceptibility to	OMIM:211980
2961	0.2256	Lung cancer, somatic	OMIM:211980
2961	0.2256	Adenocarcinoma of lung, somatic	OMIM:211980
2961	0.2256	Lung cancer, protection against	OMIM:211980
2961	0.2256	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in	OMIM:211980
2961	0.2256	Nonsmall cell lung cancer, susceptibility to	OMIM:211980
2961	0.2256	Lung cancer, resistance to	OMIM:211980
2977	0.2255	Polymerase proofreading-related adenomatous polyposis	ORPHA:447877
2977	0.2255	Polymerase proofreading-related adenomatous polyposis	ORPHA:447877
2977	0.2255	Spina bifida, susceptibility to	OMIM:182940
2977	0.2255	Neural tube defects	OMIM:182940
2977	0.2255	Neural tube defects, susceptibility to	OMIM:182940
2977	0.2255	Neural tube defects, susceptibility to	OMIM:182940
2977	0.2255	Neural tube defects, susceptibility to	OMIM:182940
2977	0.2255	Dysferlin-related limb-girdle muscular dystrophy R2	ORPHA:268
2985	0.2254	Resistance to thyrotropin-releasing hormone syndrome	ORPHA:99832
2986	0.2253	Prostate cancer/brain cancer susceptibility, somatic	OMIM:603688
2986	0.2253	Glioma susceptibility 1	OMIM:137800
2986	0.2253	Glioma, susceptibility to, somatic	OMIM:137800
2986	0.2253	Glioblastoma, somatic	OMIM:137800
2986	0.2253	?Premature ovarian failure 17	OMIM:619146
2986	0.2253	Progressive pseudorheumatoid arthropathy of childhood	ORPHA:1159
2992	0.2252	Carbamoylphosphate synthetase I deficiency	OMIM:237300
2992	0.2252	Phosphoenolpyruvate carboxykinase deficiency, cytosolic	OMIM:261680
2994	0.225	Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency	ORPHA:90793
2994	0.225	46,XY difference of sex development due to isolated 17,20-lyase deficiency	ORPHA:90796
2994	0.225	46,XY difference of sex development due to isolated 17,20-lyase deficiency	ORPHA:90796
2997	0.2249	Fibronectin glomerulopathy	ORPHA:84090
2997	0.2249	Developmental delay, impaired speech, and behavioral abnormalities	OMIM:619475
2997	0.2249	Hyperinsulinism-hyperammonemia syndrome	ORPHA:35878
3000	0.2246	Hyperthyroidism, nonautoimmune	OMIM:609152
3001	0.2245	Rheumatoid arthritis, susceptibility to	OMIM:180300
3001	0.2245	Rheumatoid arthritis, susceptibility to	OMIM:180300
3001	0.2245	Rheumatoid arthritis, progression of	OMIM:180300
3001	0.2245	Combined oxidative phosphorylation deficiency 36	OMIM:617950
3001	0.2245	Rheumatoid arthritis, susceptibility to	OMIM:180300
3001	0.2245	Rheumatoid arthritis, susceptibility to	OMIM:180300
3001	0.2245	Pyruvate carboxylase deficiency	OMIM:266150
3001	0.2245	?Mitochondrial DNA depletion syndrome 16 (hepatic type)	OMIM:618528
3001	0.2245	Rheumatoid arthritis, susceptibility to	OMIM:180300
3001	0.2245	Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome	ORPHA:457395
3011	0.2244	3-methylcrotonyl-CoA carboxylase deficiency	ORPHA:6
3011	0.2244	Argininosuccinic aciduria	OMIM:207900
3011	0.2244	3-methylcrotonyl-CoA carboxylase deficiency	ORPHA:6
3014	0.2242	Alstrom syndrome	OMIM:203800
3014	0.2242	Carnitine palmitoyl transferase II deficiency, severe infantile form	ORPHA:228305
3016	0.2241	Paragangliomas 2	OMIM:601650
3016	0.2241	Paragangliomas 2	OMIM:601650
3018	0.224	Neuroblastoma	ORPHA:635
3018	0.224	Neuroblastoma	ORPHA:635
3018	0.224	Neuroblastoma	ORPHA:635
3018	0.224	L-2-hydroxyglutaric aciduria	ORPHA:79314
3018	0.224	Neuroblastoma	ORPHA:635
3018	0.224	Neuroblastoma	ORPHA:635
3018	0.224	Neuroblastoma	ORPHA:635
3018	0.224	Neuroblastoma	ORPHA:635
3026	0.2239	Mitochondrial complex V (ATP synthase) deficiency	OMIM:618120
3026	0.2239	X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability	ORPHA:480880
3026	0.2239	Thyroid hormone metabolism, abnormal, 1	OMIM:609698
3029	0.2238	Neurooculorenal syndrome	OMIM:620305
3030	0.2237	Linear nevus sebaceus syndrome	ORPHA:2612
3030	0.2237	Linear nevus sebaceus syndrome	ORPHA:2612
3030	0.2237	Linear nevus sebaceus syndrome	ORPHA:2612
3030	0.2237	Fatal infantile lactic acidosis with methylmalonic aciduria	ORPHA:17
3034	0.2235	Combined oxidative phosphorylation deficiency 33	OMIM:617713
3034	0.2235	Xeroderma pigmentosum variant	ORPHA:90342
3034	0.2235	Histiocytoid cardiomyopathy	ORPHA:137675
3037	0.2231	?Lipodystrophy, familial partial, type 5	OMIM:615238
3038	0.223	Xeroderma pigmentosum-Cockayne syndrome complex	ORPHA:220295
3038	0.223	Xeroderma pigmentosum-Cockayne syndrome complex	ORPHA:220295
3038	0.223	Xeroderma pigmentosum-Cockayne syndrome complex	ORPHA:220295
3038	0.223	Xeroderma pigmentosum-Cockayne syndrome complex	ORPHA:220295
3038	0.223	Xeroderma pigmentosum, group E, DDB-negative subtype	OMIM:278740
3038	0.223	Oculocutaneous albinism type 1B	ORPHA:79434
3044	0.2229	Orthostatic hypotension 1, due to DBH deficiency	OMIM:223360
3045	0.2228	Lynch syndrome 5	OMIM:614350
3046	0.2227	Hypoparathyroidism-retardation-dysmorphism syndrome	OMIM:241410
3047	0.2225	Vitamin D-dependent rickets, type I	OMIM:264700
3047	0.2225	Saccharopinuria	ORPHA:3124
3049	0.2223	Pseudohypoparathyroidism type 1B	ORPHA:94089
3049	0.2223	Pseudohypoparathyroidism type 1C	ORPHA:79444
3049	0.2223	Pseudohypoparathyroidism type 1B	ORPHA:94089
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3052	0.2222	Familial melanoma	ORPHA:618
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer	OMIM:114500
3063	0.2221	Colorectal cancer, susceptibility to	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer with chromosomal instability, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	?Colorectal cancer, susceptibility to	OMIM:114500
3063	0.2221	Colon cancer, somatic	OMIM:114500
3063	0.2221	Colon cancer, somatic	OMIM:114500
3063	0.2221	Colon cancer, somatic	OMIM:114500
3063	0.2221	Colon cancer, susceptibility to	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, susceptibility to	OMIM:114500
3063	0.2221	Classical Ehlers-Danlos syndrome	ORPHA:287
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease	OMIM:209880
3063	0.2221	Neuroblastoma, susceptibility to, 2	OMIM:613013
3063	0.2221	Neuroblastoma with Hirschsprung disease	OMIM:613013
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colon cancer, advanced, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, susceptibility to	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Colorectal cancer, somatic	OMIM:114500
3063	0.2221	Classical Ehlers-Danlos syndrome	ORPHA:287
3063	0.2221	Classical Ehlers-Danlos syndrome	ORPHA:287
3097	0.222	Combined oxidative phosphorylation defect type 39	ORPHA:565624
3098	0.2216	Neurodevelopmental disorder with language delay and seizures	OMIM:619908
3098	0.2216	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	OMIM:245400
3098	0.2216	Hypophosphatemic rickets with hypercalciuria	OMIM:241530
3101	0.2214	Legius syndrome	OMIM:611431
3101	0.2214	Blau syndrome	OMIM:186580
3101	0.2214	Endocrinopathy due to proprotein convertase 1/3 deficiency	OMIM:600955
3104	0.2213	Schwannomatosis-2, susceptibility to	OMIM:615670
3104	0.2213	Metachondromatosis	OMIM:156250
3104	0.2213	Premature ovarian failure 8	OMIM:615723
3107	0.221	Hypoparathyroidism, familial isolated 1	OMIM:146200
3107	0.221	Thyroid hormone resistance, autosomal recessive	OMIM:274300
3107	0.221	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	OMIM:202010
3107	0.221	CPT II deficiency, infantile	OMIM:600649
3107	0.221	VLCAD deficiency	OMIM:201475
3107	0.221	Hypoparathyroidism, familial isolated 2	OMIM:618883
3113	0.2209	Yunis-Varon syndrome	ORPHA:3472
3113	0.2209	Yunis-Varon syndrome	ORPHA:3472
3113	0.2209	Achondrogenesis, type IA	OMIM:200600
3116	0.2208	Desmoid tumor	ORPHA:873
3116	0.2208	Desmoid tumor	ORPHA:873
3118	0.2207	Laron syndrome	ORPHA:633
3119	0.2206	Combined oxidative phosphorylation deficiency 3	OMIM:610505
3120	0.2205	Hyperinsulinemic hypoglycemia, familial, 5	OMIM:609968
3120	0.2205	Long QT syndrome 3	OMIM:603830
3120	0.2205	Marshall-Smith syndrome	OMIM:602535
3120	0.2205	Fetal akinesia deformation sequence 1	OMIM:208150
3120	0.2205	ACTH-independent macronodular adrenal hyperplasia 2	OMIM:615954
3125	0.2204	Familial adenomatous polyposis 4	OMIM:617100
3126	0.2202	Rubinstein-Taybi syndrome due to CREBBP mutations	ORPHA:353277
3126	0.2202	Rubinstein-Taybi syndrome due to EP300 haploinsufficiency	ORPHA:353284
3128	0.2201	Nephrogenic syndrome of inappropriate antidiuresis	OMIM:300539
3129	0.22	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
3129	0.22	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
3129	0.22	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
3129	0.22	Non-acquired panhypopituitarism	ORPHA:90695
3129	0.22	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
3129	0.22	Non-acquired panhypopituitarism	ORPHA:90695
3129	0.22	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
3129	0.22	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
3129	0.22	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
3129	0.22	Heart defect-tongue hamartoma-polysyndactyly syndrome	ORPHA:1338
3139	0.2199	Megalencephaly-capillary malformation-polymicrogyria syndrome	ORPHA:60040
3139	0.2199	MEHMO syndrome	OMIM:300148
3139	0.2199	Hypocalcemic vitamin D-dependent rickets	ORPHA:289157
3139	0.2199	Hypocalcemic vitamin D-dependent rickets	ORPHA:289157
3143	0.2198	Pilomatrixoma	ORPHA:91414
3144	0.2197	Acyl-CoA dehydrogenase, medium chain, deficiency of	OMIM:201450
3145	0.2196	Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency	ORPHA:5
3146	0.2195	Vitamin D-dependent rickets, type 3	OMIM:619073
3146	0.2195	Short stature due to partial GHR deficiency	ORPHA:314802
3146	0.2195	Short stature due to GHSR deficiency	ORPHA:314811
3146	0.2195	Rhabdomyosarcoma, embryonal, 2	OMIM:180295
3150	0.2194	Estrogen resistance	OMIM:615363
3150	0.2194	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	OMIM:112250
3152	0.2193	Bohring-Opitz syndrome	ORPHA:97297
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Wolf-Hirschhorn syndrome	ORPHA:280
3152	0.2193	Megacystis-microcolon-intestinal hypoperistalsis syndrome	ORPHA:2241
3152	0.2193	Spermatogenic failure 2	OMIM:108420
3152	0.2193	Megacystis-microcolon-intestinal hypoperistalsis syndrome	ORPHA:2241
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Genetic recurrent myoglobinuria	ORPHA:99845
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Wolf-Hirschhorn syndrome	ORPHA:280
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities	OMIM:618505
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Megacystis-microcolon-intestinal hypoperistalsis syndrome	ORPHA:2241
3152	0.2193	?Spermatogenic failure 15	OMIM:616950
3152	0.2193	Omodysplasia 1	OMIM:258315
3152	0.2193	Coffin-Siris syndrome 1	OMIM:135900
3152	0.2193	Genetic recurrent myoglobinuria	ORPHA:99845
3152	0.2193	Genetic recurrent myoglobinuria	ORPHA:99845
3152	0.2193	Megacystis-microcolon-intestinal hypoperistalsis syndrome	ORPHA:2241
3152	0.2193	Branchio-oculo-facial syndrome	ORPHA:1297
3152	0.2193	Wolf-Hirschhorn syndrome	ORPHA:280
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Wolf-Hirschhorn syndrome	ORPHA:280
3152	0.2193	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3	OMIM:619950
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Wolf-Hirschhorn syndrome	ORPHA:280
3152	0.2193	Microform holoprosencephaly	ORPHA:280200
3152	0.2193	Genetic recurrent myoglobinuria	ORPHA:99845
3152	0.2193	Wolf-Hirschhorn syndrome	ORPHA:280
3190	0.2192	Autosomal dominant polycystic kidney disease	ORPHA:730
3190	0.2192	Autosomal dominant polycystic kidney disease	ORPHA:730
3190	0.2192	Spinocerebellar ataxia with axonal neuropathy type 1	ORPHA:94124
3190	0.2192	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	OMIM:607250
3190	0.2192	Autosomal dominant polycystic kidney disease	ORPHA:730
3190	0.2192	Nephrotic syndrome, type 11	OMIM:616730
3190	0.2192	Autosomal dominant polycystic kidney disease	ORPHA:730
3190	0.2192	Autosomal dominant polycystic kidney disease	ORPHA:730
3190	0.2192	Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal	OMIM:618810
3190	0.2192	Autosomal dominant polycystic kidney disease	ORPHA:730
3190	0.2192	Autosomal dominant polycystic kidney disease	ORPHA:730
3190	0.2192	Autosomal dominant polycystic kidney disease	ORPHA:730
3202	0.2191	Thyroid carcinoma, follicular, somatic	OMIM:188470
3202	0.2191	Thyroid carcinoma, follicular, somatic	OMIM:188470
3202	0.2191	Carnitine palmitoyl transferase 1A deficiency	ORPHA:156
3202	0.2191	Growth hormone deficiency, isolated, type IB	OMIM:612781
3202	0.2191	Thyroid cancer, nonmedullary, 2	OMIM:188470
3202	0.2191	Thyroid carcinoma, follicular	OMIM:188470
3202	0.2191	LIPE-related familial partial lipodystrophy	ORPHA:435660
3202	0.2191	?RHYNS syndrome	OMIM:602152
3210	0.2189	Multiple congenital anomalies-hypotonia-seizures syndrome	ORPHA:280633
3210	0.2189	46XY sex reversal 11	OMIM:273250
3210	0.2189	?Mitochondrial complex I deficiency, nuclear type 35	OMIM:619003
3210	0.2189	Familial isolated hypoparathyroidism due to agenesis of parathyroid gland	ORPHA:2239
3214	0.2187	Tenorio syndrome	OMIM:616260
3215	0.2186	Smith-Magenis syndrome	ORPHA:819
3215	0.2186	Smith-Magenis syndrome	ORPHA:819
3215	0.2186	Smith-Magenis syndrome	OMIM:182290
3215	0.2186	Smith-Magenis syndrome	ORPHA:819
3215	0.2186	Smith-Magenis syndrome	ORPHA:819
3220	0.2185	?Ovarian dysgenesis 8	OMIM:618187
3220	0.2185	Diabetes, permanent neonatal 2, with or without neurologic features	OMIM:618856
3220	0.2185	Mitochondrial complex IV deficiency, nuclear type 23	OMIM:620275
3220	0.2185	Mitochondrial complex III deficiency, nuclear type 3	OMIM:615158
3220	0.2185	Mitochondrial pyruvate carrier deficiency	OMIM:614741
3220	0.2185	Combined oxidative phosphorylation deficiency 54	OMIM:619737
3220	0.2185	?Mitochondrial complex III deficiency, nuclear type 9	OMIM:616111
3220	0.2185	Ovarian dysgenesis 9	OMIM:619665
3228	0.2182	Fish-eye disease	OMIM:136120
3228	0.2182	Epidermodysplasia verruciformis	ORPHA:302
3228	0.2182	Epidermodysplasia verruciformis	ORPHA:302
3228	0.2182	Oculocutaneous albinism type 1A	ORPHA:79431
3228	0.2182	Epidermodysplasia verruciformis	ORPHA:302
3228	0.2182	Epidermodysplasia verruciformis	ORPHA:302
3228	0.2182	Epidermodysplasia verruciformis	OMIM:226400
3235	0.2179	Hypothyroidism, congenital nongoitrous, 5	OMIM:225250
3235	0.2179	Glycogen storage disease due to glycogen debranching enzyme deficiency	ORPHA:366
3237	0.2178	Hypercholesterolemia, familial, 2	OMIM:144010
3237	0.2178	Squalene synthase deficiency	OMIM:618156
3239	0.2177	Bladder cancer, somatic	OMIM:109800
3239	0.2177	Bladder cancer, somatic	OMIM:109800
3239	0.2177	Bladder cancer, somatic	OMIM:109800
3239	0.2177	Bladder cancer, somatic	OMIM:109800
3239	0.2177	Congenital myopathy 1B, autosomal recessive	OMIM:255320
3244	0.2176	Pigmented nodular adrenocortical disease, primary, 1	OMIM:610489
3244	0.2176	Distal myopathy, Tateyama type	ORPHA:488650
3246	0.2174	Acromelic frontonasal dysostosis	OMIM:603671
3247	0.2172	2p21 microdeletion syndrome	ORPHA:163693
3247	0.2172	Timothy syndrome	OMIM:601005
3247	0.2172	AICA-ribosiduria due to ATIC deficiency	OMIM:608688
3247	0.2172	2p21 microdeletion syndrome	ORPHA:163693
3247	0.2172	2p21 microdeletion syndrome	ORPHA:163693
3247	0.2172	2p21 microdeletion syndrome	ORPHA:163693
3247	0.2172	?Angioedema, hereditary, 7	OMIM:619366
3254	0.217	Rhabdoid tumor predisposition syndrome 1	OMIM:609322
3254	0.217	Rhabdoid tumors, somatic	OMIM:609322
3254	0.217	?Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2	OMIM:620085
3257	0.2169	ANE syndrome	ORPHA:157954
3257	0.2169	Propionic acidemia	ORPHA:35
3257	0.2169	Propionic acidemia	ORPHA:35
3260	0.2168	MPDU1-CDG	ORPHA:79323
3261	0.2167	Hyperglycinemia, lactic acidosis, and seizures	OMIM:614462
3261	0.2167	Combined oxidative phosphorylation defect type 27	ORPHA:477774
3261	0.2167	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	OMIM:617186
3264	0.2166	3-Methylcrotonyl-CoA carboxylase 1 deficiency	OMIM:210200
3265	0.2165	Striatonigral degeneration, childhood-onset	OMIM:617054
3265	0.2165	Apparent mineralocorticoid excess	ORPHA:320
3267	0.2164	?Hypogonadotropic hypogonadism 12 with or without anosmia	OMIM:614841
3268	0.2162	Dermatofibrosarcoma protuberans	ORPHA:31112
3268	0.2162	Hypogonadotropic hypogonadism 23 with or without anosmia	OMIM:228300
3268	0.2162	Muscle glycogenosis	OMIM:300559
3268	0.2162	Hyperproinsulinemia	OMIM:616214
3268	0.2162	Dermatofibrosarcoma protuberans	ORPHA:31112
3273	0.216	?Tumoral calcinosis, hyperphosphatemic, familial, 3	OMIM:617994
3274	0.2158	Choroid plexus papilloma	OMIM:260500
3274	0.2158	Glioma susceptibility 2	OMIM:613028
3276	0.2157	Hypogonadotropic hypogonadism 22, with or without anosmia	OMIM:616030
3276	0.2157	Hypogonadotropic hypogonadism 16 with or without anosmia	OMIM:614897
3278	0.2156	Bachmann-Bupp syndrome	OMIM:619075
3279	0.2155	?Diarrhea 13	OMIM:620357
3279	0.2155	Lipoyltransferase 1 deficiency	OMIM:616299
3281	0.2154	ACTH-independent macronodular adrenal hyperplasia	OMIM:219080
3281	0.2154	Growth delay due to insulin-like growth factor type 1 deficiency	ORPHA:73272
3283	0.2153	Hereditary pulmonary alveolar proteinosis	ORPHA:264675
3283	0.2153	Hereditary pulmonary alveolar proteinosis	ORPHA:264675
3283	0.2153	Enamel-renal syndrome	ORPHA:1031
3286	0.2152	Keratitis-ichthyosis-deafness syndrome, autosomal recessive	OMIM:242150
3286	0.2152	Pallister-Hall-like syndrome	OMIM:241800
3288	0.2151	Hyperinsulinemic hypoglycemia, familial, 2	OMIM:601820
3288	0.2151	Glutaric acidemia IIA	OMIM:231680
3288	0.2151	Hypoglycemia of infancy, leucine-sensitive	OMIM:240800
3288	0.2151	Glutaricaciduria, type I	OMIM:231670
3288	0.2151	Glutaric acidemia IIB	OMIM:231680
3288	0.2151	Glutaric acidemia IIC	OMIM:231680
3294	0.215	Schwartz-Jampel syndrome	ORPHA:800
3295	0.2149	Acid-labile subunit, deficiency of	OMIM:615961
3295	0.2149	SLC35A2-CDG	ORPHA:356961
3295	0.2149	Congenital disorder of deglycosylation 1	OMIM:615273
3298	0.2148	Neurocutaneous melanosis, somatic	OMIM:249400
3298	0.2148	Hemangioma, capillary infantile, somatic	OMIM:602089
3298	0.2148	Hemangioma, capillary infantile, susceptibility to	OMIM:602089
3298	0.2148	Myxoma, intracardiac	OMIM:255960
3298	0.2148	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	OMIM:165800
3298	0.2148	Capillary malformation-arteriovenous malformation 1	OMIM:608354
3298	0.2148	Autosomal dominant Robinow syndrome	ORPHA:3107
3298	0.2148	Autosomal dominant Robinow syndrome	ORPHA:3107
3298	0.2148	Omodysplasia 2	OMIM:164745
3298	0.2148	Autosomal dominant Robinow syndrome	ORPHA:3107
3298	0.2148	CATSHL syndrome	OMIM:610474
3298	0.2148	Carney complex variant	OMIM:608837
3298	0.2148	Hemangioma, capillary infantile, somatic	OMIM:602089
3298	0.2148	Cornelia de Lange syndrome 4	OMIM:614701
3298	0.2148	Autosomal dominant Robinow syndrome	ORPHA:3107
3298	0.2148	L√©ri-Weill dyschondrosteosis	ORPHA:240
3298	0.2148	Craniolenticulosutural dysplasia	ORPHA:50814
3298	0.2148	Craniolenticulosutural dysplasia	OMIM:607812
3298	0.2148	Seizures-scoliosis-macrocephaly syndrome	ORPHA:466926
3298	0.2148	Autosomal dominant otospondylomegaepiphyseal dysplasia	ORPHA:166100
3298	0.2148	Occipital horn syndrome	ORPHA:198
3298	0.2148	VACTERL/VATER association	ORPHA:887
3298	0.2148	Neurofacioskeletal syndrome with or without renal agenesis	OMIM:619194
3298	0.2148	?Hemangioma, capillary infantile, susceptibility to	OMIM:602089
3298	0.2148	8q24.3 microdeletion syndrome	ORPHA:508488
3298	0.2148	Diastrophic dysplasia	OMIM:222600
3298	0.2148	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	OMIM:308700
3298	0.2148	Autosomal dominant otospondylomegaepiphyseal dysplasia	ORPHA:166100
3298	0.2148	Czech dysplasia	OMIM:609162
3327	0.2147	Rickets, vitamin D-resistant, type IIA	OMIM:277440
3327	0.2147	Acne inversa, familial, 2, with or without Dowling-Degos disease	OMIM:613736
3329	0.2146	COG1-CDG	ORPHA:263508
3329	0.2146	Sandhoff disease, infantile, juvenile, and adult forms	OMIM:268800
3329	0.2146	Sandhoff disease, infantile form	ORPHA:309155
3329	0.2146	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	ORPHA:2590
3329	0.2146	Haddad syndrome	ORPHA:99803
3329	0.2146	Bent bone dysplasia syndrome	OMIM:614592
3329	0.2146	3-hydroxyacyl-CoA dehydrogenase deficiency	OMIM:231530
3329	0.2146	Retinitis pigmentosa 89	OMIM:618955
3329	0.2146	PCWH syndrome	OMIM:609136
3329	0.2146	Growth delay-intellectual disability-hepatopathy syndrome	ORPHA:541423
3329	0.2146	Hepatorenocardiac degenerative fibrosis	OMIM:619902
3329	0.2146	Haddad syndrome	ORPHA:99803
3329	0.2146	Ichthyosis, congenital, autosomal recessive 4A	OMIM:601277
3329	0.2146	Peroxisome biogenesis disorder 11B	OMIM:614885
3329	0.2146	Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome	ORPHA:466794
3329	0.2146	Haddad syndrome	ORPHA:99803
3329	0.2146	Spondyloepimetaphyseal dysplasia, Shohat type	ORPHA:93352
3329	0.2146	COG5-CDG	ORPHA:263487
3329	0.2146	Polycystic kidney disease 5	OMIM:617610
3329	0.2146	Meckel syndrome 7	OMIM:267010
3329	0.2146	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	OMIM:618416
3329	0.2146	VPS11-related autosomal recessive hypomyelinating leukodystrophy	ORPHA:466934
3351	0.2144	Hypomagnesemia 3, renal	OMIM:248250
3351	0.2144	Paget disease of bone 5, juvenile-onset	OMIM:239000
3353	0.2143	Autosomal dominant hypocalcemia	ORPHA:428
3353	0.2143	Molybdenum cofactor deficiency C	OMIM:615501
3353	0.2143	Gabriele-de Vries syndrome	ORPHA:506358
3353	0.2143	Autosomal dominant hypocalcemia	ORPHA:428
3357	0.2142	Mitochondrial trifunctional protein deficiency	ORPHA:746
3357	0.2142	Mitochondrial trifunctional protein deficiency	ORPHA:746
3359	0.2141	Laminin subunit alpha 2-related congenital muscular dystrophy	ORPHA:258
3359	0.2141	Sebocystomatosis	ORPHA:841
3361	0.214	Osteosarcoma	OMIM:259500
3361	0.214	Osteosarcoma, somatic	OMIM:259500
3361	0.214	Osteosarcoma, somatic	OMIM:259500
3361	0.214	Rett syndrome	ORPHA:778
3365	0.2139	Mitochondrial complex IV deficiency, nuclear type 7	OMIM:619051
3365	0.2139	CIDEC-related familial partial lipodystrophy	ORPHA:435651
3365	0.2139	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	OMIM:614052
3368	0.2137	Peroxisome biogenesis disorder 3B	OMIM:266510
3368	0.2137	Epidermodysplasia verruciformis 2	OMIM:618231
3370	0.2136	D-glyceric aciduria	OMIM:220120
3370	0.2136	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy	OMIM:620152
3372	0.2134	Lymphangioleiomyomatosis, somatic	OMIM:606690
3372	0.2134	Lymphangioleiomyomatosis	OMIM:606690
3372	0.2134	Boomerang dysplasia	ORPHA:1263
3375	0.2133	Hyperthyroidism, familial gestational	OMIM:603373
3375	0.2133	Hypothyroidism, congenital, nongoitrous 4	OMIM:275100
3375	0.2133	Hypothyroidism, congenital, nongoitrous, 9	OMIM:301035
3375	0.2133	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	OMIM:615418
3379	0.2132	Lipodystrophy, familial partial, type 6	OMIM:615980
3380	0.213	Polycystic kidney disease 2	OMIM:613095
3381	0.2129	Hyperkalemic periodic paralysis	ORPHA:682
3381	0.2129	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	OMIM:614388
3381	0.2129	Phenylketonuria	OMIM:261600
3384	0.2127	Megalencephaly-severe kyphoscoliosis-overgrowth syndrome	ORPHA:457359
3384	0.2127	?Premature ovarian failure 18	OMIM:619203
3386	0.2126	Melanoma and neural system tumor syndrome	OMIM:155755
3386	0.2126	Premature aging syndrome, Penttinen type	OMIM:601812
3386	0.2126	Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome	ORPHA:444077
3386	0.2126	Autoimmune polyendocrinopathy type 1	ORPHA:3453
3386	0.2126	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	OMIM:616007
3391	0.2125	Palmoplantar carcinoma, multiple self-healing	OMIM:615225
3391	0.2125	?Combined oxidative phosphorylation deficiency 25	OMIM:616430
3393	0.2124	Familial afibrinogenemia	ORPHA:98880
3393	0.2124	Familial afibrinogenemia	ORPHA:98880
3393	0.2124	Osteosarcoma	ORPHA:668
3393	0.2124	Osteosarcoma	ORPHA:668
3393	0.2124	Osteosarcoma	ORPHA:668
3393	0.2124	Familial afibrinogenemia	ORPHA:98880
3393	0.2124	Atrial septal defect, ostium secundum type	ORPHA:99103
3393	0.2124	Cranio-osteoarthropathy	ORPHA:1525
3393	0.2124	Atrial septal defect, ostium secundum type	ORPHA:99103
3393	0.2124	Atrial septal defect, ostium secundum type	ORPHA:99103
3393	0.2124	Atrial septal defect, ostium secundum type	ORPHA:99103
3393	0.2124	Atrial septal defect, ostium secundum type	ORPHA:99103
3393	0.2124	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
3393	0.2124	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
3393	0.2124	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
3393	0.2124	Familial calcium pyrophosphate deposition	ORPHA:1416
3393	0.2124	Faundes-Banka syndrome	OMIM:619376
3393	0.2124	Alkaptonuria	ORPHA:56
3393	0.2124	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
3393	0.2124	Atrial septal defect, ostium secundum type	ORPHA:99103
3393	0.2124	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
3393	0.2124	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
3393	0.2124	Atrial septal defect, ostium secundum type	ORPHA:99103
3393	0.2124	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
3393	0.2124	Atrial septal defect, ostium secundum type	ORPHA:99103
3393	0.2124	Spondyloepiphyseal dysplasia tarda	ORPHA:93284
3393	0.2124	Familial calcium pyrophosphate deposition	ORPHA:1416
3393	0.2124	Multiple epiphyseal dysplasia, Beighton type	ORPHA:166011
3393	0.2124	Progressive pseudorheumatoid dysplasia	OMIM:208230
3422	0.2123	Rickets due to defect in vitamin D 25-hydroxylation deficiency	OMIM:600081
3423	0.2121	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	OMIM:613752
3423	0.2121	Apolipoprotein C-III deficiency	OMIM:614028
3423	0.2121	Allan-Herndon-Dudley syndrome	OMIM:300523
3426	0.212	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	OMIM:609734
3427	0.2119	Pseudopseudohypoparathyroidism	ORPHA:79445
3427	0.2119	Pseudohypoparathyroidism Ib	OMIM:603233
3427	0.2119	Pseudohypoparathyroidism, type IB	OMIM:603233
3430	0.2118	Adrenocorticotropic hormone deficiency	OMIM:201400
3431	0.2117	Tumoral calcinosis, hyperphosphatemic, familial, 1	OMIM:211900
3431	0.2117	Neurodegeneration and seizures due to copper transport defect	OMIM:620306
3433	0.2116	Thyroid hormone resistance	OMIM:188570
3434	0.2113	Wiedemann-Rautenstrauch syndrome	ORPHA:3455
3434	0.2113	?Mitochondrial complex IV deficiency, nuclear type 20	OMIM:619064
3434	0.2113	Combined oxidative phosphorylation deficiency 21	OMIM:615918
3434	0.2113	Mitochondrial complex I deficiency, nuclear type 36	OMIM:619170
3434	0.2113	?Mitochondrial complex IV deficiency, nuclear type 15	OMIM:619059
3434	0.2113	Pyruvate dehydrogenase phosphatase deficiency	ORPHA:79246
3440	0.2112	2,4-dienoyl-CoA reductase deficiency	OMIM:616034
3441	0.2109	Pseudohypoparathyroidism Ia	OMIM:103580
3441	0.2109	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
3441	0.2109	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
3441	0.2109	X-linked Emery-Dreifuss muscular dystrophy	ORPHA:98863
3441	0.2109	Autosomal recessive Emery-Dreifuss muscular dystrophy	ORPHA:98855
3441	0.2109	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
3441	0.2109	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	OMIM:616516
3441	0.2109	X-linked Emery-Dreifuss muscular dystrophy	ORPHA:98863
3441	0.2109	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
3450	0.2107	Atypical teratoid rhabdoid tumor	ORPHA:99966
3450	0.2107	Multiple symmetric lipomatosis	ORPHA:2398
3450	0.2107	Lipomatosis, multiple symmetric, with or without peripheral neuropathy	OMIM:151800
3450	0.2107	Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome	ORPHA:1555
3450	0.2107	Enlarged parietal foramina	ORPHA:60015
3450	0.2107	X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome	ORPHA:459070
3450	0.2107	MERRF	ORPHA:551
3450	0.2107	Leri-Weill dyschondrosteosis	OMIM:127300
3450	0.2107	Diastrophic dysplasia	ORPHA:628
3450	0.2107	Enlarged parietal foramina	ORPHA:60015
3450	0.2107	X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome	ORPHA:480907
3461	0.2105	Hypogonadotropic hypogonadism 10 with or without anosmia	OMIM:614839
3461	0.2105	Delayed puberty, self-limited	OMIM:619613
3463	0.2103	Neurofibromatosis, familial spinal	OMIM:162210
3464	0.2102	Cutis laxa, autosomal recessive, type IIIA	OMIM:219150
3465	0.21	?Hypogonadotropic hypogonadism 13 with or without anosmia	OMIM:614842
3466	0.2099	Thyroid cancer, nonmedullary, 1	OMIM:188550
3466	0.2099	Barrett esophagus/esophageal adenocarcinoma	OMIM:614266
3466	0.2099	Barrett esophagus/esophageal adenocarcinoma	OMIM:614266
3466	0.2099	Paragangliomas 7	OMIM:618475
3466	0.2099	Barrett esophagus/esophageal adenocarcinoma	OMIM:614266
3471	0.2098	Hypophosphatemic rickets, X-linked dominant	OMIM:307800
3472	0.2097	Pigmented nodular adrenocortical disease, primary, 2	OMIM:610475
3473	0.2096	Ovarian cancer, somatic	OMIM:167000
3473	0.2096	Ovarian cancer, somatic	OMIM:167000
3473	0.2096	Insulin-like growth factor I deficiency	OMIM:608747
3473	0.2096	Ovarian cancer, somatic	OMIM:167000
3473	0.2096	Ovarian cancer, somatic	OMIM:167000
3473	0.2096	Ovarian cancer, somatic	OMIM:167000
3473	0.2096	Ovarian cancer, somatic	OMIM:167000
3473	0.2096	Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome	ORPHA:436174
3473	0.2096	Ovarian cancer, somatic	OMIM:167000
3482	0.2095	Hereditary renal hypouricemia	ORPHA:94088
3482	0.2095	Hereditary renal hypouricemia	ORPHA:94088
3482	0.2095	Hypophosphatemic rickets	OMIM:300554
3485	0.2093	Amyloidosis, hereditary, transthyretin-related	OMIM:105210
3485	0.2093	?Fanconi renotubular syndrome 2	OMIM:613388
3485	0.2093	Infant acute respiratory distress syndrome	ORPHA:70587
3485	0.2093	Infant acute respiratory distress syndrome	ORPHA:70587
3485	0.2093	Infant acute respiratory distress syndrome	ORPHA:70587
3490	0.2092	Spermatogenic failure 77	OMIM:620103
3490	0.2092	?Spermatogenic failure 14	OMIM:615842
3492	0.2091	X-linked recessive ocular albinism	ORPHA:54
3492	0.2091	Piebaldism	ORPHA:2884
3492	0.2091	Erythrokeratodermia variabilis	ORPHA:317
3492	0.2091	Cylindromatosis, familial	OMIM:132700
3492	0.2091	Piebaldism	ORPHA:2884
3492	0.2091	Erythrokeratodermia variabilis	ORPHA:317
3492	0.2091	Mucolipidosis III gamma	OMIM:252605
3492	0.2091	Oculocutaneous albinism type 4	ORPHA:79435
3492	0.2091	Mucolipidosis III alpha/beta	OMIM:252600
3492	0.2091	Erythrokeratodermia variabilis	ORPHA:317
3492	0.2091	Erythrokeratodermia variabilis	ORPHA:317
3492	0.2091	X-linked recessive ocular albinism	ORPHA:54
3504	0.209	?Premature ovarian failure 15	OMIM:618096
3504	0.209	Growth hormone deficiency, isolated, type II	OMIM:173100
3504	0.209	Intellectual developmental disorder, X-linked syndromic 13	OMIM:300055
3504	0.209	Growth hormone deficiency, isolated, type IV	OMIM:618157
3504	0.209	Xeroderma pigmentosum, group A	OMIM:278700
3504	0.209	X-linked intellectual disability with isolated growth hormone deficiency	ORPHA:67045
3504	0.209	Intellectual disability-strabismus syndrome	ORPHA:363528
3504	0.209	?Pancreatic cancer, susceptibility to, 5	OMIM:618680
3504	0.209	?Joubert syndrome 38	OMIM:619476
3513	0.2089	EAST syndrome	ORPHA:199343
3513	0.2089	SESAME syndrome	OMIM:612780
3515	0.2087	Pancreatic agenesis-holoprosencephaly syndrome	ORPHA:556955
3516	0.2086	Hypoxanthine guanine phosphoribosyltransferase partial deficiency	ORPHA:79233
3516	0.2086	Hypouricemia, renal	OMIM:220150
3516	0.2086	Renal cysts and diabetes syndrome	OMIM:137920
3519	0.2085	Beta-ureidopropionase deficiency	OMIM:613161
3519	0.2085	Pyruvate dehydrogenase E3-binding protein deficiency	ORPHA:255182
3521	0.2083	Glutaric acidemia type 3	ORPHA:35706
3521	0.2083	Combined oxidative phosphorylation deficiency 12	OMIM:614924
3523	0.2076	Hypermanganesemia with dystonia 2	OMIM:617013
3523	0.2076	McArdle disease	OMIM:232600
3525	0.2075	Melanoma, malignant, somatic	OMIM:155600
3525	0.2075	Melanoma, malignant, somatic	OMIM:155600
3527	0.2074	Distal renal tubular acidosis 1	OMIM:179800
3527	0.2074	Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome	ORPHA:457212
3527	0.2074	Mitochondrial complex I deficiency, nuclear type 32	OMIM:618252
3530	0.2073	Primary hyperaldosteronism-seizures-neurological abnormalities syndrome	ORPHA:369929
3530	0.2073	Hyperinsulinism-hyperammonemia syndrome	OMIM:606762
3532	0.2072	46XY sex reversal 6	OMIM:613762
3532	0.2072	46XY sex reversal 7	OMIM:233420
3534	0.2071	Cerebral creatine deficiency syndrome 2	OMIM:612736
3534	0.2071	Hyperphenylalaninemia, BH4-deficient, B	OMIM:233910
3534	0.2071	Combined oxidative phosphorylation deficiency 4	OMIM:610678
3534	0.2071	Hyperphenylalaninemia, BH4-deficient, A	OMIM:261640
3534	0.2071	Developmental and epileptic encephalopathy 82	OMIM:618721
3534	0.2071	Hyperphenylalaninemia, BH4-deficient, C	OMIM:261630
3534	0.2071	Combined oxidative phosphorylation deficiency 27	OMIM:616672
3541	0.207	Familial hyperaldosteronism type III	ORPHA:251274
3542	0.2067	Medulloblastoma	OMIM:155255
3542	0.2067	Progressive non-fluent aphasia	ORPHA:100070
3542	0.2067	Progressive non-fluent aphasia	ORPHA:100070
3542	0.2067	Small cell cancer of the lung, somatic	OMIM:182280
3542	0.2067	Medulloblastoma	OMIM:155255
3542	0.2067	Progressive non-fluent aphasia	ORPHA:100070
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	Progressive non-fluent aphasia	ORPHA:100070
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome	ORPHA:435938
3542	0.2067	Medulloblastoma, somatic	OMIM:155255
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	Paget disease of bone 3	OMIM:167250
3542	0.2067	Progressive non-fluent aphasia	ORPHA:100070
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	Medulloblastoma	OMIM:155255
3542	0.2067	Progressive non-fluent aphasia	ORPHA:100070
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome	ORPHA:536467
3542	0.2067	Chondrosarcoma	OMIM:215300
3542	0.2067	Chondrosarcoma, extraskeletal myxoid	OMIM:612237
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	Medulloblastoma, somatic	OMIM:155255
3542	0.2067	Pilomatricoma, somatic	OMIM:132600
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	Coffin-Siris syndrome	ORPHA:1465
3542	0.2067	Progressive non-fluent aphasia	ORPHA:100070
3542	0.2067	Medulloblastoma predisposition syndrome	OMIM:155255
3542	0.2067	Chondrosarcoma, extraskeletal myxoid	OMIM:612237
3542	0.2067	Progressive non-fluent aphasia	ORPHA:100070
3575	0.2064	Microcephaly 30, primary, autosomal recessive	OMIM:620183
3575	0.2064	Multiple congenital anomalies-hypotonia-seizures syndrome 2	OMIM:300868
3575	0.2064	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	OMIM:617069
3575	0.2064	Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation	ORPHA:453504
3575	0.2064	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	OMIM:616479
3575	0.2064	Developmental and epileptic encephalopathy 53	OMIM:617389
3575	0.2064	Yunis-Varon syndrome	OMIM:216340
3575	0.2064	Developmental and epileptic encephalopathy 96	OMIM:619340
3575	0.2064	Brachytelephalangic chondrodysplasia punctata	ORPHA:79345
3575	0.2064	Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment	OMIM:620066
3575	0.2064	Dyssegmental dysplasia, Silverman-Handmaker type	ORPHA:1865
3575	0.2064	Cornelia de Lange syndrome	ORPHA:199
3575	0.2064	Cornelia de Lange syndrome	ORPHA:199
3575	0.2064	Blomstrand lethal chondrodysplasia	ORPHA:50945
3575	0.2064	Thanatophoric dysplasia type 1	ORPHA:1860
3575	0.2064	Thanatophoric dysplasia type 2	ORPHA:93274
3575	0.2064	Arthrogryposis, distal, type 1C	OMIM:619110
3575	0.2064	Cornelia de Lange syndrome	ORPHA:199
3575	0.2064	Phocomelia, Schinzel type	ORPHA:2879
3575	0.2064	Fibrochondrogenesis 1	OMIM:228520
3575	0.2064	Cornelia de Lange syndrome	ORPHA:199
3575	0.2064	Intellectual developmental disorder, autosomal dominant 47	OMIM:617635
3575	0.2064	Cornelia de Lange syndrome	ORPHA:199
3575	0.2064	Autosomal recessive omodysplasia	ORPHA:93329
3575	0.2064	Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome	ORPHA:544488
3575	0.2064	?Combined oxidative phosphorylation deficiency 43	OMIM:618851
3575	0.2064	Short rib-polydactyly syndrome, Verma-Naumoff type	ORPHA:93271
3575	0.2064	Cornelia de Lange syndrome	ORPHA:199
3575	0.2064	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	OMIM:617070
3575	0.2064	Combined oxidative phosphorylation deficiency 24	OMIM:616239
3575	0.2064	Spinocerebellar ataxia, autosomal recessive 30	OMIM:619405
3575	0.2064	Neurodevelopmental disorder with seizures and speech and walking impairment	OMIM:618480
3575	0.2064	Short rib-polydactyly syndrome, Verma-Naumoff type	ORPHA:93271
3575	0.2064	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	OMIM:610131
3575	0.2064	Perrault syndrome 5	OMIM:616138
3575	0.2064	Neurodevelopmental disorder with hypotonia, microcephaly, and seizures	OMIM:618862
3575	0.2064	Congenital hypotonia, epilepsy, developmental delay, and digital anomalies	OMIM:618494
3575	0.2064	Multiple mitochondrial dysfunctions syndrome 5	OMIM:617613
3575	0.2064	ALG9-CDG	ORPHA:79328
3575	0.2064	Skeletal dysplasia, mild, with joint laxity and advanced bone age	OMIM:618870
3575	0.2064	Achondrogenesis type 1A	ORPHA:93299
3575	0.2064	Short rib-polydactyly syndrome, Verma-Naumoff type	ORPHA:93271
3575	0.2064	Short rib-polydactyly syndrome, Verma-Naumoff type	ORPHA:93271
3575	0.2064	Achondrogenesis type 1B	ORPHA:93298
3575	0.2064	Mitochondrial complex IV deficiency, nuclear type 11	OMIM:619054
3575	0.2064	Short rib-polydactyly syndrome, Verma-Naumoff type	ORPHA:93271
3575	0.2064	Glycogen storage disease XI	OMIM:612933
3575	0.2064	Platyspondylic dysplasia, Torrance type	ORPHA:85166
3575	0.2064	Meckel syndrome 14	OMIM:619879
3575	0.2064	Short rib-polydactyly syndrome, Verma-Naumoff type	ORPHA:93271
3575	0.2064	?Myopathy, isolated mitochondrial, autosomal dominant	OMIM:616209
3626	0.2063	Sitosterolemia 2	OMIM:618666
3626	0.2063	?Pancreatic lipase deficiency	OMIM:614338
3626	0.2063	Temple syndrome due to maternal uniparental disomy of chromosome 14	ORPHA:96184
3626	0.2063	Temple syndrome due to paternal 14q32.2 hypomethylation	ORPHA:254531
3626	0.2063	Temple syndrome due to paternal 14q32.2 hypomethylation	ORPHA:254531
3626	0.2063	Temple syndrome due to maternal uniparental disomy of chromosome 14	ORPHA:96184
3626	0.2063	Bardet-Biedl syndrome 20	OMIM:619471
3626	0.2063	Kaufman oculocerebrofacial syndrome	OMIM:244450
3626	0.2063	Coronary artery disease, autosomal dominant, 1	OMIM:608320
3635	0.2061	Adenosine monophosphate deaminase deficiency	ORPHA:45
3635	0.2061	Adenosine monophosphate deaminase deficiency	ORPHA:45
3635	0.2061	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	OMIM:607459
3635	0.2061	Short stature, Dauber-Argente type	OMIM:619489
3635	0.2061	Autosomal dominant mitochondrial myopathy with exercise intolerance	ORPHA:457050
3640	0.206	Hypocalcemic vitamin D-resistant rickets	ORPHA:93160
3640	0.206	Sanjad-Sakati syndrome	ORPHA:2323
3640	0.206	Metaphyseal chondrodysplasia, Murk Jansen type	OMIM:156400
3640	0.206	Fanconi renotubular syndrome 1	OMIM:134600
3640	0.206	Hypercalcemia, infantile, 2	OMIM:616963
3645	0.2059	Combined oxidative phosphorylation deficiency 39	OMIM:618397
3645	0.2059	Developmental and epileptic encephalopathy 39	OMIM:612949
3645	0.2059	Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities	OMIM:619026
3648	0.2058	Gitelman syndrome	OMIM:263800
3648	0.2058	Bartter syndrome, type 5, antenatal, transient	OMIM:300971
3650	0.2056	SHORT syndrome	OMIM:269880
3650	0.2056	Type 1 diabetes mellitus	OMIM:222100
3650	0.2056	Diabetes, type 1, susceptibility to	OMIM:222100
3650	0.2056	?46XY sex reversal 5	OMIM:613080
3650	0.2056	HELIX syndrome	OMIM:617671
3650	0.2056	Silver-Russell syndrome due to a point mutation	ORPHA:397590
3650	0.2056	Oculodentodigital dysplasia	ORPHA:2710
3650	0.2056	Pyridoxine-dependent epilepsy	ORPHA:3006
3650	0.2056	Pancreatic agenesis and congenital heart defects	OMIM:600001
3650	0.2056	Greig cephalopolysyndactyly syndrome	OMIM:175700
3650	0.2056	Combined oxidative phosphorylation deficiency 9	OMIM:614582
3650	0.2056	?Combined oxidative phosphorylation deficiency 38	OMIM:618378
3650	0.2056	3-hydroxy-3-methylglutaryl-CoA synthase deficiency	ORPHA:35701
3650	0.2056	Cole disease	OMIM:615522
3650	0.2056	Neurodegeneration, childhood-onset, with progressive microcephaly	OMIM:619847
3650	0.2056	Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome	ORPHA:457279
3650	0.2056	Hogue-Janssens syndrome 1	OMIM:616355
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Diabetes mellitus, insulin-dependent	OMIM:222100
3650	0.2056	MODY, type III	OMIM:600496
3650	0.2056	Shashi-Pena syndrome	OMIM:617190
3650	0.2056	Silver-Russell syndrome due to a point mutation	ORPHA:397590
3650	0.2056	?Mitochondrial complex I deficiency, nuclear type 28	OMIM:618249
3650	0.2056	HELLP syndrome, maternal, of pregnancy	OMIM:609016
3650	0.2056	Spinocerebellar ataxia with epilepsy	ORPHA:254881
3650	0.2056	Diabetes, type 1, susceptibility to	OMIM:222100
3650	0.2056	2-methylbutyrylglycinuria	OMIM:610006
3650	0.2056	Diabetes mellitus, permanent neonatal 3, with or without neurologic features	OMIM:618857
3650	0.2056	Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome	ORPHA:391408
3650	0.2056	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	OMIM:617668
3650	0.2056	Cone-rod synaptic disorder syndrome, congenital nonprogressive	OMIM:618970
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Combined oxidative phosphorylation deficiency 30	OMIM:616974
3650	0.2056	?Paganini-Miozzo syndrome	OMIM:301025
3650	0.2056	Pituitary hormone deficiency, combined, 4	OMIM:262700
3650	0.2056	PEPCK deficiency, mitochondrial	OMIM:261650
3650	0.2056	Congenital cataracts-facial dysmorphism-neuropathy syndrome	ORPHA:48431
3650	0.2056	Malonyl-CoA decarboxylase deficiency	OMIM:248360
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Dihydrolipoamide dehydrogenase deficiency	OMIM:246900
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	3-methylglutaconic aciduria type 1	ORPHA:67046
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Bardet-Biedl syndrome 9	OMIM:615986
3650	0.2056	Fructose-1,6-bisphosphatase deficiency	OMIM:229700
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Coenzyme Q10 deficiency, primary, 5	OMIM:614654
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	HSD10 mitochondrial disease	OMIM:300438
3650	0.2056	Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures	OMIM:614501
3650	0.2056	Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome	ORPHA:391408
3650	0.2056	Silver-Russell syndrome due to a point mutation	ORPHA:397590
3650	0.2056	Combined oxidative phosphorylation deficiency 31	OMIM:617228
3650	0.2056	Mitochondrial complex I deficiency, nuclear type 29	OMIM:618250
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Mitochondrial complex I deficiency, nuclear type 19	OMIM:618241
3650	0.2056	Maturity-onset diabetes of the young, type 10	OMIM:613370
3650	0.2056	Silver-Russell syndrome due to a point mutation	ORPHA:397590
3650	0.2056	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	OMIM:201910
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Pyruvate dehydrogenase E1-alpha deficiency	OMIM:312170
3650	0.2056	Isolated complex I deficiency	ORPHA:2609
3650	0.2056	Pyridoxine-dependent epilepsy	ORPHA:3006
3650	0.2056	Riboflavin deficiency	OMIM:615026
3733	0.2053	Neuropathy, hereditary sensory, with spastic paraplegia	OMIM:256840
3734	0.205	Iron overload, susceptibility to	OMIM:620121
3734	0.205	Obesity due to pro-opiomelanocortin deficiency	ORPHA:71526
3734	0.205	Obesity due to prohormone convertase I deficiency	ORPHA:71528
3734	0.205	Dimethylglycine dehydrogenase deficiency	OMIM:605850
3734	0.205	Dent disease 2	OMIM:300555
3739	0.2049	Hypoalphalipoproteinemia, primary, 2, intermediate	OMIM:619836
3740	0.2048	Autosomal recessive Kenny-Caffey syndrome	ORPHA:93324
3741	0.2047	Rhabdoid tumor predisposition syndrome 2	OMIM:613325
3742	0.2046	?Liddle syndrome 3	OMIM:618126
3742	0.2046	Liddle syndrome 2	OMIM:618114
3742	0.2046	Liddle syndrome 1	OMIM:177200
3742	0.2046	Interstitial nephritis, karyomegalic	OMIM:614817
3742	0.2046	Mullerian aplasia and hyperandrogenism	OMIM:158330
3742	0.2046	Dysautonomia, familial	OMIM:223900
3742	0.2046	?Spermatogenic failure 13	OMIM:615841
3742	0.2046	Apparent mineralocorticoid excess	OMIM:218030
3750	0.2045	Pancreatic cancer 2	OMIM:613347
3750	0.2045	Pancreatic carcinoma, somatic	OMIM:260350
3750	0.2045	Pancreatic cancer, somatic	OMIM:260350
3750	0.2045	Costello syndrome	ORPHA:3071
3750	0.2045	Keratosis, seborrheic, somatic	OMIM:182000
3750	0.2045	Disseminated superficial actinic porokeratosis	ORPHA:79152
3750	0.2045	Pancreatic cancer, somatic	OMIM:260350
3750	0.2045	Pancreatic cancer, somatic	OMIM:260350
3750	0.2045	Basal cell carcinoma, somatic	OMIM:605462
3750	0.2045	Dowling-Degos disease	ORPHA:79145
3750	0.2045	Pachyonychia congenita	ORPHA:2309
3750	0.2045	Trichoepithelioma, multiple familial, 1	OMIM:601606
3750	0.2045	Familial multiple trichoepithelioma	ORPHA:867
3750	0.2045	Squamous cell carcinoma, head and neck	OMIM:275355
3750	0.2045	Basal cell carcinoma, somatic	OMIM:605462
3750	0.2045	Pancreatic cancer, somatic	OMIM:260350
3750	0.2045	Basal cell carcinoma, somatic	OMIM:605462
3750	0.2045	Basal cell carcinoma, somatic	OMIM:605462
3750	0.2045	Disseminated superficial actinic porokeratosis	ORPHA:79152
3750	0.2045	Disseminated superficial actinic porokeratosis	ORPHA:79152
3750	0.2045	Fibrocalculous pancreatic diabetes, susceptibility to	OMIM:608189
3750	0.2045	Tropical calcific pancreatitis	OMIM:608189
3750	0.2045	Methylmalonate semialdehyde dehydrogenase deficiency	OMIM:614105
3750	0.2045	Keratitis-ichthyosis-deafness syndrome	OMIM:148210
3750	0.2045	Hystrix-like ichthyosis with deafness	OMIM:602540
3750	0.2045	Dowling-Degos disease	ORPHA:79145
3750	0.2045	Dowling-Degos disease	ORPHA:79145
3750	0.2045	Pachyonychia congenita 2	OMIM:167210
3750	0.2045	Steatocystoma multiplex	OMIM:184500
3750	0.2045	Pachyonychia congenita	ORPHA:2309
3750	0.2045	Pachyonychia congenita	ORPHA:2309
3750	0.2045	Dowling-Degos disease	ORPHA:79145
3750	0.2045	Squamous cell carcinoma, head and neck, somatic	OMIM:275355
3750	0.2045	Pachyonychia congenita	ORPHA:2309
3750	0.2045	Pachyonychia congenita 4	OMIM:615728
3750	0.2045	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	OMIM:618373
3750	0.2045	Disseminated superficial actinic porokeratosis	ORPHA:79152
3787	0.2042	Adrenocortical carcinoma, pediatric	OMIM:202300
3787	0.2042	Denys-Drash syndrome	OMIM:194080
3789	0.2041	Spasticity, childhood-onset, with hyperglycinemia	OMIM:616859
3789	0.2041	Frontonasal dysplasia 1	OMIM:136760
3789	0.2041	Multiple mitochondrial dysfunctions syndrome 1	OMIM:605711
3789	0.2041	?Mitochondrial complex IV deficiency, nuclear type 19	OMIM:619063
3793	0.2038	HDL deficiency, familial, 1	OMIM:604091
3793	0.2038	Hyperlipidemia due to hepatic triacylglycerol lipase deficiency	ORPHA:140905
3793	0.2038	Childhood-onset spasticity with hyperglycinemia	ORPHA:401866
3796	0.2037	Androgen insensitivity	OMIM:300068
3797	0.2036	Noonan syndrome 8	OMIM:615355
3797	0.2036	Familial cold autoinflammatory syndrome 3	OMIM:614468
3797	0.2036	Singleton-Merten syndrome 1	OMIM:182250
3797	0.2036	Osteogenesis imperfecta, type II	OMIM:166210
3797	0.2036	Congenital myopathy 10B, mild variant	OMIM:620249
3797	0.2036	Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures	OMIM:619876
3797	0.2036	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	OMIM:618265
3797	0.2036	Pancreatitis, hereditary	OMIM:167800
3797	0.2036	Familial or sporadic hemiplegic migraine	ORPHA:569
3797	0.2036	Encephalopathy, acute, infection-induced, 3, susceptibility to	OMIM:608033
3797	0.2036	Familial acute necrotizing encephalopathy	ORPHA:88619
3797	0.2036	Migraine, familial basilar	OMIM:602481
3797	0.2036	Familial or sporadic hemiplegic migraine	ORPHA:569
3797	0.2036	Familial or sporadic hemiplegic migraine	ORPHA:569
3797	0.2036	KCNQ2-related epileptic encephalopathy	ORPHA:439218
3797	0.2036	Hypertriglyceridemia, susceptibility to	OMIM:145750
3797	0.2036	Schneckenbecken dysplasia	OMIM:269250
3797	0.2036	Pancreatitis, hereditary	OMIM:167800
3797	0.2036	X-linked intellectual disability, Snyder type	ORPHA:3063
3797	0.2036	Familial or sporadic hemiplegic migraine	ORPHA:569
3797	0.2036	Encephalopathy, acute, infection-induced, 4, susceptibility to	OMIM:614212
3797	0.2036	Carboxypeptidase N deficiency	OMIM:212070
3797	0.2036	Combined oxidative phosphorylation deficiency 57	OMIM:620167
3797	0.2036	Angioedema induced by ACE inhibitors, susceptibility to	OMIM:300909
3797	0.2036	Cardiomyopathy, familial hypertrophic 27	OMIM:618052
3797	0.2036	Pancreatitis, chronic, susceptibility to	OMIM:167800
3797	0.2036	Pancreatitis, hereditary	OMIM:167800
3797	0.2036	Osteogenesis imperfecta, type II	OMIM:166210
3825	0.2034	McCune-Albright syndrome, somatic, mosaic	OMIM:174800
3826	0.2033	Coronary artery disease, autosomal dominant, 2	OMIM:610947
3826	0.2033	Hypobetalipoproteinemia, familial, 2	OMIM:605019
3826	0.2033	Hypophosphatemic rickets, AR	OMIM:241520
3826	0.2033	Hypophosphatemic rickets, autosomal dominant	OMIM:193100
3826	0.2033	Hyperaldosteronism, familial, type III	OMIM:613677
3831	0.2032	Primary aldosteronism, seizures, and neurologic abnormalities	OMIM:615474
3831	0.2032	Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome	ORPHA:95433
3833	0.2031	Neutral lipid storage myopathy	ORPHA:98908
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	?Renal cell carcinoma, clear cell	OMIM:144700
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	?Respiratory papillomatosis, juvenile recurrent, congenital	OMIM:618803
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Renal cell carcinoma	OMIM:144700
3834	0.203	Renal cell carcinoma, somatic	OMIM:144700
3834	0.203	Renal cell carcinoma	OMIM:144700
3834	0.203	Renal cell carcinoma, clear cell, somatic	OMIM:144700
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Renal cell carcinoma	OMIM:144700
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Renal carcinoma, chromophobe, somatic	OMIM:144700
3834	0.203	Focal dermal hypoplasia	OMIM:305600
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Renal cell carcinoma, papillary, 1	OMIM:300854
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Hirschsprung disease	ORPHA:388
3834	0.203	Hirschsprung disease	ORPHA:388
3858	0.2028	Galloway-Mowat syndrome 6	OMIM:618347
3858	0.2028	Dent disease 1	OMIM:300009
3860	0.2026	Hypogonadotropic hypogonadism 8 with or without anosmia	OMIM:614837
3860	0.2026	?Hypogonadotropic hypogonadism 27 without anosmia	OMIM:619755
3860	0.2026	Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism	OMIM:619761
3863	0.2025	Obesity due to melanocortin 4 receptor deficiency	ORPHA:71529
3863	0.2025	Severe neurodegenerative syndrome with lipodystrophy	ORPHA:363400
3865	0.2024	Breast-ovarian cancer, familial, 2	OMIM:612555
3865	0.2024	Breast-ovarian cancer, familial, 1	OMIM:604370
3865	0.2024	Neutral lipid storage disease with myopathy	OMIM:610717
3865	0.2024	Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection	OMIM:619986
3865	0.2024	Immunodeficiency 77	OMIM:619223
3870	0.2023	Sotos syndrome	OMIM:117550
3870	0.2023	Griscelli syndrome type 1	ORPHA:79476
3870	0.2023	Aromatase deficiency	ORPHA:91
3870	0.2023	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	OMIM:618158
3870	0.2023	Renal agenesis, bilateral	ORPHA:1848
3870	0.2023	Renal agenesis, bilateral	ORPHA:1848
3870	0.2023	Renal agenesis, bilateral	ORPHA:1848
3870	0.2023	Renal agenesis, bilateral	ORPHA:1848
3870	0.2023	Renal agenesis, bilateral	ORPHA:1848
3870	0.2023	Congenital disorder of glycosylation, type Im	OMIM:610768
3870	0.2023	Mandibuloacral dysplasia with type B lipodystrophy	ORPHA:90154
3870	0.2023	Kabuki syndrome 2	OMIM:300867
3870	0.2023	Short chain acyl-CoA dehydrogenase deficiency	ORPHA:26792
3870	0.2023	Dicarboxylic aminoaciduria	OMIM:222730
3870	0.2023	Bile acid synthesis defect, congenital, 6	OMIM:617308
3870	0.2023	Monocarboxylate transporter 1 deficiency	OMIM:616095
3870	0.2023	Microcephaly, short stature, and impaired glucose metabolism 2	OMIM:616817
3870	0.2023	Intellectual developmental disorder, autosomal dominant 45	OMIM:617600
3870	0.2023	X-linked dominant chondrodysplasia punctata	ORPHA:35173
3870	0.2023	Mandibuloacral dysplasia with type A lipodystrophy	ORPHA:90153
3870	0.2023	Renal agenesis, bilateral	ORPHA:1848
3891	0.2021	Breast-ovarian cancer, familial, susceptibility to, 3	OMIM:613399
3892	0.2018	Hyperferritinemia-cataract syndrome	OMIM:600886
3893	0.2016	Autoimmune pulmonary alveolar proteinosis	ORPHA:747
3893	0.2016	Insulin-like growth factor I, resistance to	OMIM:270450
3893	0.2016	Short stature due to primary acid-labile subunit deficiency	ORPHA:140941
3893	0.2016	Increased responsiveness to growth hormone	OMIM:604271
3893	0.2016	Laron dwarfism	OMIM:262500
3893	0.2016	Brain-lung-thyroid syndrome	ORPHA:209905
3893	0.2016	Diabetes insipidus, neurohypophyseal	OMIM:125700
3893	0.2016	Hypothyroidism, congenital, nongoitrous, 1	OMIM:275200
3893	0.2016	Persistent Mullerian duct syndrome, type I	OMIM:261550
3893	0.2016	Thyroid hormone resistance, selective pituitary	OMIM:145650
3893	0.2016	Persistent Mullerian duct syndrome, type II	OMIM:261550
3893	0.2016	Hypothyroidism, central, and testicular enlargement	OMIM:300888
3893	0.2016	Osteogenesis imperfecta, type XXII	OMIM:619795
3893	0.2016	Distal deletion 15q	ORPHA:1596
3907	0.2012	GRACILE syndrome	OMIM:603358
3908	0.201	Blepharophimosis-ptosis-epicanthus inversus syndrome plus	ORPHA:572333
3909	0.2009	Congenital myopathy 2C, severe infantile, autosomal dominant	OMIM:620278
3910	0.2005	Hyperlysinemia	ORPHA:2203
3911	0.2004	Insulinomatosis and diabetes mellitus	OMIM:147630
3912	0.2003	Argininosuccinic aciduria	ORPHA:23
3913	0.2002	Acrokeratosis verruciformis of Hopf	ORPHA:79151
3913	0.2002	Pancreatic cancer, susceptibility to, 1	OMIM:606856
3913	0.2002	Tropical pancreatitis	ORPHA:103918
3913	0.2002	Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome	ORPHA:85112
3913	0.2002	Huriez syndrome	OMIM:181600
3913	0.2002	Tropical pancreatitis	ORPHA:103918
3913	0.2002	Pituitary adenoma 2, GH-secreting	OMIM:300943
3913	0.2002	Lipoid proteinosis	ORPHA:530
3913	0.2002	Immunodeficiency due to ficolin 3 deficiency	OMIM:613860
3922	0.1995	Bohring-Opitz syndrome	OMIM:605039
3922	0.1995	Meningioma	OMIM:607174
3922	0.1995	Meningioma, familial, susceptibility to	OMIM:607174
3922	0.1995	Pendred syndrome	ORPHA:705
3922	0.1995	Renal cell carcinoma, papillary, 1, familial and somatic	OMIM:605074
3922	0.1995	Kahrizi syndrome	OMIM:612713
3922	0.1995	Intellectual developmental disorder, autosomal recessive 67	OMIM:618295
3922	0.1995	Meningioma, familial, susceptibility to	OMIM:607174
3922	0.1995	Meningioma, SIS-related	OMIM:607174
3922	0.1995	Meningioma	OMIM:607174
3922	0.1995	3C syndrome	ORPHA:7
3922	0.1995	Noonan syndrome-like disorder with loose anagen hair 2	OMIM:617506
3922	0.1995	Pendred syndrome	ORPHA:705
3922	0.1995	Renal cell carcinoma, papillary	OMIM:605074
3922	0.1995	Pendred syndrome	ORPHA:705
3922	0.1995	3C syndrome	ORPHA:7
3922	0.1995	3C syndrome	ORPHA:7
3922	0.1995	Meningioma, NF2-related, somatic	OMIM:607174
3922	0.1995	Native American myopathy	ORPHA:168572
3922	0.1995	3C syndrome	ORPHA:7
3942	0.1994	Myofibromatosis, infantile, 1	OMIM:228550
3943	0.1989	Hyperinsulinemic hypoglycemia, familial, 4	OMIM:609975
3943	0.1989	Hyperinsulinemic hypoglycemia, familial, 3	OMIM:602485
3943	0.1989	Hyperinsulinemic hypoglycemia, familial, 1	OMIM:256450
3946	0.1987	Oculoskeletodental syndrome	ORPHA:557003
3946	0.1987	Encephalopathy, acute, infection-induced, susceptibility to, 9	OMIM:618426
3946	0.1987	Desmoid disease, hereditary	OMIM:135290
3946	0.1987	Hypomagnesemia, seizures, and impaired intellectual development 2	OMIM:618314
3946	0.1987	Hypomagnesemia 2, renal	OMIM:154020
3946	0.1987	Hypomagnesemia 1, intestinal	OMIM:602014
3946	0.1987	Nephronophthisis 2, infantile	OMIM:602088
3953	0.1986	Hypogonadotropic hypogonadism 24 without anosmia	OMIM:229070
3954	0.1984	Pseudohypoaldosteronism, type IIC	OMIM:614492
3955	0.1983	6-pyruvoyl-tetrahydropterin synthase deficiency	ORPHA:13
3955	0.1983	Autosomal recessive dopa-responsive dystonia	ORPHA:101150
3955	0.1983	Autosomal recessive dopa-responsive dystonia	ORPHA:101150
3955	0.1983	Developmental and epileptic encephalopathy 34	OMIM:616645
3955	0.1983	Joubert syndrome 12	OMIM:200990
3960	0.1982	Primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement	ORPHA:2196
3960	0.1982	Atrial standstill 2	OMIM:615745
3960	0.1982	Idiopathic achalasia	ORPHA:930
3960	0.1982	Boucher-Neuhauser syndrome	OMIM:215470
3960	0.1982	Idiopathic achalasia	ORPHA:930
3960	0.1982	Pentosuria	ORPHA:2843
3960	0.1982	Idiopathic achalasia	ORPHA:930
3960	0.1982	Idiopathic achalasia	ORPHA:930
3960	0.1982	Oocyte/zygote/embryo maturation arrest 8	OMIM:619009
3960	0.1982	Epiphyseal chondrodysplasia, Miura type	OMIM:615923
3970	0.1981	Birk-Landau-Perez syndrome	OMIM:617595
3971	0.1977	Myopathy, tubular aggregate, 2	OMIM:615883
3971	0.1977	Myoglobinuria, acute recurrent, autosomal recessive	OMIM:268200
3971	0.1977	Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis	OMIM:620138
3971	0.1977	Hypogonadotropic hypogonadism 25 with anosmia	OMIM:618841
3975	0.1974	Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency	ORPHA:284426
3976	0.1963	Distal 16p11.2 microdeletion syndrome	ORPHA:261222
3976	0.1963	Hyperuricemia, HRPT-related	OMIM:300323
3976	0.1963	Juvenile Paget disease	ORPHA:2801
3976	0.1963	Juvenile Paget disease	ORPHA:2801
3976	0.1963	Dystonia-parkinsonism-hypermanganesemia syndrome	ORPHA:521406
3976	0.1963	SLC39A8-CDG	ORPHA:468699
3976	0.1963	Molybdenum cofactor deficiency B	OMIM:252160
3976	0.1963	Severe phosphoribosylpyrophosphate synthetase superactivity	ORPHA:411543
3976	0.1963	Mild phosphoribosylpyrophosphate synthetase superactivity	ORPHA:411536
3976	0.1963	Phosphoribosylpyrophosphate synthetase superactivity	OMIM:300661
3976	0.1963	Xanthinuria, type II	OMIM:603592
3976	0.1963	Uric acid concentration, serum, QTL 2	OMIM:612076
3976	0.1963	Hypouricemia, renal, 2	OMIM:612076
3976	0.1963	Tubulointerstitial kidney disease, autosomal dominant, 1	OMIM:162000
3976	0.1963	Molybdenum cofactor deficiency A	OMIM:252150
3991	0.1961	Melanocytic nevus syndrome, congenital, somatic	OMIM:137550
3991	0.1961	Melanoma, cutaneous malignant, 2	OMIM:155601
3991	0.1961	Spitz nevus or nevus spilus, somatic	OMIM:137550
3991	0.1961	Esophageal cancer, somatic	OMIM:133239
3991	0.1961	Mesothelioma, somatic	OMIM:156240
3991	0.1961	Melanoma, cutaneous malignant, susceptibility to, 8	OMIM:614456
3991	0.1961	Lynch syndrome 4	OMIM:614337
3991	0.1961	Tylosis with esophageal cancer	OMIM:148500
3991	0.1961	Mesothelioma, somatic	OMIM:156240
3991	0.1961	?Thyroid cancer, nonmedullary, 5	OMIM:616535
3991	0.1961	Melanoma, cutaneous malignant, 3	OMIM:609048
3991	0.1961	Medullary thyroid carcinoma	OMIM:155240
3991	0.1961	Visceral myopathy 2	OMIM:619350
3991	0.1961	Esophageal carcinoma, somatic	OMIM:133239
3991	0.1961	Carney-Stratakis syndrome	ORPHA:97286
3991	0.1961	Paraganglioma and gastric stromal sarcoma	OMIM:606864
3991	0.1961	?Mungan syndrome	OMIM:611376
3991	0.1961	Paraganglioma and gastric stromal sarcoma	OMIM:606864
3991	0.1961	Carney-Stratakis syndrome	ORPHA:97286
3991	0.1961	Paragangliomas 5	OMIM:614165
3991	0.1961	Carney-Stratakis syndrome	ORPHA:97286
3991	0.1961	Paraganglioma and gastric stromal sarcoma	OMIM:606864
3991	0.1961	Esophageal squamous cell carcinoma, somatic	OMIM:133239
3991	0.1961	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	OMIM:138800
3991	0.1961	Esophageal carcinoma, somatic	OMIM:133239
3991	0.1961	Atelosteogenesis type II	ORPHA:56304
3991	0.1961	Esophageal squamous cell carcinoma, somatic	OMIM:133239
4018	0.1957	Central core disease	ORPHA:597
4019	0.1954	Pterin-4 alpha-carbinolamine dehydratase deficiency	ORPHA:1578
4020	0.195	Cerebrotendinous xanthomatosis	ORPHA:909
4020	0.195	Mitochondrial complex III deficiency, nuclear type 4	OMIM:615159
4020	0.195	RARS-related autosomal recessive hypomyelinating leukodystrophy	ORPHA:438114
4020	0.195	Mitochondrial complex IV deficiency, nuclear type 2	OMIM:604377
4020	0.195	?Neurodegeneration with brain iron accumulation 8	OMIM:617917
4020	0.195	Combined oxidative phosphorylation deficiency 28	OMIM:616794
4020	0.195	MEDNIK syndrome	ORPHA:171851
4020	0.195	MEDNIK syndrome	ORPHA:171851
4020	0.195	Deafness, congenital, and adult-onset progressive leukoencephalopathy	OMIM:619196
4020	0.195	Leukodystrophy, hypomyelinating, 4	OMIM:612233
4020	0.195	Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome	OMIM:614748
4020	0.195	Combined oxidative phosphorylation defect type 29	ORPHA:478029
4020	0.195	?Combined oxidative phosphorylation deficiency 29	OMIM:616811
4020	0.195	?Combined oxidative phosphorylation deficiency 45	OMIM:618951
4020	0.195	Pontocerebellar hypoplasia, type 9	OMIM:615809
4020	0.195	?Galloway-Mowat syndrome 8	OMIM:618349
4020	0.195	DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect	ORPHA:330050
4020	0.195	Combined oxidative phosphorylation deficiency 1	OMIM:609060
4020	0.195	?ACAT2 deficiency	OMIM:614055
4020	0.195	Combined oxidative phosphorylation deficiency 15	OMIM:614947
4020	0.195	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	ORPHA:70595
4020	0.195	Progressive external ophthalmoplegia, autosomal dominant 1	OMIM:157640
4020	0.195	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	ORPHA:70472
4020	0.195	ALG1-CDG	ORPHA:79327
4020	0.195	Pancreatic agenesis 1	OMIM:260370
4020	0.195	Oxoglutarate dehydrogenase deficiency	OMIM:203740
4020	0.195	Congenital cataracts, hearing loss, and neurodegeneration	OMIM:614482
4020	0.195	Mitochondrial complex II deficiency, nuclear type 4	OMIM:619224
4020	0.195	Mitochondrial complex II deficiency, nuclear type 1	OMIM:252011
4020	0.195	Combined oxidative phosphorylation defect type 13	ORPHA:319514
4020	0.195	Combined oxidative phosphorylation deficiency 13	OMIM:614932
4020	0.195	Cardiomyopathy, dilated, 1D	OMIM:601494
4020	0.195	?Congenital disorder of glycosylation, type IIq	OMIM:617395
4020	0.195	Combined oxidative phosphorylation deficiency 48	OMIM:619012
4020	0.195	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	OMIM:609283
4020	0.195	Charcot-Marie-Tooth disease, type 4K	OMIM:616684
4020	0.195	Pyruvate dehydrogenase E1-alpha deficiency	ORPHA:79243
4020	0.195	3-methylglutaconic aciduria type 9	ORPHA:505216
4020	0.195	3-methylglutaconic aciduria, type IX	OMIM:617698
4020	0.195	Coenzyme Q10 deficiency, primary, 2	OMIM:614651
4020	0.195	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	ORPHA:137898
4020	0.195	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	OMIM:616277
4020	0.195	Multiple mitochondrial dysfunctions syndrome 6	OMIM:617954
4020	0.195	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	OMIM:614441
4020	0.195	Galloway-Mowat syndrome 1	OMIM:251300
4020	0.195	Mitochondrial complex I deficiency, nuclear type 5	OMIM:618226
4020	0.195	Pontocerebellar hypoplasia, type 6	OMIM:611523
4020	0.195	Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency	ORPHA:88639
4020	0.195	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	OMIM:615147
4020	0.195	Intellectual developmental disorder, autosomal recessive 1	OMIM:249500
4020	0.195	Menkes disease	OMIM:309400
4020	0.195	Mitochondrial complex I deficiency, nuclear type 11	OMIM:618234
4020	0.195	Cardiomyopathy, dilated, 2F	OMIM:619747
4020	0.195	Combined oxidative phosphorylation deficiency 16	OMIM:615395
4020	0.195	Mitochondrial complex I deficiency, nuclear type 8	OMIM:618230
4020	0.195	Mitochondrial complex I deficiency, nuclear type 2	OMIM:618222
4020	0.195	Mitochondrial complex I deficiency, nuclear type 6	OMIM:618228
4020	0.195	?Mitochondrial complex I deficiency, nuclear type 24	OMIM:618245
4020	0.195	Mitochondrial complex I deficiency, nuclear type 4	OMIM:618225
4020	0.195	Mitochondrial complex I deficiency, nuclear type 12	OMIM:301020
4020	0.195	Mitochondrial complex I deficiency, nuclear type 17	OMIM:618239
4020	0.195	Mitochondrial complex I deficiency, nuclear type 23	OMIM:618244
4020	0.195	Mitochondrial complex I deficiency, nuclear type 37	OMIM:619272
4020	0.195	Mitochondrial complex I deficiency, nuclear type 26	OMIM:618247
4020	0.195	Combined oxidative phosphorylation deficiency 7	OMIM:613559
4020	0.195	Mitochondrial complex I deficiency, nuclear type 14	OMIM:618236
4020	0.195	Mitochondrial complex IV deficiency, nuclear type 16	OMIM:619060
4020	0.195	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	OMIM:609286
4020	0.195	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	ORPHA:70595
4020	0.195	Ocular anomalies-axonal neuropathy-developmental delay syndrome	ORPHA:496790
4020	0.195	Harel-Yoon syndrome	OMIM:617183
4020	0.195	Autosomal recessive ataxia due to ubiquinone deficiency	ORPHA:139485
4020	0.195	Coenzyme Q10 deficiency, primary, 4	OMIM:612016
4020	0.195	Coenzyme Q10 deficiency, primary, 7	OMIM:616276
4020	0.195	Mitochondrial complex IV deficiency, nuclear type 18	OMIM:619062
4020	0.195	Combined oxidative phosphorylation deficiency 32	OMIM:617664
4020	0.195	Combined oxidative phosphorylation deficiency 8	OMIM:614096
4020	0.195	Cardiomyopathy-hypotonia-lactic acidosis syndrome	ORPHA:91130
4020	0.195	Mitochondrial complex I deficiency, nuclear type 15	OMIM:618237
4020	0.195	Mitochondrial complex III deficiency, nuclear type 7	OMIM:615824
4020	0.195	Combined oxidative phosphorylation deficiency 23	OMIM:616198
4020	0.195	Cardiomyopathy, dilated, 2C	OMIM:618189
4020	0.195	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction	OMIM:620089
4020	0.195	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	OMIM:614458
4020	0.195	?Mitochondrial complex IV deficiency, nuclear type 10	OMIM:619053
4020	0.195	Combined oxidative phosphorylation deficiency 44	OMIM:618855
4020	0.195	Spastic tetraplegia and axial hypotonia, progressive	OMIM:618598
4020	0.195	Developmental and epileptic encephalopathy 51	OMIM:617339
4020	0.195	Nephrotic syndrome, type 15	OMIM:617609
4020	0.195	Pyruvate dehydrogenase E1-alpha deficiency	ORPHA:79243
4020	0.195	Epilepsy, early-onset, 1, vitamin B6-dependent	OMIM:617290
4020	0.195	Severe X-linked mitochondrial encephalomyopathy	ORPHA:238329
4020	0.195	Combined oxidative phosphorylation deficiency 6	OMIM:300816
4020	0.195	?Mitochondrial myopathy with lactic acidosis	OMIM:251950
4020	0.195	Combined oxidative phosphorylation deficiency 11	OMIM:614922
4115	0.1948	Uveal melanoma	ORPHA:39044
4115	0.1948	Uveal melanoma	ORPHA:39044
4115	0.1948	Uveal melanoma	ORPHA:39044
4115	0.1948	Uveal melanoma	ORPHA:39044
4115	0.1948	Uveal melanoma	ORPHA:39044
4120	0.1946	Isolated ATP synthase deficiency	ORPHA:254913
4120	0.1946	Isolated ATP synthase deficiency	ORPHA:254913
4120	0.1946	Isolated ATP synthase deficiency	ORPHA:254913
4120	0.1946	Isolated ATP synthase deficiency	ORPHA:254913
4120	0.1946	Isolated ATP synthase deficiency	ORPHA:254913
4120	0.1946	Isolated ATP synthase deficiency	ORPHA:254913
4120	0.1946	Isolated ATP synthase deficiency	ORPHA:254913
4120	0.1946	Isolated ATP synthase deficiency	ORPHA:254913
4128	0.1944	?Mitochondrial DNA depletion syndrome 17	OMIM:618567
4129	0.1941	IMAGE syndrome	OMIM:614732
4129	0.1941	?Webb-Dattani syndrome	OMIM:615926
4129	0.1941	Hyperaldosteronism, familial, type II	OMIM:605635
4132	0.1939	Carbamoyl-phosphate synthetase 1 deficiency	ORPHA:147
4132	0.1939	Glutamine deficiency, congenital	OMIM:610015
4134	0.1936	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	OMIM:605115
4135	0.1935	Hereditary arterial and articular multiple calcification syndrome	ORPHA:289601
4135	0.1935	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	OMIM:612287
4135	0.1935	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	OMIM:612286
4135	0.1935	Canavan disease	OMIM:271900
4135	0.1935	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	OMIM:308990
4135	0.1935	Raine syndrome	OMIM:259775
4135	0.1935	Alport syndrome 3, autosomal dominant	OMIM:104200
4142	0.1934	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	OMIM:238970
4143	0.1933	?Uruguay faciocardiomusculoskeletal syndrome	OMIM:300280
4144	0.1931	Argininemia	OMIM:207800
4145	0.1929	Wilms tumor	OMIM:194070
4145	0.1929	Mosaic variegated aneuploidy syndrome 3	OMIM:617598
4145	0.1929	Wilms tumor 6, susceptibility to	OMIM:616806
4145	0.1929	Wilms tumor, type 1	OMIM:194070
4145	0.1929	Nephrotic syndrome, type 4	OMIM:256370
4145	0.1929	Denys-Drash syndrome	ORPHA:220
4145	0.1929	Cervical cancer, somatic	OMIM:603956
4145	0.1929	2q37 microdeletion syndrome	ORPHA:1001
4145	0.1929	Wilms tumor, somatic	OMIM:194070
4145	0.1929	GLOW syndrome, somatic mosaic	OMIM:618272
4145	0.1929	N-acetylglutamate synthase deficiency	OMIM:237310
4145	0.1929	Isolated hemihyperplasia	ORPHA:2128
4145	0.1929	Wilms tumor susceptibility-5	OMIM:601583
4145	0.1929	Ehlers-Danlos syndrome, periodontal type, 2	OMIM:617174
4159	0.1925	Spermatogenic failure 28	OMIM:618086
4159	0.1925	Intellectual developmental disorder, X-linked syndromic 16	OMIM:305400
4159	0.1925	Spermatogenic failure, X-linked, 4	OMIM:301077
4162	0.1923	Noonan syndrome 7	OMIM:613706
4163	0.1921	Aldosteronism, glucocorticoid-remediable	OMIM:103900
4164	0.1919	Pediatric hepatocellular carcinoma	ORPHA:33402
4164	0.1919	Neurodegeneration with brain iron accumulation 3	OMIM:606159
4164	0.1919	L-ferritin deficiency, dominant and recessive	OMIM:615604
4164	0.1919	Neuroferritinopathy	ORPHA:157846
4164	0.1919	Ataxia-oculomotor apraxia 3	OMIM:615217
4164	0.1919	Autoimmune interstitial lung, joint, and kidney disease	OMIM:616414
4164	0.1919	Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome	ORPHA:330054
4164	0.1919	Chronic granulomatous disease 3, autosomal recessive	OMIM:613960
4164	0.1919	Primrose syndrome	OMIM:259050
4164	0.1919	Pediatric hepatocellular carcinoma	ORPHA:33402
4174	0.1914	Kosaki overgrowth syndrome	OMIM:616592
4174	0.1914	?Myofibromatosis, infantile 2	OMIM:615293
4176	0.1913	Watson syndrome	OMIM:193520
4177	0.1911	?Lacrimal duct defect	OMIM:149700
4178	0.191	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	OMIM:612716
4178	0.191	Hyperphenylalaninemia, BH4-deficient, D	OMIM:264070
4180	0.1908	Facioscapulohumeral dystrophy	ORPHA:269
4180	0.1908	Facioscapulohumeral dystrophy	ORPHA:269
4180	0.1908	Facioscapulohumeral dystrophy	ORPHA:269
4183	0.1907	Microcephalic primordial dwarfism-insulin resistance syndrome	ORPHA:436182
4183	0.1907	Glycosylphosphatidylinositol biosynthesis defect 17	OMIM:618010
4183	0.1907	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	OMIM:615381
4183	0.1907	Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	ORPHA:85167
4183	0.1907	Progressive external ophthalmoplegia, autosomal recessive 1	OMIM:258450
4183	0.1907	Lipodystrophy, familial partial, type 4	OMIM:613877
4183	0.1907	Classical-like Ehlers-Danlos syndrome type 2	ORPHA:536532
4183	0.1907	Epiphyseal dysplasia, multiple, 3, with or without myopathy	OMIM:600969
4183	0.1907	Microcephalic primordial dwarfism-insulin resistance syndrome	ORPHA:436182
4183	0.1907	Isolated follicle stimulating hormone deficiency	ORPHA:52901
4183	0.1907	Glycogen storage disease due to muscle glycogen phosphorylase deficiency	ORPHA:368
4183	0.1907	Lipase deficiency, combined	OMIM:246650
4183	0.1907	Encephalopathy, progressive, with or without lipodystrophy	OMIM:615924
4183	0.1907	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	OMIM:181350
4183	0.1907	Laing distal myopathy	OMIM:160500
4198	0.1906	Inclusion body myopathy and brain white matter abnormalities	OMIM:619733
4199	0.1903	Hyperprolinemia type 2	ORPHA:79101
4200	0.1899	Breast cancer, male, susceptibility to	OMIM:114480
4200	0.1899	Breast cancer, somatic	OMIM:114480
4200	0.1899	Breast cancer, somatic	OMIM:114480
4200	0.1899	Breast cancer, susceptibility to	OMIM:114480
4200	0.1899	Breast cancer, susceptibility to	OMIM:114480
4200	0.1899	Baller-Gerold syndrome	OMIM:218600
4200	0.1899	Breast cancer, somatic	OMIM:114480
4200	0.1899	?Breast cancer susceptibility	OMIM:114480
4200	0.1899	Breast cancer, susceptibility to	OMIM:114480
4200	0.1899	Breast cancer, susceptibility to	OMIM:114480
4200	0.1899	Breast cancer, somatic	OMIM:114480
4200	0.1899	C syndrome	ORPHA:1308
4200	0.1899	Breast cancer, susceptibility to	OMIM:114480
4200	0.1899	Saethre-Chotzen syndrome with or without eyelid anomalies	OMIM:101400
4200	0.1899	Breast cancer, early-onset, susceptibility to	OMIM:114480
4200	0.1899	Breast cancer, lobular, somatic	OMIM:114480
4200	0.1899	Saethre-Chotzen syndrome	OMIM:101400
4200	0.1899	Breast cancer, susceptibility to	OMIM:114480
4200	0.1899	Breast cancer, somatic	OMIM:114480
4200	0.1899	Breast cancer, invasive ductal	OMIM:114480
4200	0.1899	Breast cancer, susceptibility to	OMIM:114480
4200	0.1899	Breast cancer, somatic	OMIM:114480
4200	0.1899	Oligodontia-colorectal cancer syndrome	OMIM:608615
4200	0.1899	Breast cancer, somatic	OMIM:114480
4200	0.1899	Breast cancer, protection against	OMIM:114480
4200	0.1899	Breast cancer, somatic	OMIM:114480
4226	0.1891	Cerebellar dysfunction with variable cognitive and behavioral abnormalities	OMIM:614756
4227	0.189	HJV or HAMP-related hemochromatosis	ORPHA:79230
4227	0.189	Obesity, morbid, due to leptin deficiency	OMIM:614962
4227	0.189	Congenital nephrotic syndrome, Finnish type	ORPHA:839
4227	0.189	Alpha-fetoprotein deficiency	OMIM:615969
4227	0.189	Epidermolysis bullosa, junctional 5B, with pyloric atresia	OMIM:226730
4227	0.189	Keppen-Lubinsky syndrome	OMIM:614098
4227	0.189	Hutchinson-Gilford progeria syndrome	ORPHA:740
4227	0.189	Nestor-Guillermo progeria syndrome	OMIM:614008
4227	0.189	GRACILE syndrome	ORPHA:53693
4227	0.189	Hutchinson-Gilford progeria syndrome	ORPHA:740
4227	0.189	HJV or HAMP-related hemochromatosis	ORPHA:79230
4238	0.1888	?Ovarian dysgenesis 10	OMIM:619834
4238	0.1888	?Premature ovarian failure 14	OMIM:618014
4238	0.1888	Ovarian dysgenesis 7	OMIM:618117
4238	0.1888	Ovarian dysgenesis 5	OMIM:617690
4242	0.1887	Rhabdomyosarcoma, alveolar	OMIM:268220
4242	0.1887	Rhabdomyosarcoma 2, alveolar	OMIM:268220
4242	0.1887	Rhabdomyosarcoma 2, alveolar	OMIM:268220
4245	0.1885	Muscle filaminopathy	ORPHA:171445
4245	0.1885	Carnitine palmitoyl transferase II deficiency, myopathic form	ORPHA:228302
4247	0.1883	Apolipoprotein A-I deficiency	ORPHA:425
4247	0.1883	Hypoalphalipoproteinemia, primary, 2	OMIM:618463
4247	0.1883	Apolipoprotein A-I deficiency	ORPHA:425
4247	0.1883	Hyperalphalipoproteinemia	OMIM:143470
4251	0.1882	White-Sutton syndrome	OMIM:616364
4252	0.1881	X-linked intellectual disability, Van Esch type	ORPHA:163976
4252	0.1881	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	ORPHA:254864
4254	0.188	Becker nevus syndrome	ORPHA:64755
4254	0.188	Fibrodysplasia ossificans progressiva	OMIM:135100
4254	0.188	Nevus comedonicus syndrome	ORPHA:64754
4254	0.188	3-phosphoserine phosphatase deficiency, infantile/juvenile form	ORPHA:79350
4254	0.188	Orofaciodigital syndrome type 4	ORPHA:2753
4259	0.1877	Homocystinuria due to methylene tetrahydrofolate reductase deficiency	ORPHA:395
4260	0.1865	Rotor syndrome	ORPHA:3111
4260	0.1865	Rotor syndrome	ORPHA:3111
4260	0.1865	Currarino syndrome	OMIM:176450
4260	0.1865	Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis	OMIM:619685
4264	0.1862	Orofaciodigital syndrome type 6	ORPHA:2754
4264	0.1862	Orofaciodigital syndrome type 6	ORPHA:2754
4264	0.1862	Orofaciodigital syndrome I	OMIM:311200
4264	0.1862	Orofaciodigital syndrome type 1	ORPHA:2750
4264	0.1862	Congenital disorder of deglycosylation 2	OMIM:619775
4264	0.1862	Orofaciodigital syndrome type 6	ORPHA:2754
4264	0.1862	Orofaciodigital syndrome type 6	ORPHA:2754
4264	0.1862	Orofaciodigital syndrome VI	OMIM:277170
4264	0.1862	Orofaciodigital syndrome type 6	ORPHA:2754
4264	0.1862	Orofaciodigital syndrome type 6	ORPHA:2754
4264	0.1862	Orofaciodigital syndrome type 6	ORPHA:2754
4264	0.1862	Orofaciodigital syndrome type 6	ORPHA:2754
4264	0.1862	Orofaciodigital syndrome type 6	ORPHA:2754
4264	0.1862	Spermatogenic failure 44	OMIM:619044
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Rabin-Pappas syndrome	OMIM:620155
4278	0.1857	Intellectual developmental disorder, autosomal dominant 70	OMIM:620157
4278	0.1857	Hyperkalemic periodic paralysis	OMIM:170500
4278	0.1857	Hypokalemic periodic paralysis, type 2	OMIM:613345
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Liddle syndrome	ORPHA:526
4278	0.1857	Liddle syndrome	ORPHA:526
4278	0.1857	Brain abnormalities, neurodegeneration, and dysosteosclerosis	OMIM:618476
4278	0.1857	Liddle syndrome	ORPHA:526
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Hypomagnesemia 5, renal, with ocular involvement	OMIM:248190
4278	0.1857	?Hypomagnesemia 4, renal	OMIM:611718
4278	0.1857	Hypokalemic periodic paralysis, type 1	OMIM:170400
4278	0.1857	Thyrotoxic periodic paralysis, susceptibility to, 1	OMIM:188580
4278	0.1857	Adenine phosphoribosyltransferase deficiency	OMIM:614723
4278	0.1857	Pseudohypoaldosteronism, type IIE	OMIM:614496
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Hypocalcemia, autosomal dominant 2	OMIM:615361
4278	0.1857	Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome	ORPHA:476126
4278	0.1857	?Fanconi renotubular syndrome 3	OMIM:615605
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Andersen syndrome	OMIM:170390
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Coenzyme Q10 deficiency, primary, 8	OMIM:616733
4278	0.1857	Pseudohypoaldosteronism, type IIB	OMIM:614491
4278	0.1857	Cranioectodermal dysplasia 1	OMIM:218330
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Familial dysautonomia	ORPHA:1764
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Hyperparathyroidism, familial primary	OMIM:145000
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Paget disease of bone 2, early-onset	OMIM:602080
4278	0.1857	Pseudohypoaldosteronism, type IID	OMIM:614495
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4278	0.1857	Hypotaurinemic retinal degeneration and cardiomyopathy	OMIM:145350
4278	0.1857	Short-rib thoracic dysplasia 5 with or without polydactyly	OMIM:614376
4278	0.1857	Branched-chain keto acid dehydrogenase kinase deficiency	OMIM:614923
4278	0.1857	Hypomagnesemia 6, renal	OMIM:613882
4278	0.1857	Hypomagnesemia, seizures, and impaired intellectual development 1	OMIM:616418
4278	0.1857	?Nephronophthisis-like nephropathy 2	OMIM:619468
4278	0.1857	COACH syndrome 2	OMIM:619111
4278	0.1857	Urocanic aciduria	ORPHA:210128
4278	0.1857	Cystinosis, ocular nonnephropathic	OMIM:219750
4278	0.1857	Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities	OMIM:620330
4278	0.1857	Vascular Ehlers-Danlos syndrome	ORPHA:286
4278	0.1857	Acute intermittent porphyria	ORPHA:79276
4278	0.1857	Hartsfield syndrome	OMIM:615465
4278	0.1857	Romano-Ward syndrome	ORPHA:101016
4336	0.1853	Rhabdomyosarcoma, somatic	OMIM:268210
4337	0.1848	Peroxisome biogenesis disorder 12A (Zellweger)	OMIM:614886
4338	0.1847	Crigler-Najjar syndrome type 1	ORPHA:79234
4338	0.1847	Crigler-Najjar syndrome type 2	ORPHA:79235
4338	0.1847	Hypercholanemia, familial 2	OMIM:619256
4338	0.1847	Cholestasis, benign recurrent intrahepatic	OMIM:243300
4342	0.1845	LDL cholesterol level QTL2	OMIM:143890
4342	0.1845	Hypercholesterolemia, familial, modifier of	OMIM:143890
4342	0.1845	Hypercholesterolemia, familial, modifier of	OMIM:143890
4342	0.1845	Intellectual developmental disorder with poor growth and with or without seizures or ataxia	OMIM:618808
4342	0.1845	Hypercholesterolemia, susceptibility to	OMIM:143890
4342	0.1845	Hypercholesterolemia, familial, due to LDLR defect, modifier of	OMIM:143890
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	Cerebral cavernous malformations 4, somatic	OMIM:619538
4348	0.1842	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	OMIM:116860
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	Apert syndrome	ORPHA:87
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	Branchiootorenal syndrome 1, with or without cataracts	OMIM:113650
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	Intellectual developmental disorder, autosomal dominant 66	OMIM:619910
4348	0.1842	Perrault syndrome 4	OMIM:615300
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	Cerebral cavernous malformations-3	OMIM:603285
4348	0.1842	Cerebral cavernous malformations-2	OMIM:603284
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	46,XX gonadal dysgenesis	ORPHA:243
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4348	0.1842	1p36 deletion syndrome	ORPHA:1606
4380	0.1838	Ovarian dysgenesis 4	OMIM:616185
4380	0.1838	Progressive encephalopathy with leukodystrophy due to DECR deficiency	ORPHA:431361
4380	0.1838	?Premature ovarian failure 16	OMIM:618723
4380	0.1838	Premature ovarian failure 21	OMIM:620311
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Thyroid dyshormonogenesis 2A	OMIM:274500
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Adult-onset dystonia-parkinsonism	ORPHA:199351
4384	0.1835	Congenital myopathy 14	OMIM:618414
4384	0.1835	Hypothyroidism, congenital, nongoitrous, 7	OMIM:618573
4384	0.1835	Marinesco-Sj√∂gren syndrome	ORPHA:559
4384	0.1835	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	OMIM:617519
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Marinesco-Sj√∂gren syndrome	ORPHA:559
4384	0.1835	?Congenital myopathy 12	OMIM:612540
4384	0.1835	Congenital myopathy 11	OMIM:619967
4384	0.1835	Charcot-Marie-Tooth disease, axonal, type 2II	OMIM:620068
4384	0.1835	Congenital myopathy 24	OMIM:617336
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency	ORPHA:263297
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Alpha-B crystallin-related late-onset myopathy	ORPHA:399058
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Centronuclear myopathy 5	OMIM:615959
4384	0.1835	Distal myopathy with anterior tibial onset	ORPHA:178400
4384	0.1835	Arthrogryposis multiplex congenita 3, myogenic type	OMIM:618484
4384	0.1835	Autosomal recessive myogenic arthrogryposis multiplex congenita	ORPHA:319332
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	?Centronuclear myopathy 4	OMIM:614807
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	Walker-Warburg syndrome	ORPHA:899
4384	0.1835	TRAPPC11-related limb-girdle muscular dystrophy R18	ORPHA:369840
4417	0.1833	D-2-hydroxyglutaric aciduria 2	OMIM:613657
4417	0.1833	Hawkinsinuria	ORPHA:2118
4417	0.1833	Argininemia	ORPHA:90
4417	0.1833	Congenital disorder of glycosylation, type Ip	OMIM:613661
4417	0.1833	Biotinidase deficiency	ORPHA:79241
4417	0.1833	L-2-hydroxyglutaric aciduria	OMIM:236792
4417	0.1833	Pyruvate dehydrogenase E1-beta deficiency	OMIM:614111
4417	0.1833	Hydroxykynureninuria	ORPHA:79155
4417	0.1833	TMEM70-related mitochondrial encephalo-cardio-myopathy	ORPHA:1194
4426	0.1827	Papilloma of choroid plexus	ORPHA:2807
4427	0.1819	Trichomegaly-retina pigmentary degeneration-dwarfism syndrome	ORPHA:3363
4428	0.1816	Prostate cancer	OMIM:176807
4428	0.1816	Gastrointestinal stromal tumor, familial	OMIM:606764
4428	0.1816	Prostate cancer, familial, susceptibility to	OMIM:176807
4428	0.1816	Prostate cancer, somatic	OMIM:176807
4428	0.1816	Prostate cancer, susceptibility to	OMIM:176807
4428	0.1816	Prostate cancer 1	OMIM:601518
4428	0.1816	Atrophoderma vermiculata	ORPHA:79100
4428	0.1816	Prostate cancer, susceptibility to	OMIM:176807
4428	0.1816	Prostate cancer, somatic	OMIM:176807
4428	0.1816	Prostate cancer, somatic	OMIM:176807
4428	0.1816	Gastrointestinal stromal tumor	OMIM:606764
4428	0.1816	Gastrointestinal stromal tumor	OMIM:606764
4428	0.1816	Prostate cancer, somatic	OMIM:176807
4428	0.1816	Prostate cancer, somatic	OMIM:176807
4428	0.1816	Acromelic frontonasal dysplasia	ORPHA:1827
4428	0.1816	Symmetric circumferential skin creases, congenital, 1	OMIM:156610
4444	0.1811	Hypokalemic tubulopathy and deafness	OMIM:619406
4445	0.181	Cardiomyopathy, dilated, 3B	OMIM:302045
4445	0.181	Mahvash disease	OMIM:619290
4445	0.181	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
4445	0.181	Dystonia, DOPA-responsive	OMIM:128230
4445	0.181	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
4445	0.181	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
4445	0.181	Rhizomelic chondrodysplasia punctata, type 2	OMIM:222765
4445	0.181	Leukoencephalopathy with vanishing white matter 1, with or without ovarian failure	OMIM:603896
4445	0.181	Intellectual disability-severe speech delay-mild dysmorphism syndrome	ORPHA:391372
4445	0.181	Arrhythmogenic right ventricular dysplasia 10	OMIM:610193
4445	0.181	Trichohepatoenteric syndrome 2	OMIM:614602
4456	0.1808	?Hypervalinemia or hyperleucine-isoleucinemia	OMIM:618850
4457	0.1803	Iminoglycinuria	ORPHA:42062
4457	0.1803	Iminoglycinuria	ORPHA:42062
4457	0.1803	Iminoglycinuria	ORPHA:42062
4457	0.1803	Iminoglycinuria	ORPHA:42062
4461	0.1799	Achalasia-addisonianism-alacrimia syndrome	OMIM:231550
4462	0.1797	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	OMIM:604292
4463	0.179	Nasopharyngeal carcinoma, somatic	OMIM:607107
4463	0.179	Uveal melanoma, susceptibility to, 1	OMIM:606660
4463	0.179	Uveal melanoma, susceptibility to, 2	OMIM:606661
4463	0.179	Nasopharyngeal carcinoma, susceptibility to, 3	OMIM:617075
4463	0.179	Blepharophimosis-intellectual disability syndrome, SBBYS type	ORPHA:3047
4468	0.1788	Corneal dystrophy, Fuchs endothelial, 3	OMIM:613267
4468	0.1788	Posterior polymorphous corneal dystrophy	ORPHA:98973
4468	0.1788	Glaucoma 3, primary congenital, E	OMIM:617272
4468	0.1788	Posterior polymorphous corneal dystrophy	ORPHA:98973
4468	0.1788	Corneal dystrophy, Fuchs endothelial, 1	OMIM:136800
4468	0.1788	Posterior polymorphous corneal dystrophy	ORPHA:98973
4468	0.1788	Corneal dystrophy, Fuchs endothelial, 6	OMIM:613270
4468	0.1788	Congenital hereditary endothelial dystrophy type II	ORPHA:293603
4468	0.1788	Lattice corneal dystrophy type I	ORPHA:98964
4468	0.1788	Posterior polymorphous corneal dystrophy	ORPHA:98973
4468	0.1788	Posterior polymorphous corneal dystrophy	ORPHA:98973
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Obesity (BMIQ20)	OMIM:618406
4479	0.1787	Obesity, resistance to (BMIQ20)	OMIM:618406
4479	0.1787	Platelet-activating factor acetylhydrolase deficiency	OMIM:614278
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Spastic paraplegia 26, autosomal recessive	OMIM:609195
4479	0.1787	Autosomal recessive spastic paraplegia type 26	ORPHA:101006
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	?Phosphoserine aminotransferase deficiency	OMIM:610992
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Familial partial lipodystrophy, K√∂bberling type	ORPHA:79084
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4479	0.1787	Retinitis pigmentosa	ORPHA:791
4589	0.1785	Myofibrillar myopathy 10	OMIM:619040
4589	0.1785	Myopathy, tubular aggregate, 1	OMIM:160565
4589	0.1785	Intellectual developmental disorder, autosomal recessive 5	OMIM:611091
4589	0.1785	Charcot-Marie-Tooth disease, type 2Y	OMIM:616687
4589	0.1785	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
4589	0.1785	Autosomal dominant Charcot-Marie-Tooth disease type 2Y	ORPHA:435387
4589	0.1785	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	OMIM:167320
4589	0.1785	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	OMIM:613954
4589	0.1785	Charcot-Marie-Tooth disease type 1B	ORPHA:101082
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	OMIM:614643
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	OMIM:616052
4589	0.1785	Muscle-eye-brain disease	ORPHA:588
4589	0.1785	Myotonia congenita, atypical, acetazolamide-responsive	OMIM:608390
4589	0.1785	Myopathy, distal, 6, adult onset	OMIM:618655
4589	0.1785	Congenital myopathy 10A, severe variant	OMIM:614399
4589	0.1785	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	OMIM:618331
4589	0.1785	Congenital disorder of glycosylation, type Iu	OMIM:615042
4589	0.1785	Mitochondrial DNA depletion syndrome 2 (myopathic type)	OMIM:609560
4589	0.1785	Autosomal recessive progressive external ophthalmoplegia	ORPHA:254886
4589	0.1785	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
4589	0.1785	Hyperphosphatasia with impaired intellectual development syndrome 6	OMIM:616809
4589	0.1785	Dworschak-Punetha neurodevelopmental syndrome	OMIM:619955
4589	0.1785	Typical nemaline myopathy	ORPHA:171436
4589	0.1785	Spinal and bulbar muscular atrophy of Kennedy	OMIM:313200
4589	0.1785	Sandhoff disease, adult form	ORPHA:309169
4589	0.1785	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	OMIM:618387
4589	0.1785	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	OMIM:611773
4589	0.1785	Parkinson disease 14, autosomal recessive	OMIM:612953
4589	0.1785	Spinal muscular atrophy, X-linked 2, infantile	OMIM:301830
4589	0.1785	Miyoshi muscular dystrophy 3	OMIM:613319
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 12	OMIM:611307
4589	0.1785	Anoctamin-5-related limb-girdle muscular dystrophy R12	ORPHA:206549
4589	0.1785	Lethal congenital contracture syndrome 5	OMIM:615368
4589	0.1785	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	OMIM:255100
4589	0.1785	TRIM32-related limb-girdle muscular dystrophy R8	ORPHA:1878
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 8	OMIM:254110
4589	0.1785	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	OMIM:618098
4589	0.1785	Myopathy, myofibrillar, 5	OMIM:609524
4589	0.1785	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	OMIM:615424
4589	0.1785	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
4589	0.1785	Duchenne muscular dystrophy	ORPHA:98896
4589	0.1785	Becker muscular dystrophy	ORPHA:98895
4589	0.1785	Becker muscular dystrophy	OMIM:300376
4589	0.1785	Duchenne muscular dystrophy	OMIM:310200
4589	0.1785	Schwartz-Jampel syndrome, type 1	OMIM:255800
4589	0.1785	Myopathy, sarcoplasmic body	OMIM:620286
4589	0.1785	Congenital myopathy 18 due to dihydropyridine receptor defect	OMIM:620246
4589	0.1785	Spinal muscular atrophy with progressive myoclonic epilepsy	OMIM:159950
4589	0.1785	Congenital myopathy 21 with early respiratory failure	OMIM:620326
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 25	OMIM:616812
4589	0.1785	Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy	OMIM:619424
4589	0.1785	Epidermolysis bullosa simplex with pyloric atresia	ORPHA:158684
4589	0.1785	Muscular dystrophy, congenital, due to ITGA7 deficiency	OMIM:613204
4589	0.1785	Typical nemaline myopathy	ORPHA:171436
4589	0.1785	Glycogen storage disease XIII	OMIM:612932
4589	0.1785	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	OMIM:615156
4589	0.1785	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	OMIM:612999
4589	0.1785	Muscular dystrophy, congenital, merosin deficient or partially deficient	OMIM:607855
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 23	OMIM:618138
4589	0.1785	Bethlem myopathy 1	OMIM:158810
4589	0.1785	Bethlem myopathy	ORPHA:610
4589	0.1785	Congenital muscular dystrophy, Ullrich type	ORPHA:75840
4589	0.1785	Congenital muscular dystrophy, Ullrich type	ORPHA:75840
4589	0.1785	Bethlem myopathy 1	OMIM:158810
4589	0.1785	Bethlem myopathy	ORPHA:610
4589	0.1785	Distal myotilinopathy	ORPHA:98911
4589	0.1785	Autosomal dominant limb-girdle muscular dystrophy type 1A	ORPHA:266
4589	0.1785	Myopathy, myofibrillar, 3	OMIM:609200
4589	0.1785	Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome	ORPHA:370022
4589	0.1785	Myopathy, distal, with rimmed vacuoles	OMIM:617158
4589	0.1785	Oculopharyngodistal myopathy 2	OMIM:618940
4589	0.1785	Muscular dystrophy, congenital, with cataracts and intellectual disability	OMIM:617404
4589	0.1785	Nonaka myopathy	OMIM:605820
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	OMIM:612937
4589	0.1785	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
4589	0.1785	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	OMIM:615422
4589	0.1785	Typical nemaline myopathy	ORPHA:171436
4589	0.1785	Rippling muscle disease 2	OMIM:606072
4589	0.1785	Myopathy, distal, Tateyama type	OMIM:614321
4589	0.1785	Creatine phosphokinase, elevated serum	OMIM:123320
4589	0.1785	Myopathy, X-linked, with excessive autophagy	OMIM:310440
4589	0.1785	Autosomal recessive spastic paraplegia type 48	ORPHA:306511
4589	0.1785	Autosomal recessive progressive external ophthalmoplegia	ORPHA:254886
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	OMIM:615287
4589	0.1785	King-Denborough syndrome	OMIM:619542
4589	0.1785	Autosomal dominant adult-onset proximal spinal muscular atrophy	ORPHA:209335
4589	0.1785	Epilepsy, progressive myoclonic 6	OMIM:614018
4589	0.1785	Muscular dystrophy, congenital, with or without seizures	OMIM:620166
4589	0.1785	Epilepsy, progressive myoclonic 6	OMIM:614018
4589	0.1785	Muscular dystrophy, congenital, with or without seizures	OMIM:620166
4589	0.1785	Calpain-3-related limb-girdle muscular dystrophy R1	ORPHA:267
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal dominant 4	OMIM:618129
4589	0.1785	Congenital disorder of glycosylation, type IIh	OMIM:611182
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 7	OMIM:601954
4589	0.1785	Typical nemaline myopathy	ORPHA:171436
4589	0.1785	Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria	ORPHA:1933
4589	0.1785	Vacuolar myopathy with sarcoplasmic reticulum protein aggregates	ORPHA:88635
4589	0.1785	Myopathy, vacuolar, with CASQ1 aggregates	OMIM:616231
4589	0.1785	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 27	OMIM:619566
4589	0.1785	Charcot-Marie-Tooth disease, dominant intermediate E	OMIM:614455
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	OMIM:615352
4589	0.1785	GMPPB-related limb-girdle muscular dystrophy R19	ORPHA:363623
4589	0.1785	Muscle-eye-brain disease	ORPHA:588
4589	0.1785	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	OMIM:615350
4589	0.1785	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14	OMIM:615351
4589	0.1785	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
4589	0.1785	Congenital muscular dystrophy, Ullrich type	ORPHA:75840
4589	0.1785	Bethlem myopathy 2	OMIM:616471
4589	0.1785	Bethlem myopathy	ORPHA:610
4589	0.1785	Alpha-dystroglycan-related limb-girdle muscular dystrophy R16	ORPHA:280333
4589	0.1785	Muscle-eye-brain disease with bilateral multicystic leucodystrophy	ORPHA:370997
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	OMIM:616538
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	OMIM:613818
4589	0.1785	Oculopharyngeal muscular dystrophy	OMIM:164300
4589	0.1785	Oculopharyngeal muscular dystrophy	ORPHA:270
4589	0.1785	Nemaline myopathy 5B, autosomal recessive, childhood-onset	OMIM:620386
4589	0.1785	Marinesco-Sjogren syndrome	OMIM:248800
4589	0.1785	Typical nemaline myopathy	ORPHA:171436
4589	0.1785	Danon disease	OMIM:300257
4589	0.1785	Cardiomyopathy, dilated, 1I	OMIM:604765
4589	0.1785	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	OMIM:615290
4589	0.1785	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome	OMIM:619518
4589	0.1785	Autosomal recessive axonal neuropathy with neuromyotonia	ORPHA:324442
4589	0.1785	Neuromyotonia and axonal neuropathy, autosomal recessive	OMIM:137200
4589	0.1785	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
4589	0.1785	Hereditary motor and sensory neuropathy, Okinawa type	ORPHA:90117
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 3	OMIM:608099
4589	0.1785	Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3	ORPHA:62
4589	0.1785	Cardiomyopathy, dilated, 1L	OMIM:606685
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 6	OMIM:601287
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 5	OMIM:253700
4589	0.1785	Myopathy, myofibrillar, 7	OMIM:617114
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 4	OMIM:604286
4589	0.1785	Beta-sarcoglycan-related limb-girdle muscular dystrophy R4	ORPHA:119
4589	0.1785	Muscular dystrophy, congenital, megaconial type	OMIM:602541
4589	0.1785	Myopathy, myofibrillar, 6	OMIM:612954
4589	0.1785	Dimethylglycine dehydrogenase deficiency	ORPHA:243343
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal dominant 3	OMIM:609115
4589	0.1785	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	OMIM:616827
4589	0.1785	Charcot-Marie-Tooth disease, axonal, type 2CC	OMIM:616924
4589	0.1785	Episodic ataxia/myokymia syndrome	OMIM:160120
4589	0.1785	Hereditary continuous muscle fiber activity	ORPHA:972
4589	0.1785	Mitochondrial DNA depletion syndrome 11	OMIM:615084
4589	0.1785	Progressive external ophthalmoplegia-myopathy-emaciation syndrome	ORPHA:352447
4589	0.1785	Glycogen storage disease X	OMIM:261670
4589	0.1785	Developmental delay with hypotonia, myopathy, and brain abnormalities	OMIM:620240
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2	OMIM:613156
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	OMIM:613150
4589	0.1785	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
4589	0.1785	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	OMIM:613158
4589	0.1785	Muscle-eye-brain disease	ORPHA:588
4589	0.1785	POMT2-related limb-girdle muscular dystrophy R14	ORPHA:206559
4589	0.1785	Polyglucosan body myopathy 2	OMIM:616199
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 21	OMIM:617232
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	OMIM:607155
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	OMIM:613153
4589	0.1785	FKRP-related limb-girdle muscular dystrophy R9	ORPHA:34515
4589	0.1785	Muscle-eye-brain disease	ORPHA:588
4589	0.1785	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B, 5	OMIM:606612
4589	0.1785	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	OMIM:253280
4589	0.1785	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
4589	0.1785	Muscle-eye-brain disease	ORPHA:588
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3	OMIM:613151
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	OMIM:613157
4589	0.1785	Nivelon-Nivelon-Mabille syndrome	OMIM:600092
4589	0.1785	Duchenne muscular dystrophy	ORPHA:98896
4589	0.1785	Myopathy, myofibrillar, 8	OMIM:617258
4589	0.1785	Sulfite oxidase deficiency	OMIM:272300
4589	0.1785	Amyotrophic lateral sclerosis 21	OMIM:606070
4589	0.1785	Typical nemaline myopathy	ORPHA:171436
4589	0.1785	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
4589	0.1785	Lissencephaly 8	OMIM:617255
4589	0.1785	?Combined oxidative phosphorylation deficiency 49	OMIM:619024
4589	0.1785	Myopathy, myofibrillar, 2	OMIM:608810
4589	0.1785	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	OMIM:613869
4589	0.1785	Cardiomyopathy, dilated, 1II	OMIM:615184
4589	0.1785	Erythrocyte lactate transporter defect	OMIM:245340
4589	0.1785	Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant	OMIM:601846
4589	0.1785	Sulfide:quinone oxidoreductase deficiency	OMIM:619221
4589	0.1785	Oculopharyngodistal myopathy 4	OMIM:619790
4589	0.1785	Nemaline myopathy 6, autosomal dominant	OMIM:609273
4589	0.1785	X-linked Charcot-Marie-Tooth disease type 6	ORPHA:352675
4589	0.1785	Emery-Dreifuss muscular dystrophy 1, X-linked	OMIM:310300
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 4	OMIM:613152
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	OMIM:253800
4589	0.1785	Cardiomyopathy, dilated, 1X	OMIM:611615
4589	0.1785	Muscle-eye-brain disease	ORPHA:588
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	OMIM:611588
4589	0.1785	Myopathy, myofibrillar, 4	OMIM:609452
4589	0.1785	Muscular dystrophy, congenital	OMIM:613205
4589	0.1785	Congenital myopathy 7B, myosin storage, autosomal recessive	OMIM:255160
4589	0.1785	Congenital myopathy 5 with cardiomyopathy	OMIM:611705
4589	0.1785	Myopathy, myofibrillar, 9, with early respiratory failure	OMIM:603689
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 10	OMIM:608807
4589	0.1785	Hereditary myopathy with early respiratory failure	ORPHA:178464
4589	0.1785	Plectin-related limb-girdle muscular dystrophy R17	ORPHA:254361
4589	0.1785	Epidermolysis bullosa simplex with pyloric atresia	ORPHA:158684
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 17	OMIM:613723
4589	0.1785	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	OMIM:615249
4589	0.1785	?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12	OMIM:616094
4589	0.1785	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
4589	0.1785	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1	OMIM:613155
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	OMIM:236670
4589	0.1785	POMT1-related limb-girdle muscular dystrophy R11	ORPHA:86812
4589	0.1785	Muscle-eye-brain disease	ORPHA:588
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	OMIM:609308
4589	0.1785	Congenital bile acid synthesis defect type 4	ORPHA:79095
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal dominant 1	OMIM:603511
4589	0.1785	Neuronopathy, distal hereditary motor, type VIII	OMIM:600175
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 2	OMIM:253601
4589	0.1785	Myopathy, distal, with anterior tibial onset	OMIM:606768
4589	0.1785	Miyoshi muscular dystrophy 1	OMIM:254130
4589	0.1785	Rhabdomyolysis, susceptibility to, 1	OMIM:620235
4589	0.1785	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	OMIM:300718
4589	0.1785	Myopathy, X-linked, with postural muscle atrophy	OMIM:300696
4589	0.1785	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	OMIM:300717
4589	0.1785	Scapuloperoneal myopathy, X-linked dominant	OMIM:300695
4589	0.1785	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	OMIM:612998
4589	0.1785	Spinal muscular atrophy, Jokela type	OMIM:615048
4589	0.1785	Lower motor neuron syndrome with late-adult onset	ORPHA:276435
4589	0.1785	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	OMIM:617193
4589	0.1785	Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome	ORPHA:496641
4589	0.1785	Cowchock syndrome	OMIM:310490
4589	0.1785	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	OMIM:618135
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 11	OMIM:615181
4589	0.1785	Muscle-eye-brain disease	ORPHA:588
4589	0.1785	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
4589	0.1785	Muscle-eye-brain disease	ORPHA:588
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	OMIM:613154
4589	0.1785	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6	OMIM:608840
4589	0.1785	Muscular dystrophy, limb-girdle, autosomal recessive 18	OMIM:615356
4589	0.1785	Neurodegeneration with brain iron accumulation 4	OMIM:614298
4589	0.1785	?Myosclerosis, congenital	OMIM:255600
4589	0.1785	Bethlem myopathy 1	OMIM:158810
4589	0.1785	Bethlem myopathy	ORPHA:610
4589	0.1785	Congenital muscular dystrophy, Ullrich type	ORPHA:75840
4589	0.1785	Neuromuscular disease and ocular or auditory anomalies with or without seizures	OMIM:618733
4589	0.1785	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	OMIM:615704
4589	0.1785	Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency	ORPHA:300179
4589	0.1785	Oculopharyngodistal myopathy 1	OMIM:164310
4589	0.1785	Carey-Fineman-Ziter syndrome	OMIM:254940
4589	0.1785	Arthrogryposis, distal, with impaired proprioception and touch	OMIM:617146
4589	0.1785	PRUNE1-related neurological syndrome	ORPHA:544469
4589	0.1785	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	OMIM:617072
4841	0.178	Phosphoserine aminotransferase deficiency, infantile/juvenile form	ORPHA:284417
4842	0.1772	Inflammatory bowel disease 28, early onset, autosomal recessive	OMIM:613148
4842	0.1772	Inflammatory bowel disease 25, early onset, autosomal recessive	OMIM:612567
4844	0.1769	Scalp-ear-nipple syndrome	ORPHA:2036
4844	0.1769	Baraitser-Winter cerebrofrontofacial syndrome	ORPHA:2995
4844	0.1769	Baraitser-Winter cerebrofrontofacial syndrome	ORPHA:2995
4844	0.1769	Non-progressive cerebellar ataxia with intellectual disability	ORPHA:314647
4844	0.1769	Macrocephaly, alopecia, cutis laxa, and scoliosis	OMIM:613075
4844	0.1769	Non-progressive cerebellar ataxia with intellectual disability	ORPHA:314647
4844	0.1769	Corneal dystrophy, Reis-Bucklers type	OMIM:608470
4844	0.1769	Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome	ORPHA:466688
4852	0.1768	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	OMIM:613646
4852	0.1768	Methylmalonic aciduria and homocysteinemia, cblX type	OMIM:309541
4854	0.1766	Alzheimer disease, late-onset, susceptibility to	OMIM:104300
4854	0.1766	Alzheimer disease, late-onset, susceptibility to	OMIM:104300
4854	0.1766	Frasier syndrome	OMIM:136680
4854	0.1766	Endometrial cancer, familial	OMIM:608089
4854	0.1766	Colorectal cancer, susceptibility to, 10	OMIM:612591
4854	0.1766	Endometrial carcinoma, somatic	OMIM:608089
4854	0.1766	Endometrial carcinoma, somatic	OMIM:608089
4854	0.1766	Crouzon syndrome	OMIM:123500
4854	0.1766	Endometrial cancer, susceptibility to	OMIM:608089
4854	0.1766	Alzheimer disease, susceptibility to	OMIM:104300
4854	0.1766	Lynch syndrome 8	OMIM:613244
4854	0.1766	Alzheimer disease 1, familial	OMIM:104300
4854	0.1766	Multiple fibroadenomas of the breast	OMIM:615554
4867	0.1761	ISPD-related limb-girdle muscular dystrophy R20	ORPHA:352479
4867	0.1761	Congenital muscular dystrophy without intellectual disability	ORPHA:370980
4867	0.1761	Congenital myopathy 22A, classic	OMIM:620351
4867	0.1761	Myasthenic syndrome, congenital, 14, with tubular aggregates	OMIM:616228
4867	0.1761	Childhood-onset nemaline myopathy	ORPHA:171439
4867	0.1761	Congenital myopathy 2B, severe infantile, autosomal recessive	OMIM:620265
4867	0.1761	Congenital myopathy 2A, typical, autosomal dominant	OMIM:161800
4867	0.1761	Infantile-onset X-linked spinal muscular atrophy	ORPHA:1145
4867	0.1761	Distal anoctaminopathy	ORPHA:399096
4867	0.1761	Centronuclear myopathy 1	OMIM:160150
4867	0.1761	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	OMIM:614369
4867	0.1761	Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome	ORPHA:397744
4867	0.1761	Myopathy, distal, 4	OMIM:614065
4867	0.1761	?Myopathy, distal, 3	OMIM:610099
4867	0.1761	Autism susceptibility, X-linked 3	OMIM:300496
4867	0.1761	Childhood-onset nemaline myopathy	ORPHA:171439
4867	0.1761	Childhood-onset nemaline myopathy	ORPHA:171439
4867	0.1761	DNA2-related mitochondrial DNA deletion syndrome	ORPHA:352470
4867	0.1761	Myopathy, distal, 5	OMIM:617030
4867	0.1761	Welander distal myopathy	OMIM:604454
4867	0.1761	Distal myopathy, Welander type	ORPHA:603
4867	0.1761	Ullrich congenital muscular dystrophy 1	OMIM:254090
4867	0.1761	Ullrich congenital muscular dystrophy 1	OMIM:254090
4867	0.1761	Distal myopathy, Welander type	ORPHA:603
4867	0.1761	GNE myopathy	ORPHA:602
4867	0.1761	DPM3-CDG	ORPHA:263494
4867	0.1761	?Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 15	OMIM:618992
4867	0.1761	Centronuclear myopathy, autosomal, modifier of	OMIM:160150
4867	0.1761	Thrombosis, hyperhomocysteinemic	OMIM:236200
4867	0.1761	Childhood-onset nemaline myopathy	ORPHA:171439
4867	0.1761	Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome	ORPHA:486815
4867	0.1761	Autism susceptibility, X-linked 1	OMIM:300425
4867	0.1761	Intellectual developmental disorder, X-linked	OMIM:300495
4867	0.1761	Autism susceptibility, X-linked 2	OMIM:300495
4867	0.1761	Neurogenic arthrogryposis multiplex congenita	ORPHA:1143
4867	0.1761	Childhood-onset nemaline myopathy	ORPHA:171439
4867	0.1761	Nemaline myopathy 2, autosomal recessive	OMIM:256030
4867	0.1761	Myasthenia, congenital, 12, with tubular aggregates	OMIM:610542
4867	0.1761	Myasthenic syndrome, congenital, 10	OMIM:254300
4867	0.1761	Charcot-Marie-Tooth disease, axonal, type 2EE	OMIM:618400
4867	0.1761	Childhood-onset nemaline myopathy	ORPHA:171439
4867	0.1761	Congenital muscular dystrophy without intellectual disability	ORPHA:370980
4867	0.1761	Neurogenic arthrogryposis multiplex congenita	ORPHA:1143
4867	0.1761	Vocal cord and pharyngeal distal myopathy	ORPHA:600
4867	0.1761	Neurogenic arthrogryposis multiplex congenita	ORPHA:1143
4867	0.1761	Childhood-onset nemaline myopathy	ORPHA:171439
4867	0.1761	Congenital muscular dystrophy without intellectual disability	ORPHA:370980
4867	0.1761	Ververi-Brady syndrome	OMIM:617982
4867	0.1761	Laing early-onset distal myopathy	ORPHA:59135
4867	0.1761	Congenital myopathy 7A, myosin storage, autosomal dominant	OMIM:608358
4867	0.1761	Tibial muscular dystrophy	ORPHA:609
4867	0.1761	Proximal myopathy with extrapyramidal signs	ORPHA:401768
4867	0.1761	Congenital muscular dystrophy without intellectual disability	ORPHA:370980
4867	0.1761	Ullrich congenital muscular dystrophy 1	OMIM:254090
4867	0.1761	Charcot-Marie-Tooth disease, recessive intermediate C	OMIM:615376
4867	0.1761	Muscular dystrophy, limb-girdle, autosomal recessive 26	OMIM:618848
4867	0.1761	X-linked intellectual disability, Stocco Dos Santos type	ORPHA:85288
4924	0.1753	?Acne inversa, familial, 3	OMIM:613737
4925	0.1752	Intellectual disability-hypotonic facies syndrome, X-linked	OMIM:309580
4925	0.1752	Dravet syndrome	ORPHA:33069
4925	0.1752	Tremor-ataxia-central hypomyelination syndrome	ORPHA:447896
4925	0.1752	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	OMIM:607694
4925	0.1752	Dyskinesia, limb and orofacial, infantile-onset	OMIM:616921
4925	0.1752	Infantile-onset generalized dyskinesia with orofacial involvement	ORPHA:494526
4925	0.1752	Shukla-Vernon syndrome	OMIM:301029
4925	0.1752	Spastic paraplegia 47, autosomal recessive	OMIM:614066
4925	0.1752	Severe intellectual disability and progressive spastic paraplegia	ORPHA:280763
4925	0.1752	Severe intellectual disability and progressive spastic paraplegia	ORPHA:280763
4925	0.1752	Spastic paraplegia 50, autosomal recessive	OMIM:612936
4925	0.1752	Dravet syndrome	ORPHA:33069
4925	0.1752	Dravet syndrome	ORPHA:33069
4925	0.1752	Severe intellectual disability and progressive spastic paraplegia	ORPHA:280763
4925	0.1752	Spastic paraplegia 52, autosomal recessive	OMIM:614067
4925	0.1752	Infantile neuroaxonal dystrophy	ORPHA:35069
4925	0.1752	Leukodystrophy, hypomyelinating, 22	OMIM:619328
4925	0.1752	Turnpenny-Fry syndrome	OMIM:618371
4925	0.1752	Spastic paraplegia 51, autosomal recessive	OMIM:613744
4925	0.1752	Severe intellectual disability and progressive spastic paraplegia	ORPHA:280763
4925	0.1752	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities	OMIM:619121
4925	0.1752	Bilateral perisylvian polymicrogyria	ORPHA:98889
4925	0.1752	Cortical dysplasia, complex, with other brain malformations 7	OMIM:610031
4925	0.1752	Ataxia-telangiectasia-like disorder	ORPHA:251347
4925	0.1752	Angelman syndrome	OMIM:105830
4925	0.1752	Intellectual developmental disorder, X-linked syndromic, Lubs type	OMIM:300260
4925	0.1752	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	OMIM:617807
4925	0.1752	FG syndrome type 1	ORPHA:93932
4925	0.1752	Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia	OMIM:619286
4925	0.1752	Arboleda-Tham syndrome	OMIM:616268
4925	0.1752	Nicolaides-Baraitser syndrome	OMIM:601358
4925	0.1752	Blepharophimosis-impaired intellectual development syndrome	OMIM:619293
4925	0.1752	Intellectual developmental disorder, autosomal recessive 70	OMIM:618402
4925	0.1752	Neurodevelopmental disorder with central hypotonia and dysmorphic facies	OMIM:619797
4925	0.1752	Intellectual developmental disorder, X-linked 30	OMIM:300558
4925	0.1752	den Hoed-de Boer-Voisin syndrome	OMIM:619229
4925	0.1752	Rolandic epilepsy-speech dyspraxia syndrome	ORPHA:163721
4925	0.1752	Rolandic epilepsy	ORPHA:1945
4925	0.1752	Developmental and epileptic encephalopathy 103	OMIM:619913
4925	0.1752	Developmental and epileptic encephalopathy 99	OMIM:619606
4925	0.1752	Dystonia-12	OMIM:128235
4925	0.1752	Rapid-onset dystonia-parkinsonism	ORPHA:71517
4925	0.1752	Developmental and epileptic encephalopathy 46	OMIM:617162
4925	0.1752	Dravet syndrome	ORPHA:33069
4925	0.1752	Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome	ORPHA:500533
4925	0.1752	RIN2 syndrome	ORPHA:217335
4925	0.1752	Troyer syndrome	OMIM:275900
4925	0.1752	Rolandic epilepsy	ORPHA:1945
4925	0.1752	Dravet syndrome	ORPHA:33069
4925	0.1752	Intellectual developmental disorder, X-linked 108	OMIM:301024
4925	0.1752	Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome	ORPHA:477673
4925	0.1752	Neurodevelopmental disorder with microcephaly and spastic paraplegia	OMIM:616281
4925	0.1752	Mowat-Wilson syndrome	OMIM:235730
4925	0.1752	Intellectual developmental disorder, autosomal dominant 43	OMIM:616977
4925	0.1752	Rolandic epilepsy	ORPHA:1945
4925	0.1752	Rolandic epilepsy-speech dyspraxia syndrome	ORPHA:163721
4925	0.1752	Bilateral perisylvian polymicrogyria	ORPHA:98889
4925	0.1752	Pitt-Hopkins-like syndrome 2	OMIM:614325
4925	0.1752	Nizon-Isidor syndrome	OMIM:618872
4925	0.1752	SATB2-associated syndrome due to a chromosomal rearrangement	ORPHA:251028
4925	0.1752	SATB2-associated syndrome due to a pathogenic variant	ORPHA:576283
4925	0.1752	Developmental and epileptic encephalopathy 59	OMIM:617904
4925	0.1752	Pyruvate dehydrogenase E2 deficiency	OMIM:245348
4925	0.1752	Rett syndrome, congenital variant	OMIM:613454
4925	0.1752	Dravet syndrome	ORPHA:33069
4925	0.1752	Amyotrophic lateral sclerosis 2, juvenile	OMIM:205100
4925	0.1752	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	OMIM:616657
4925	0.1752	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures	OMIM:619580
4925	0.1752	Isolated childhood apraxia of speech	ORPHA:209908
4925	0.1752	Branchioskeletogenital syndrome	ORPHA:1299
4925	0.1752	Microcephaly 27, primary, autosomal dominant	OMIM:619180
4925	0.1752	Intellectual developmental disorder, X-linked syndromic 34	OMIM:300967
4925	0.1752	Neurodevelopmental disorder with variable motor and speech impairment	OMIM:617804
4925	0.1752	Arts syndrome	OMIM:301835
4925	0.1752	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia	OMIM:618718
4925	0.1752	Intellectual developmental disorder, X-linked syndromic, Bain type	OMIM:300986
4925	0.1752	Snijders Blok-Fisher syndrome	OMIM:618604
4925	0.1752	Bilateral perisylvian polymicrogyria	ORPHA:98889
4925	0.1752	Acute inflammatory demyelinating polyradiculoneuropathy	ORPHA:98916
4925	0.1752	Intellectual developmental disorder with language impairment with or without autistic features	OMIM:613670
4925	0.1752	Ehlers-Danlos syndrome, dermatosparaxis type	OMIM:225410
4925	0.1752	Intellectual developmental disorder, X-linked 29	OMIM:300419
4925	0.1752	Congenital limbs-face contractures-hypotonia-developmental delay syndrome	ORPHA:562528
4925	0.1752	Congenital contractures of the limbs and face, hypotonia, and developmental delay	OMIM:616266
4925	0.1752	Charcot-Marie-Tooth disease type 4C	ORPHA:99949
4925	0.1752	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	OMIM:618367
4925	0.1752	Microcephaly 16, primary, autosomal recessive	OMIM:616681
4925	0.1752	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	OMIM:618090
4925	0.1752	Intellectual developmental disorder, autosomal recessive 73	OMIM:619717
4925	0.1752	Dravet syndrome	ORPHA:33069
4925	0.1752	Suleiman-El-Hattab syndrome	OMIM:618950
4925	0.1752	Intellectual developmental disorder, X-linked 98	OMIM:300912
4925	0.1752	Intellectual developmental disorder, autosomal dominant 23	OMIM:615761
4925	0.1752	Intellectual developmental disorder, X-linked syndromic, Hedera type	OMIM:300423
4925	0.1752	X-linked intellectual disability, Hedera type	ORPHA:93952
4925	0.1752	Intellectual developmental disorder, autosomal dominant 34	OMIM:616351
4925	0.1752	Intellectual developmental disorder, autosomal dominant 1	OMIM:156200
4925	0.1752	Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features	OMIM:616579
4925	0.1752	Intellectual developmental disorder, X-linked syndromic, Christianson type	OMIM:300243
4925	0.1752	Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures	OMIM:617171
4925	0.1752	Intellectual disability-epilepsy-extrapyramidal syndrome	ORPHA:468620
4925	0.1752	Intellectual developmental disorder, autosomal recessive 69	OMIM:618383
4925	0.1752	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	OMIM:616819
4925	0.1752	Neurodevelopmental disorder with speech impairment and with or without seizures	OMIM:620114
4925	0.1752	Intellectual developmental disorder, autosomal dominant 5	OMIM:612621
4925	0.1752	Wieacker-Wolff syndrome, female-restricted	OMIM:301041
4925	0.1752	Wieacker-Wolff syndrome	OMIM:314580
5032	0.1745	Hijazi-Reis syndrome	OMIM:301094
5032	0.1745	Congenital cataracts, facial dysmorphism, and neuropathy	OMIM:604168
5034	0.1743	Dystonia 30	OMIM:619291
5034	0.1743	Optic nerve hypoplasia and abnormalities of the central nervous system	OMIM:206900
5036	0.1739	Mucolipidosis IV	OMIM:252650
5037	0.1732	?Maple syrup urine disease, mild variant	OMIM:615135
5038	0.173	D-glyceric aciduria	ORPHA:941
5039	0.1725	Dubin-Johnson syndrome	OMIM:237500
5039	0.1725	Cholestasis, benign recurrent intrahepatic, 2	OMIM:605479
5039	0.1725	Arthrogryposis, renal dysfunction, and cholestasis 2	OMIM:613404
5039	0.1725	Peroxisome biogenesis disorder 13A (Zellweger)	OMIM:614887
5039	0.1725	Crigler-Najjar syndrome, type II	OMIM:606785
5039	0.1725	Hyperbilirubinemia, familial transient neonatal	OMIM:237900
5039	0.1725	Crigler-Najjar syndrome, type I	OMIM:218800
5039	0.1725	Isolated polycystic liver disease	ORPHA:2924
5039	0.1725	Lissencephaly due to LIS1 mutation	ORPHA:95232
5039	0.1725	?Combined oxidative phosphorylation deficiency 22	OMIM:616045
5039	0.1725	Hypercholanemia, familial 1	OMIM:607748
5039	0.1725	Isolated polycystic liver disease	ORPHA:2924
5039	0.1725	Congenital disorder of glycosylation, type IIm	OMIM:300896
5039	0.1725	Isolated polycystic liver disease	ORPHA:2924
5039	0.1725	Hyperbilirubinemia, Rotor type, digenic	OMIM:237450
5039	0.1725	Hyperbilirubinemia, Rotor type, digenic	OMIM:237450
5039	0.1725	Bile acid conjugation defect 1	OMIM:619232
5039	0.1725	Lacticacidemia due to PDX1 deficiency	OMIM:245349
5039	0.1725	?Cholestasis, progressive familial intrahepatic, 11	OMIM:619874
5039	0.1725	?Cholestasis, progressive familial intrahepatic, 6	OMIM:619484
5039	0.1725	?Bile acid malabsorption, primary, 2	OMIM:619481
5039	0.1725	Asparagine synthetase deficiency	OMIM:615574
5039	0.1725	Combined oxidative phosphorylation deficiency 20	OMIM:615917
5062	0.172	Auriculocondylar syndrome	ORPHA:137888
5062	0.172	Auriculocondylar syndrome	ORPHA:137888
5062	0.172	Auriculocondylar syndrome	ORPHA:137888
5062	0.172	Orofaciodigital syndrome type 2	ORPHA:2751
5062	0.172	Short-rib thoracic dysplasia 13 with or without polydactyly	OMIM:616300
5062	0.172	Orofaciodigital syndrome V	OMIM:174300
5062	0.172	Orofaciodigital syndrome type 3	ORPHA:2752
5062	0.172	?Short-rib thoracic dysplasia 20 with polydactyly	OMIM:617925
5062	0.172	Congenital heart defects, hamartomas of tongue, and polysyndactyly	OMIM:217085
5062	0.172	Orofaciodigital syndrome type 14	ORPHA:434179
5062	0.172	Orofaciodigital syndrome XIV	OMIM:615948
5062	0.172	Orofaciodigital syndrome IV	OMIM:258860
5062	0.172	Orofaciodigital syndrome XVI	OMIM:617563
5062	0.172	Short-rib thoracic dysplasia 3 with or without polydactyly	OMIM:613091
5076	0.1717	Retinitis pigmentosa 27	OMIM:613750
5076	0.1717	?Retinitis pigmentosa 9	OMIM:180104
5076	0.1717	Retinitis pigmentosa 11	OMIM:600138
5079	0.1711	Piebaldism	OMIM:172800
5079	0.1711	Distal 22q11.2 microdeletion syndrome	ORPHA:261330
5079	0.1711	Gorlin syndrome	ORPHA:377
5079	0.1711	PCNA-related progressive neurodegenerative photosensitivity syndrome	ORPHA:438134
5079	0.1711	Distal 22q11.2 microdeletion syndrome	ORPHA:261330
5079	0.1711	Distal 22q11.2 microdeletion syndrome	ORPHA:261330
5079	0.1711	Multiple self-healing squamous epithelioma, susceptibility to	OMIM:132800
5079	0.1711	Brooke-Spiegler syndrome	OMIM:605041
5079	0.1711	Gorlin syndrome	ORPHA:377
5079	0.1711	Gorlin syndrome	ORPHA:377
5079	0.1711	Codeine sensitivity	OMIM:608902
5079	0.1711	Butyrylcholinesterase deficiency	ORPHA:132
5079	0.1711	UV-sensitive syndrome 1	OMIM:600630
5079	0.1711	UV-sensitive syndrome 1	OMIM:600630
5079	0.1711	Pityriasis rubra pilaris	ORPHA:2897
5094	0.1707	Leukonychia totalis	ORPHA:2387
5095	0.1706	Cholestasis, intrahepatic, of pregnancy, 3	OMIM:614972
5095	0.1706	Microcephaly, short stature, and impaired glucose metabolism 1	OMIM:616033
5095	0.1706	Cholestasis, intrahepatic, of pregnancy, 1	OMIM:147480
5098	0.1701	Erythermalgia, primary	OMIM:133020
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Birdshot chorioretinopathy	ORPHA:179
5098	0.1701	Retinitis pigmentosa 57	OMIM:613582
5098	0.1701	LADD syndrome 1	OMIM:149730
5098	0.1701	Lacrimoauriculodentodigital syndrome	ORPHA:2363
5098	0.1701	Yao syndrome	OMIM:617321
5098	0.1701	Lacrimoauriculodentodigital syndrome	ORPHA:2363
5098	0.1701	Retinitis pigmentosa 83	OMIM:618173
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Prune belly syndrome	OMIM:100100
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Retinitis pigmentosa 78	OMIM:617433
5098	0.1701	Retinitis pigmentosa 78	OMIM:617433
5098	0.1701	LADD syndrome 3	OMIM:620193
5098	0.1701	Aplasia of lacrimal and salivary glands	OMIM:180920
5098	0.1701	Lacrimoauriculodentodigital syndrome	ORPHA:2363
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Kilquist syndrome	OMIM:619080
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Retinitis punctata albescens	ORPHA:52427
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Retinitis pigmentosa 90	OMIM:619007
5098	0.1701	Retinitis punctata albescens	ORPHA:52427
5098	0.1701	Retinitis pigmentosa 13	OMIM:600059
5098	0.1701	Retinitis punctata albescens	ORPHA:52427
5098	0.1701	Retinitis punctata albescens	ORPHA:52427
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Retinitis pigmentosa 42	OMIM:612943
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies	OMIM:618527
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Retinitis pigmentosa 76	OMIM:617123
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	OMIM:614941
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Retinitis pigmentosa 77	OMIM:617304
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Bietti crystalline dystrophy	ORPHA:41751
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	MAGEL2-related Prader-Willi-like syndrome	ORPHA:398069
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	?Congenital disorder of glycosylation, type 1bb	OMIM:613861
5098	0.1701	Retinitis pigmentosa 59	OMIM:613861
5098	0.1701	Retinitis pigmentosa 86	OMIM:618613
5098	0.1701	Retinitis pigmentosa 88	OMIM:618826
5098	0.1701	Microphthalmia, isolated 5	OMIM:611040
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5098	0.1701	Amyotrophic lateral sclerosis	ORPHA:803
5168	0.1698	Currarino syndrome	ORPHA:1552
5168	0.1698	Adenomas, salivary gland pleomorphic, somatic	OMIM:181030
5170	0.1687	Cystathioninuria	ORPHA:212
5170	0.1687	X-linked cerebral adrenoleukodystrophy	ORPHA:139396
5170	0.1687	?Glucocorticoid deficiency 5	OMIM:617825
5173	0.1684	Tricho-dento-osseous syndrome	ORPHA:3352
5174	0.1681	Cushing syndrome, ACTH-independent adrenal, somatic	OMIM:615830
5175	0.1678	Pituitary adenoma 5, multiple types	OMIM:617540
5176	0.1675	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	OMIM:613571
5177	0.1669	Arterial calcification, generalized, of infancy, 2	OMIM:614473
5177	0.1669	Arterial calcification, generalized, of infancy, 1	OMIM:208000
5177	0.1669	Hypophosphatemic rickets, autosomal recessive, 2	OMIM:613312
5177	0.1669	Succinic semialdehyde dehydrogenase deficiency	OMIM:271980
5177	0.1669	Histidinemia	ORPHA:2157
5177	0.1669	Phosphoserine phosphatase deficiency	OMIM:614023
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Craniodiaphyseal dysplasia, autosomal dominant	OMIM:122860
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5183	0.1656	Kallmann syndrome	ORPHA:478
5205	0.1652	Hawkinsinuria	OMIM:140350
5205	0.1652	Tyrosinemia, type III	OMIM:276710
5205	0.1652	Polyposis syndrome, hereditary mixed, 2	OMIM:610069
5205	0.1652	Homocystinuria due to MTHFR deficiency	OMIM:236250
5205	0.1652	Tyrosinemia, type II	OMIM:276600
5210	0.1635	46XX sex reversal 5	OMIM:618901
5210	0.1635	M√ºllerian aplasia and hyperandrogenism	ORPHA:247768
5210	0.1635	Sarcosinemia	ORPHA:3129
5210	0.1635	Osteoporosis-pseudoglioma syndrome	ORPHA:2788
5210	0.1635	Gyrate atrophy of choroid and retina with or without ornithinemia	OMIM:258870
5210	0.1635	Gyrate atrophy of choroid and retina	ORPHA:414
5216	0.1628	Melanoma, cutaneous malignant, 9	OMIM:615134
5216	0.1628	Progressive osseous heteroplasia	ORPHA:2762
5216	0.1628	Melanoma, cutaneous malignant, susceptibility to, 10	OMIM:615848
5216	0.1628	Acromesomelic dysplasia, Grebe type	ORPHA:2098
5216	0.1628	Xeroderma pigmentosum, group D	OMIM:278730
5216	0.1628	Acromesomelic dysplasia, Grebe type	ORPHA:2098
5216	0.1628	?De Sanctis-Cacchione syndrome	OMIM:278800
5216	0.1628	?De Sanctis-Cacchione syndrome	OMIM:278800
5224	0.1623	Acromesomelic dysplasia 3	OMIM:609441
5224	0.1623	Perrault syndrome 3	OMIM:614129
5224	0.1623	Ovarian dysgenesis 3	OMIM:614324
5224	0.1623	Premature ovarian failure 20	OMIM:619938
5224	0.1623	46XY sex reversal 3	OMIM:612965
5224	0.1623	Premature ovarian failure 7	OMIM:612964
5224	0.1623	?Precocious puberty, central, 1	OMIM:176400
5224	0.1623	?Premature ovarian failure 2A	OMIM:300511
5224	0.1623	46XX sex reversal 1	OMIM:400045
5224	0.1623	Premature ovarian failure 9	OMIM:615724
5224	0.1623	Premature ovarian failure 6	OMIM:612310
5224	0.1623	?Premature ovarian failure 10	OMIM:612885
5236	0.1619	Global developmental delay, progressive ataxia, and elevated glutamine	OMIM:618412
5236	0.1619	Leber congenital amaurosis 1	OMIM:204000
5236	0.1619	Glycine encephalopathy1	OMIM:605899
5236	0.1619	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	OMIM:614299
5236	0.1619	Multiple mitochondrial dysfunctions syndrome 3	OMIM:615330
5236	0.1619	Hyperprolinemia, type II	OMIM:239510
5236	0.1619	Schizophrenia, susceptibility to, 4	OMIM:600850
5236	0.1619	Hyperprolinemia type 1	ORPHA:419
5236	0.1619	Hyperprolinemia, type I	OMIM:239500
5245	0.1603	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	OMIM:250850
5245	0.1603	Autosomal dominant popliteal pterygium syndrome	ORPHA:1300
5245	0.1603	?Developmental and epileptic encephalopathy 88	OMIM:618959
5245	0.1603	Glycine N-methyltransferase deficiency	OMIM:606664
5245	0.1603	Peroxisome biogenesis disorder 2B	OMIM:202370
5245	0.1603	Peroxisome biogenesis disorder 1A (Zellweger)	OMIM:214100
5245	0.1603	Glycine encephalopathy 2	OMIM:620398
5245	0.1603	Adrenoleukodystrophy	OMIM:300100
5253	0.1601	?Charcot-Marie-Tooth disease, recessive intermediate, B	OMIM:613641
5253	0.1601	Autosomal dominant epidermolytic ichthyosis	ORPHA:312
5253	0.1601	Autosomal dominant epidermolytic ichthyosis	ORPHA:312
5256	0.159	Terminal osseous dysplasia-pigmentary defects syndrome	ORPHA:88630
5256	0.159	Colorectal cancer, susceptibility to, 12	OMIM:615083
5256	0.159	Neuroepithelioma	OMIM:612219
5256	0.159	Histiocytoma, angiomatoid fibrous, somatic	OMIM:612160
5260	0.1573	MUTYH-related attenuated familial adenomatous polyposis	ORPHA:247798
5261	0.1572	Pigmented nodular adrenocortical disease, primary, 3	OMIM:614190
5261	0.1572	Periodic fever, menstrual cycle dependent	OMIM:614674
5263	0.1567	Otodental syndrome	ORPHA:2791
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Leydig cell hypoplasia with pseudohermaphroditism	OMIM:238320
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Peroxisome biogenesis disorder 6B	OMIM:614871
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Ovarian dysgenesis 1	OMIM:233300
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Refsum disease	OMIM:266500
5264	0.1557	Blepharophimosis, epicanthus inversus, and ptosis, type 2	OMIM:110100
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Perrault syndrome 1	OMIM:233400
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Peroxisome biogenesis disorder 5B	OMIM:614867
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Peroxisome biogenesis disorder 9B	OMIM:614879
5264	0.1557	Rhizomelic chondrodysplasia punctata, type 1	OMIM:215100
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Peroxisome biogenesis disorder 8B	OMIM:614877
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Premature ovarian failure 1	OMIM:311360
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Alpha-methylacyl-CoA racemase deficiency	OMIM:614307
5264	0.1557	Infantile Refsum disease	ORPHA:772
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5264	0.1557	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
5323	0.1556	Alveolar soft-part sarcoma	OMIM:606243
5323	0.1556	?Sarcoma, synovial	OMIM:300813
5325	0.155	Monosomy 13q14	ORPHA:1587
5325	0.155	Frontorhiny	ORPHA:391474
5325	0.155	Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome	ORPHA:306542
5328	0.1529	Wiedemann-Steiner syndrome	ORPHA:319182
5328	0.1529	Mosaic variegated aneuploidy syndrome 2	OMIM:614114
5328	0.1529	Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome	ORPHA:280679
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities	OMIM:618922
5328	0.1529	Obesity, morbid, due to leptin receptor deficiency	OMIM:614963
5328	0.1529	Witteveen-Kolk syndrome	OMIM:613406
5328	0.1529	15q24 microdeletion syndrome	ORPHA:94065
5328	0.1529	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	OMIM:613743
5328	0.1529	Growth hormone insensitivity with immune dysregulation 1, autosomal recessive	OMIM:245590
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Hyperaldosteronism, familial, type IV	OMIM:617027
5328	0.1529	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	OMIM:617260
5328	0.1529	Axenfeld-Rieger syndrome, type 1	OMIM:180500
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Holoprosencephaly 9	OMIM:610829
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Single median maxillary central incisor	OMIM:147250
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Oliver-McFarlane syndrome	OMIM:275400
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Meier-Gorlin syndrome 6	OMIM:616835
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Growth hormone deficiency, isolated partial	OMIM:615925
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome	ORPHA:231720
5328	0.1529	Pituitary hormone deficiency, combined, 3	OMIM:221750
5328	0.1529	Andersen-Tawil syndrome	ORPHA:37553
5328	0.1529	Andersen-Tawil syndrome	ORPHA:37553
5328	0.1529	Prader-Willi syndrome due to translocation	ORPHA:177907
5328	0.1529	Intellectual developmental disorder, X-linked, with isolated growth hormone deficiency	OMIM:300123
5328	0.1529	Juberg-Hayward syndrome	OMIM:216100
5328	0.1529	X-linked intellectual disability-short stature-overweight syndrome	ORPHA:457240
5328	0.1529	Xq21 microdeletion syndrome	ORPHA:1435
5328	0.1529	Premature ovarian failure 11	OMIM:616946
5328	0.1529	Premature ovarian failure 11	OMIM:616946
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Short stature, oligodontia, dysmorphic facies, and motor delay	OMIM:619234
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Pituitary hormone deficiency, combined, 5	OMIM:182230
5328	0.1529	Pituitary hormone deficiency, combined or isolated, 7	OMIM:618160
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
5328	0.1529	Helsmoortel-van der Aa syndrome	OMIM:615873
5328	0.1529	Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism	OMIM:615866
5328	0.1529	Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1	OMIM:213980
5328	0.1529	Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies	OMIM:615286
5328	0.1529	Ritscher-Schinzel syndrome 1	OMIM:220210
5328	0.1529	?Premature ovarian failure 13	OMIM:617442
5328	0.1529	Semilobar holoprosencephaly	ORPHA:220386
5328	0.1529	Lobar holoprosencephaly	ORPHA:93924
5328	0.1529	Myasthenic syndrome, congenital, 22	OMIM:616224
5328	0.1529	Spermatogenic failure 75	OMIM:619949
5328	0.1529	Joubert syndrome 26	OMIM:616784
5328	0.1529	Alobar holoprosencephaly	ORPHA:93925
5328	0.1529	TBCK-related intellectual disability syndrome	ORPHA:488632
5435	0.1523	Terminal osseous dysplasia	OMIM:300244
5436	0.1486	?Fibromatosis, gingival, 1	OMIM:135300
5436	0.1486	Hereditary gingival fibromatosis	ORPHA:2024
5436	0.1486	Fibromatosis, gingival, 5	OMIM:617626
5436	0.1486	Hereditary gingival fibromatosis	ORPHA:2024
5436	0.1486	Desmosterolosis	OMIM:602398
5436	0.1486	Ramon syndrome	ORPHA:3019
5436	0.1486	Hyaline fibromatosis syndrome	OMIM:228600
5436	0.1486	Juvenile hyaline fibromatosis	ORPHA:2028
5436	0.1486	Lethal osteosclerotic bone dysplasia	ORPHA:1832
5436	0.1486	Gingival fibromatosis-hypertrichosis syndrome	ORPHA:2026
5436	0.1486	?Hypertrichosis, congenital generalized, with gingival hyperplasia	OMIM:135400
5436	0.1486	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	OMIM:204690
5448	0.1387	Ichthyosis, X-linked	OMIM:308100
